Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3020630	s-prot	g/l (g/l)	32015	85310	0.01%
3020630	s-prot	— (—)	4453	6275	100.00%	Distribution not available
3020630	s-prot	g/l_______ (g/l)	829	2215	0.00%
3020630	s-prot	g/L (g/l)	29	38	0.00%
3020630	s-prot	G/L (g/l)	26	39	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of mineral metabolism

985

2751

4.47

322.40

4.0

2.7

65.38

66.63

g/l

4.38

910

2518

Disorders of other endocrine glands

3270

16069

2.16

320.47

2.7

2.6

65.84

66.35

g/l

3.49

3003

14682

Diverticular disease of intestine

5327

18876

1.86

319.78

2.8

2.7

66.08

66.48

g/l

3.20

4890

17322

Disorders of calcium metabolism

832

2090

5.23

319.49

4.3

2.7

65.16

66.60

g/l

4.70

768

1922

Other dorsopathies, not elsewhere classified

6364

19496

1.77

317.60

2.6

2.5

66.76

66.30

g/l

4.72

5834

17953

Symptoms and signs involving the urinary system

5615

24804

1.81

316.75

2.6

2.7

66.02

66.36

g/l

2.64

5090

22748

Any event in cancer register

5715

19314

1.81

314.45

3.9

1.8

65.78

66.98

g/l

23.90

5358

17686

Dermatitis

4580

25099

1.89

314.41

2.6

2.7

66.65

66.30

g/l

2.36

4268

23014

Certain infectious and parasitic diseases, including avohilmo

4447

11786

1.98

311.96

2.8

2.2

66.04

67.20

g/l

17.07

4124

10769

Depression medications

1133

1442

4.13

311.29

2.1

1.3

67.45

68.74

g/l

5.71

1069

1353

Purpura and other haemorrhagic conditions

1362

4727

3.41

310.85

3.1

2.7

65.45

66.28

g/l

3.01

1290

4321

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

5861

25229

2.21

307.65

2.7

65.95

66.35

g/l

3.26

5442

23038

Heart failure, not strict

8008

18185

3.43

307.65

2.8

2.7

64.74

67.19

g/l

115.24

7466

16650

Renal failure

7641

16760

5.09

307.65

3.0

2.6

64.89

66.34

g/l

37.77

7179

15077

Hypertensive heart and/or renal disease

2454

7171

2.82

307.65

2.5

2.8

65.41

66.09

g/l

3.63

2258

6454

Diabetes mellitus

6639

22645

1.77

307.65

2.4

2.8

66.43

g/l

0.01

6117

20800

Diseases of arteries, arterioles and capillaries

5421

22204

1.92

307.65

2.3

2.8

65.36

66.35

g/l

16.04

4952

20259

Other specific joint derangements/joint disorders

4566

15265

1.95

307.65

2.4

2.7

67.08

66.30

g/l

9.58

4210

14118

Other heart diseases, wide

6127

18224

2.15

307.65

2.6

65.94

67.17

g/l

26.61

5717

16815

Non-rheumatic valve diseases

3804

12362

2.40

307.65

2.7

2.8

65.58

66.89

g/l

19.21

3517

11273

Cerebrovascular diseases (FINNGEN)

2181

4925

3.40

307.65

2.2

2.7

65.99

67.68

g/l

17.13

2035

4529

Fever of other and unknown origin

5836

15567

3.69

307.65

4.2

2.4

65.23

66.93

g/l

42.89

5469

14229

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

8379

24295

2.49

307.65

3.3

2.4

64.92

67.10

g/l

102.47

7808

22294

Type 2 diabetes

6470

22219

1.76

307.65

2.3

2.8

66.49

66.41

g/l

0.30

5954

20391

Liquid cancers

4494

10600

5.29

307.65

8.4

1.7

65.97

66.61

g/l

4.58

4317

9547

Condition for Implicit Sepsis (Organ dysfunction codes)

7574

22077

2.60

307.65

2.7

2.5

65.12

67.00

g/l

67.56

7002

20237

Bacterial Sepsis

5381

16228

3.17

307.65

3.2

2.5

64.26

66.74

g/l

76.98

4951

14752

Medical observation and evaluation for suspected diseases and conditions

4375

10829

2.18

307.65

2.6

2.4

66.61

66.40

g/l

0.85

3981

9998

Certain infectious and parasitic diseases

6478

16404

2.08

307.65

2.9

2.2

65.83

67.23

g/l

33.56

6016

15004

Implicit Sepsis

7441

21609

2.83

307.65

2.8

2.5

64.85

66.94

g/l

80.58

6842

19783

Hypertensive diseases (excluding secondary)

3220

6380

3.15

307.65

2.7

2.5

66.53

67.79

g/l

14.34

3041

5896

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

11277

22547

3.90

307.65

3.0

2.5

65.68

66.76

g/l

31.96

10514

20579

Implicit bacterial Sepsis, including avohilmo

5208

16000

3.14

307.65

3.0

2.5

64.20

66.72

g/l

79.08

4782

14534

Polyneuropathies and other disorders of the peripheral nervous system

3308

8751

5.10

307.65

2.6

2.7

67.03

65.98

g/l

12.81

3093

7950

Hypothyroidism and >3 levothyroxin purchases

1120

1392

4.76

307.65

2.9

1.3

66.65

68.63

g/l

11.48

1053

1304

Erysipelas

4615

18956

2.28

307.65

2.6

2.4

65.36

66.89

g/l

30.86

4245

17275

General symptoms and signs

8073

17063

2.54

307.65

2.8

2.4

66.14

67.02

g/l

16.94

7526

15630

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1432

2879

7.89

307.65

3.7

2.6

68.85

65.95

g/l

27.28

1325

2601

Asthma (mode)

4820

12108

2.20

307.65

2.4

2.3

66.43

67.40

g/l

14.05

4476

11057

Hypertensive diseases

5084

13698

2.22

307.65

2.6

2.7

66.33

66.77

g/l

3.32

4769

12579

Abnormalities of breathing

6410

17422

2.24

307.65

2.6

65.99

66.67

g/l

8.98

5924

16057

Anaemias

2185

1368

11.95

307.65

3.0

1.4

65.86

68.57

g/l

27.44

2074

1282

Implicit viral Sepsis

2144

7737

3.21

307.65

3.7

2.4

64.25

66.56

g/l

29.64

2002

6987

Pneumonias (Asthma/COPD co-morbidities)

8489

24028

2.50

307.65

3.3

2.3

64.89

67.16

g/l

111.68

7925

22039

Septicaemia

4423

15377

2.99

307.65

3.6

2.4

64.39

66.74

g/l

55.86

4085

13932

Complications of surgical and medical care, not elsewhere classified

7499

27367

1.94

307.65

2.7

2.6

65.79

66.55

g/l

12.98

6901

25109

Nutritional anaemias

4734

20343

2.46

307.65

2.4

2.7

65.54

66.24

g/l

7.18

4309

18495

Explicit Sepsis

4532

15995

2.93

307.65

3.6

2.5

64.39

66.76

g/l

58.71

4189

14547

Other systemic involvement of connective tissue

2933

10487

3.28

307.65

2.2

2.7

67.16

66.08

g/l

10.92

2699

9502

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

7579

21698

2.56

307.65

2.7

2.5

65.31

67.08

g/l

60.80

7014

19928

Abnormal findings on diagnostic imaging of lung

4210

20711

2.10

307.65

2.7

65.85

66.23

g/l

2.28

3897

18859

Other CVD (FINNGEN)

1095

2255

4.34

307.65

3.1

2.7

64.99

67.21

g/l

14.58

997

2027

Bacterial infection, other or unspecified, including avohilmo

6635

18746

3.36

307.65

3.6

2.4

64.44

66.88

g/l

94.21

6150

17044

Atrial fibrillation and flutter

2099

4650

3.17

307.65

2.8

2.7

65.62

67.63

g/l

22.48

1975

4267

Aplastic and other anaemias

6477

17773

4.13

307.65

3.1

2.6

65.39

66.22

g/l

11.62

5989

16054

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2401

6044

2.65

307.65

2.8

2.6

66.21

67.76

g/l

16.05

2258

5574

Complications of medical and surgical care

5520

27776

1.90

307.65

2.7

2.6

65.69

66.47

g/l

10.58

5089

25457

Asthma (only as main-diagnosis)

4496

11997

2.21

307.65

2.3

66.21

67.40

g/l

19.83

4150

10953

ILD differential diagnosis

4884

12108

2.12

307.65

2.8

2.3

66.13

67.40

g/l

22.06

4562

11057

Persons encountering health services for specific procedures and health care

8121

23173

2.21

307.65

3.1

2.4

65.46

67.01

g/l

52.64

7605

21162

Unspecified kidney failure

1515

3710

5.48

307.65

3.2

2.4

64.49

66.00

g/l

8.99

1424

3306

Care involving dialysis

1284

2532

7.53

307.65

3.4

2.5

62.79

66.77

g/l

50.66

1234

2307

Asthma

4923

11997

2.23

307.65

2.3

66.36

67.40

g/l

16.36

4572

10953

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

6963

23687

1.96

307.65

3.1

2.5

65.66

66.73

g/l

23.09

6454

21810

Implicit bacterial Sepsis

4807

15106

3.18

307.65

3.1

2.5

64.07

66.70

g/l

78.48

4413

13704

Glomerular disorders in diseases classified elsewhere

1709

4057

5.82

307.65

3.6

2.6

64.41

66.47

g/l

17.60

1627

3713

Other and unspecified iron deficiency

3378

13794

2.77

307.65

2.3

2.6

65.73

66.21

g/l

2.80

3073

12484

Other diseases of blood and blood-forming organs, wide

2221

8252

3.15

307.65

3.6

2.7

65.53

66.41

g/l

5.25

2095

7553

Coagulation defects, purpura and other haemorrhagic conditions

1810

6925

3.00

307.65

3.0

2.6

65.51

66.36

g/l

4.20

1712

6324

Malignant neoplasm

5736

17839

1.99

307.65

4.3

1.6

65.83

66.96

g/l

20.66

5394

16290

Diabetic nephropathy, excluding more controls

1669

4573

3.64

307.65

2.7

2.4

65.11

66.79

g/l

13.73

1580

4139

Rheumatoid arthritis

2586

10082

2.49

307.65

2.0

2.9

66.05

g/l

0.00

2425

9220

Covid-19 confirmed case

3450

15614

2.46

307.65

3.4

2.5

64.63

66.30

g/l

28.32

3220

14186

Other specified/unspecified arthritis

2312

9072

2.84

307.65

2.5

2.9

66.75

66.12

g/l

3.66

2159

8373

Hypertension

5075

13697

2.21

307.65

2.6

2.7

66.33

66.77

g/l

3.37

4761

12578

L04AX Other immunosuppressants

5169

20613

2.80

307.65

5.8

2.1

66.23

66.52

g/l

1.81

4895

18944

Reimbursement for rheumatic diseases

4606

22002

2.26

307.65

2.0

2.8

66.67

66.32

g/l

2.17

4323

20061

COPD differential diagnosis

4890

12112

2.13

307.65

2.8

2.3

66.13

67.40

g/l

22.08

4568

11061

7477

18711

2.53

307.65

3.3

2.2

64.95

67.13

g/l

88.99

6991

17148

Any death

5040

19768

1.92

307.65

3.3

2.7

63.82

66.95

g/l

112.06

4669

18132

Other pleural conditions

1549

3873

5.52

307.65

2.8

2.7

63.36

66.19

g/l

31.42

1479

3468

ILD medications

10017

20373

2.90

307.65

3.4

2.0

66.04

66.80

g/l

14.86

9324

18557

Caries of dentine

2105

7254

3.17

307.65

4.3

2.4

64.48

66.40

g/l

19.60

1980

6692

Insulin medication

4533

20474

1.96

307.65

2.6

2.8

65.73

66.19

g/l

3.39

4204

18760

Other and unspecified polyneuropathies, also in other diseases

3047

7703

5.51

307.65

2.4

2.7

67.15

65.93

g/l

15.61

2845

6993

Dental caries

2330

8072

3.07

307.65

4.3

2.4

64.55

66.39

g/l

20.13

2196

7442

Autoimmune diseases related-to ILD

6393

27907

2.04

307.65

2.3

2.7

66.77

66.35

g/l

3.99

5958

25546

Pneumonia, organism unspecified

8012

22948

2.62

307.65

3.3

2.3

64.87

67.14

g/l

105.65

7460

21030

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

989

1346

6.02

307.65

2.3

3.2

66.03

65.50

g/l

0.90

945

1242

ILD medications: prednisolone, methylprednisolone, prednisone

9709

20265

2.92

307.65

2.6

2.0

65.96

66.79

g/l

17.32

9007

18451

Heart failure and antihypertensive medication

2599

4150

4.82

307.65

2.6

3.1

64.53

66.71

g/l

26.85

2456

3805

Inflammatory bowel disease treatment related agents

9741

22873

2.56

307.65

2.4

2.7

66.09

66.66

g/l

8.84

9057

20898

All-cause Heart Failure

6030

17674

2.71

307.65

2.5

2.8

64.64

66.54

g/l

55.09

5584

16017

Cardiovascular diseases

2976

6045

2.74

307.65

2.5

2.4

66.83

67.88

g/l

9.16

2812

5617

Infections, IBD-co-morbidities

1395

1669

6.75

307.65

4.3

3.1

64.48

65.78

g/l

4.86

1298

1553

ILD medications: immunosuppressive drugs

6767

18242

3.86

307.65

5.1

2.0

65.84

66.87

g/l

20.08

6435

16689

Hypothyroidism, levothyroxine purchases

1120

1392

4.76

307.65

2.9

1.3

66.65

68.63

g/l

11.48

1053

1304

All chronic kidney diseases

7804

16044

4.81

307.65

2.9

2.6

65.15

66.71

g/l

44.56

7335

14555

Acute tubulo-interstitial nephritis

4974

19402

2.34

307.65

2.7

2.6

65.15

66.73

g/l

33.56

4529

17622

Hypothyroidism (congenital or acquired)

1141

1398

4.83

307.65

3.0

1.3

66.50

68.64

g/l

13.27

1073

1310

Polymyalgia rheumatica

1626

5628

3.59

307.65

2.2

2.7

65.89

65.82

g/l

0.14

1484

5039

GASTRO-related operations

5072

9695

2.78

307.65

2.7

2.0

66.14

67.63

g/l

29.07

4705

8851

Chronic kidney disease

5615

12463

6.03

307.65

2.8

2.5

65.33

66.18

g/l

11.00

5285

11145

Dialysis

602

1026

8.86

307.65

4.0

2.7

62.69

66.92

g/l

27.55

586

956

Glomerular diseases

2467

6462

5.00

307.65

3.5

2.7

63.74

66.48

g/l

40.65

2360

5928

Glomerulonephritis

1094

3225

4.22

307.65

3.3

2.8

62.44

66.52

g/l

36.18

1057

2974

Used for control exclusion in common control thyroid runs

7155

19334

1.96

307.65

2.5

2.8

66.38

66.44

g/l

0.26

6663

17672

Gout, FINNGEN

3078

12578

2.81

307.65

3.6

2.7

65.47

66.02

g/l

3.41

2876

11388

Gout, idiopatic and unspecified

2490

11314

2.52

307.65

2.4

2.7

65.51

66.06

g/l

2.98

2318

10308

Any gastric operation

5072

9695

2.78

307.65

2.7

2.0

66.14

67.63

g/l

29.07

4705

8851

Pleural effusion

2688

6153

6.36

307.65

2.5

2.6

63.94

66.22

g/l

35.49

2598

5535

Endocrine, nutritional and metabolic diseases

4461

11499

2.04

307.65

2.7

66.33

66.96

g/l

5.60

4162

10607

Other anaemias

6094

16998

4.18

307.65

3.0

2.6

65.48

66.17

g/l

7.94

5624

15334

Diabetes, varying definitions

6616

22641

1.77

307.65

2.4

2.8

66.43

g/l

0.02

6093

20795

Dialysis, with operation codes

1941

3932

7.05

307.65

4.2

2.6

62.81

66.67

g/l

65.96

1868

3584

Erysipelas, including avohilmo

6024

20514

2.36

307.65

2.5

2.4

65.58

67.01

g/l

34.70

5545

18728

Atrial fibrillation and flutter with reimbursement

1817

3959

3.18

307.65

2.8

65.67

67.49

g/l

16.43

1705

3612

Heart failure, strict

6171

17888

2.74

307.65

2.5

2.8

64.60

66.54

g/l

58.66

5719

16220

Secondary hypertension

893

1629

6.76

307.65

3.6

2.6

64.67

67.29

g/l

15.51

854

1476

Explicit Sepsis, including avohilmo

4616

16201

2.93

307.65

3.6

2.5

64.40

66.76

g/l

59.28

4268

14742

Hypertension, essential

5075

13535

2.25

307.65

2.6

2.7

66.41

66.78

g/l

2.61

4752

12427

Dyspnoea

7644

26194

2.28

307.65

2.7

2.6

65.76

66.56

g/l

14.79

7052

24014

Heart failure,strict

5649

14187

3.23

307.65

2.5

2.8

64.60

67.00

g/l

79.45

5256

12887

Acute renal failure

3144

8534

4.76

307.65

3.3

2.5

63.36

66.26

g/l

56.40

2976

7651

Heart failure and coronary heart disease

4176

13693

2.40

307.65

2.4

2.8

64.63

66.15

g/l

26.11

3870

12330

Examination and observation for other reasons

4390

10717

2.48

307.65

2.8

2.5

66.25

66.42

g/l

0.66

4058

9915

Viral Sepsis

2149

7746

3.22

307.65

3.7

2.4

64.27

66.57

g/l

29.40

2007

6996

Implicit viral Sepsis, including avohilmo

3025

11711

2.94

307.65

3.3

2.5

64.61

66.66

g/l

34.42

2809

10612

Other medical care

4675

16953

2.58

307.65

3.8

2.5

64.56

66.69

g/l

54.70

4391

15317

Extracorporeal dialysis

886

2024

6.32

307.65

3.6

2.8

62.13

66.51

g/l

43.06

852

1884

Low back pain

5646

19221

2.11

307.65

2.7

2.6

66.47

66.29

g/l

1.01

5147

17713

Pain in limb

6476

19485

2.26

307.65

2.5

2.7

66.17

66.43

g/l

1.88

5963

17868

Malaise and fatigue

4891

14035

3.05

307.65

2.5

65.32

66.82

g/l

29.48

4464

12776

Excluding asthma or asthma-COPD overlap

4938

12110

2.15

307.65

2.8

2.3

66.15

67.39

g/l

21.17

4610

11056

All kidney diseases

9846

22356

3.31

307.65

2.8

2.5

65.30

67.02

g/l

71.50

9187

20449

Codeine or tramadol medication

7853

24445

1.83

307.65

2.5

2.7

66.46

66.43

g/l

0.14

7229

22456

Other disorders of fluid, electrolyte and acid-base balance

3250

12005

2.92

307.65

2.8

2.6

64.57

66.43

g/l

29.19

2986

10837

Pure hypercholesterolaemia

5336

19222

1.86

307.65

2.6

65.95

66.69

g/l

9.74

4936

17551

All pneumoniae

8502

24074

2.49

307.65

3.4

2.4

64.89

67.15

g/l

110.66

7941

22082

Non-ischemic cardiomyopathy

3108

10262

2.74

307.65

2.6

2.8

64.38

66.54

g/l

36.37

2871

9228

Valvular heart disease excluding rheumatic fever

3831

12408

2.41

307.65

2.7

2.8

65.53

66.88

g/l

20.28

3544

11316

Dorsalgia

6594

19476

1.88

307.65

2.6

2.5

66.73

66.30

g/l

4.35

6045

17933

Other diseases of pleura

5282

17218

3.14

307.65

2.5

2.7

64.38

66.39

g/l

56.25

4964

15593

Polyarthropathies

6312

15007

3.00

307.65

2.8

66.27

66.21

g/l

0.22

5913

13817

Lower back pain or/and sciatica

7457

27782

1.75

307.65

2.7

2.6

66.56

66.39

g/l

1.19

6809

25575

Metabolic disorders

7309

21147

2.22

307.65

2.8

2.6

65.87

66.79

g/l

18.14

6774

19364

Other bacterial diseases, including avohilmo

9109

22380

2.79

307.65

3.2

2.4

65.22

67.11

g/l

79.65

8498

20488

Other soft tissue disorders, not elsewhere classified

7069

19701

2.18

307.65

2.6

2.7

66.37

66.44

g/l

0.26

6556

18063

Heart failure and bmi 25plus

3344

9111

2.79

307.65

2.5

3.0

65.09

66.77

g/l

25.70

3082

8227

Renal tubulo-interstitial diseases

9615

22670

3.57

307.65

2.9

2.6

65.16

66.89

g/l

70.36

8942

20719

Provisional assignment of new diseases of uncertain etiology

4309

20911

2.21

307.65

3.2

2.5

65.08

66.50

g/l

26.41

4033

19101

Codes for special purposes

4313

20941

2.21

307.65

3.3

2.5

65.09

66.50

g/l

26.45

4036

19129

Transplanted organ and tissue status

1433

2902

6.92

307.65

6.7

2.6

63.54

66.80

g/l

37.14

1386

2676

Other heart diseases

3094

6384

3.41

307.65

2.7

2.5

65.66

67.77

g/l

35.79

2921

5902

Multiple myeloma, including Hilmo

1262

1478

25.26

307.65

22.4

1.6

67.16

66.47

g/l

1.40

1239

1332

Cardiac arrhythmias

3498

10182

2.32

307.65

2.7

2.8

66.37

67.34

g/l

10.40

3266

9447

Disorders of thyroid, IBD co-morbidities

1024

1763

4.28

307.65

2.3

3.0

65.88

65.82

g/l

0.08

948

1642

Malignant neoplasm, including Hilmo

5782

17939

1.98

307.65

4.1

1.6

65.89

66.96

g/l

19.12

5432

16386

COPD/asthma/ILD related infections

6653

18711

1.87

307.65

3.2

2.2

65.62

67.13

g/l

40.90

6177

17148

Other bacterial diseases

9114

23086

2.91

307.65

3.3

2.4

64.98

67.06

g/l

93.58

8485

21130

Other diseases of intestines

6775

22034

1.79

307.65

2.7

2.6

66.26

66.63

g/l

3.42

6242

20324

Influenza and pneumonia

8629

23510

2.45

307.65

3.4

2.3

65.02

67.17

g/l

101.47

8070

21564

Autoimmune diseases

7718

21019

1.96

307.65

2.5

2.7

66.44

66.41

g/l

0.13

7189

19224

Asthma, unspecified (mode), excluding more controls

3885

10176

2.96

307.65

2.4

66.07

67.68

g/l

30.75

3592

9291

Malignant neoplasm, wide definition

5776

18044

1.97

307.65

4.1

1.6

65.90

66.96

g/l

18.83

5432

16476

Autoimmune diseases excluding thyroid diseases

8178

20943

2.26

307.65

2.4

2.7

66.49

66.41

g/l

0.40

7658

19154

Bacterial infection, other or unspecified

6219

17966

3.41

307.65

3.7

2.4

64.32

66.82

g/l

92.67

5757

16317

Diseases of oesophagus, stomach and duodenum

7570

25078

1.88

307.65

2.5

2.7

66.18

66.52

g/l

3.21

6960

23078

Autoimmune diseases excluding thyroid diseases, strict definition

7899

20286

2.26

307.65

2.4

2.7

66.50

66.43

g/l

0.31

7394

18543

Abnormal findings on examination of blood, without diagnosis

4472

18345

2.47

307.65

3.1

2.6

66.70

66.18

g/l

3.93

4174

16832

Cardiovascular diseases (excluding rheumatic etc)

3419

7364

2.80

307.65

2.6

2.4

66.59

67.83

g/l

14.82

3234

6828

Osteopathies and chondropathies

5482

20515

2.74

307.65

3.3

2.6

65.94

66.40

g/l

4.19

4945

18801

Asthma (only as main-diagnosis), excluding more controls

4287

10468

2.39

307.65

2.3

66.29

67.70

g/l

26.19

3966

9566

Systemic connective tissue disorders

3870

13607

3.35

307.65

2.2

2.7

66.44

66.16

g/l

1.30

3568

12315

Any reimbursement code in KELA

2898

5583

2.72

307.65

2.8

1.6

66.85

67.92

g/l

9.52

2734

5099

Asthma, excluding more controls

4672

10468

2.43

307.65

2.3

66.46

67.70

g/l

21.80

4343

9566

Osteoporosis

3217

10193

3.51

307.65

2.7

2.5

65.82

66.00

g/l

0.59

2837

9156

Other septicaemia, including avohilmo

4001

14502

2.95

307.65

3.4

2.4

64.16

66.69

g/l

58.67

3690

13119

Complications of procedures, not elsewhere classified

5719

26817

1.81

307.65

2.6

65.90

66.54

g/l

7.61

5274

24604

Spondylopathies

5834

18304

2.00

307.65

2.8

2.6

66.60

66.21

g/l

3.31

5359

16811

Osteoporosis with pathological fracture (FG)

981

2374

5.54

307.65

2.3

2.9

65.78

65.41

g/l

0.65

848

2095

Syncope and collapse

3298

13143

2.24

307.65

2.5

65.79

66.79

g/l

10.34

2984

11950

Pain in throat and chest

5464

17270

1.96

307.65

2.6

66.45

66.67

g/l

1.30

5019

15915

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1855

3081

3.17

307.65

2.7

2.3

66.81

67.26

g/l

1.41

1738

2831

Headache

4453

15555

2.35

307.65

2.3

2.4

66.72

67.02

g/l

1.94

4135

14256

First line medication for Crohn's disease

9404

19637

2.80

307.65

3.5

1.9

65.90

66.94

g/l

26.10

8775

17862

Other systemic involvement of connective tissue (FG)

2888

8371

4.03

307.65

2.1

2.9

67.15

66.01

g/l

11.32

2656

7579

Finngen Rheumatological endpoints

6563

18522

2.13

307.65

2.4

2.7

66.91

66.38

g/l

5.85

6057

17066

Symptoms and signs involving the circulatory and respiratory systems

6079

17436

1.82

307.65

2.6

66.44

66.67

g/l

1.40

5642

16071

Malignant neoplasm

5739

17876

1.99

307.65

4.3

1.6

65.84

66.96

g/l

20.39

5400

16320

Symptoms and signs involving cognition, perception, emotional state and behaviour

6631

26617

1.74

307.65

2.3

2.7

66.29

66.46

g/l

1.00

6039

24568

Pain in joint

3921

12165

2.09

307.65

2.4

2.6

67.17

66.38

g/l

8.09

3600

11208

Pain, not elsewhere classified

2143

8305

2.82

307.65

2.8

2.4

66.17

66.93

g/l

4.47

1985

7585

Enlarged lymph nodes

1402

4422

3.62

307.65

2.6

2.5

66.44

66.93

g/l

1.34

1334

4043

Multiple myeloma

822

892

31.65

307.65

24.7

1.6

67.10

66.77

g/l

0.35

807

800

Liquid cancers, including Hilmo

5028

12059

4.65

307.65

7.9

1.6

65.94

66.66

g/l

6.31

4824

10871

L04AD Calcineurin inhibitors

1353

3073

5.77

307.65

3.7

2.9

63.56

66.97

g/l

36.69

1308

2865

Oxycodone

4071

12750

3.11

307.65

4.9

2.4

64.98

66.38

g/l

21.30

3725

11653

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1571

1564

46.48

307.65

9.6

1.4

69.27

66.34

g/l

27.87

1500

1408

Multiple myeloma and malignant plasma cell neoplasms

1292

1795

20.46

307.65

22.1

1.9

67.14

66.22

g/l

2.26

1269

1632

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

822

892

31.65

307.65

24.7

1.6

67.10

66.77

g/l

0.35

807

800

L04AA Selective immunosuppressants

2181

7322

3.48

307.65

2.8

2.6

64.94

66.70

g/l

19.74

2098

6767

Non-Hodgkin lymphoma, all, including Hilmo

1470

4605

3.91

307.65

3.3

1.6

64.55

66.60

g/l

14.70

1412

4117

Implicit Sepsis, including avohilmo

7652

22178

2.72

307.65

2.8

2.5

65.01

66.98

g/l

75.55

7050

20332

Parasetamol

4292

10275

2.21

307.65

2.7

2.3

66.52

66.78

g/l

1.12

3965

9553

Tramadol

6411

15935

2.62

307.65

2.8

2.3

66.20

66.68

g/l

4.73

5887

14645

Other septicaemia

3925

14250

2.96

307.65

3.4

2.4

64.13

66.69

g/l

58.65

3616

12878

Codeine

6332

16440

2.20

307.65

2.4

2.3

66.45

66.74

g/l

2.01

5829

15130

Oral corticosteroids

9613

22633

2.73

307.65

2.4

2.7

66.02

66.65

g/l

10.68

8928

20673

Oedema, not elsewhere classified

3011

10933

3.02

307.65

2.7

2.5

65.21

66.76

g/l

19.76

2768

9916

Asthma, unspecified (mode)

4049

11675

2.70

307.65

2.4

2.3

66.03

67.39

g/l

23.27

3730

10650

Other pulmonary diagnosis

4961

12110

2.16

307.65

2.8

2.3

66.08

67.39

g/l

23.36

4627

11056

Diseases of arteries, arterioles and capillaries (FINNGEN)

1994

3923

3.96

307.65

2.7

2.8

65.30

67.57

g/l

25.84

1866

3589

Other disorders of skin and subcutaneous tissue

5620

26576

1.90

307.65

2.6

2.7

65.61

66.45

g/l

12.16

5161

24334

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

7477

18711

2.53

307.65

3.3

2.2

64.95

67.13

g/l

88.99

6991

17148

Gout

3078

9543

3.23

307.65

3.6

2.8

65.47

65.80

g/l

1.37

2876

8710

Second line medication for Crohn's disease

5255

21098

2.77

307.65

5.7

2.1

66.26

66.52

g/l

1.59

4977

19394

Other arthritis (FG)

2614

10167

2.86

307.65

2.5

2.8

66.66

66.24

g/l

2.06

2444

9360

Type 2 diabetes, wide definition

6021

20260

2.00

307.65

2.5

2.9

66.23

66.29

g/l

0.23

5563

18565

Iron deficiency anaemia

4167

17667

2.59

307.65

2.4

2.6

65.51

66.20

g/l

6.17

3781

16033

Other and unspecified anaemias

6063

16896

4.20

307.65

3.0

2.6

65.48

66.17

g/l

7.78

5594

15240

Neurological diseases, wide definition

1439

2020

3.77

307.65

2.5

2.9

67.30

65.96

g/l

6.27

1342

1888

Bleeding

6302

25053

1.87

307.65

2.5

2.7

65.59

66.47

g/l

14.72

5781

22964

Opioids

6568

16540

2.16

307.65

2.7

2.3

66.44

66.74

g/l

2.17

6072

15217

Kidney transplant status

712

1398

7.17

307.65

3.6

3.0

62.96

66.85

g/l

27.75

692

1303

Nephropathy related operations

1820

4256

6.02

307.65

4.3

2.6

62.59

66.47

g/l

66.42

1761

3905

COPD/asthma related infections

6653

18711

1.87

307.65

3.2

2.2

65.62

67.13

g/l

40.90

6177

17148

Primary_lymphoid and hematopoietic malignant neoplasms

3778

9572

5.39

307.65

9.6

1.8

65.80

66.12

g/l

1.24

3655

8615

Disorders of lipoprotein metabolism and other lipidaemias

5987

19811

1.95

307.65

2.7

2.6

66.02

66.73

g/l

9.66

5540

18108

Symptoms and signs concerning food and fluid intake

1061

3177

3.92

305.50

2.2

2.5

66.05

66.62

g/l

1.44

977

2884

Symptoms and signs involving the skin and subcutaneous tissue

5119

28152

1.81

304.97

2.7

2.6

66.50

66.36

g/l

0.66

4745

25842

Gout, unspecified

2076

8996

2.67

304.79

2.4

2.6

65.53

66.03

g/l

2.17

1942

8172

Persons encountering health services in other circumstances, wide

7592

24393

1.66

304.15

2.6

66.17

66.51

g/l

3.21

7097

22244

Other and unspecified dermatitis

3890

21044

1.97

301.35

2.7

66.68

66.29

g/l

2.40

3635

19282

Symptoms and signs involving the nervous and musculoskeletal systems

4345

24342

1.90

301.12

2.4

2.7

66.82

66.23

g/l

6.06

4029

22269

Small fibre neuropathy

523

971

9.00

299.61

2.6

2.9

67.39

66.21

g/l

2.91

486

892

Gout, strict definition

1902

8007

2.78

299.46

2.4

2.7

65.32

66.00

g/l

3.35

1777

7295

Hard cardiovascular diseases

5601

19384

1.80

299.31

2.6

2.9

65.88

66.76

g/l

13.17

5214

17778

Disorders resulting from impaired renal tubular function

573

1145

7.69

299.29

4.6

2.9

64.57

66.65

g/l

7.66

558

1063

STROKE

3758

13211

2.04

299.26

2.5

2.9

65.73

66.89

g/l

15.61

3474

12095

Antihypertensive medication - note that there are other indications

2850

6763

2.29

297.90

2.4

2.6

66.73

67.31

g/l

3.16

2681

6279

Haemorrhage from respiratory passages

2804

12021

2.24

294.42

2.6

2.7

66.11

66.27

g/l

0.49

2567

10943

Ulcer of lower limb, not elsewhere classified

1556

6019

3.06

291.96

2.6

64.33

65.99

g/l

11.88

1431

5427

Neurological diseases

4990

14093

1.85

289.03

2.5

2.9

66.75

66.24

g/l

4.30

4613

13036

Constipation

6276

26123

1.71

288.36

2.9

2.6

65.94

66.43

g/l

5.47

5697

24066

Intracranial trauma

3392

11625

2.06

288.14

2.5

2.9

66.34

66.40

g/l

0.14

3098

10779

COPD (mode)

2335

8223

2.41

284.56

2.1

2.4

65.02

67.04

g/l

27.60

2132

7425

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

6103

21972

1.72

284.05

2.4

2.8

66.44

66.39

g/l

0.18

5601

20167

Neoplasms

4043

11241

1.96

283.39

3.2

1.4

66.45

67.19

g/l

6.84

3789

10342

Diseases of the skin and subcutaneous tissue

6205

18817

1.72

280.57

2.6

66.25

66.50

g/l

1.50

5701

17239

Dipeptidyl peptidase 4 (DPP-4) inhibitors

4437

19869

1.88

280.57

2.5

2.9

66.41

65.99

g/l

2.77

4043

18146

Persons encountering health services for other counselling and medical advice, not elsewhere classified

7235

24268

1.65

280.54

2.6

66.20

66.52

g/l

2.74

6765

22156

ILD medications: azathioprine

1090

3472

3.52

279.73

2.1

2.0

65.78

66.99

g/l

4.73

1038

3192

Hernia of abdominal wall, postoperative

1318

4633

3.10

278.90

2.6

2.2

65.73

67.59

g/l

14.08

1213

4226

Continuous positive airway pressure

1407

4226

3.06

277.78

2.4

3.1

65.90

67.10

g/l

6.03

1264

3907

Spinal stenosis

3940

15993

1.94

275.26

2.6

2.7

66.21

66.07

g/l

0.52

3571

14629

Hyperlipidaemia, other/unspecified

3156

14744

2.09

275.23

3.0

2.7

65.97

66.43

g/l

2.77

2910

13383

Hypo-osmolality and hyponatraemia

1671

6766

2.79

275.22

2.8

2.5

64.70

66.20

g/l

10.30

1521

6043

Percutaneous Coronary Intervention

5424

19685

1.77

273.69

2.6

2.8

65.79

66.61

g/l

11.47

5078

17979

Diabetic nephropathy

1681

6910

2.87

273.64

2.7

2.4

65.11

66.39

g/l

9.29

1591

6300

Asthma, hospital admission 2, infections

4177

23167

1.86

271.19

2.5

2.7

65.61

66.37

g/l

8.43

3848

21172

Asthma-related infections

4177

23167

1.86

271.19

2.5

2.7

65.61

66.37

g/l

8.43

3848

21172

Preparatory care for dialysis

629

1480

6.19

269.87

2.4

3.0

63.73

66.48

g/l

14.09

600

1373

Insulin, combination of fast acting with intermediate-acting or long-acting

4538

23988

1.82

269.73

2.6

65.73

66.32

g/l

5.36

4207

21941

Genitourinary diseases

3290

8312

2.08

264.47

2.6

66.30

67.27

g/l

9.14

3095

7702

Spondylosis

3929

17125

1.90

264.24

2.3

2.6

66.68

66.20

g/l

3.78

3611

15736

Intestinal infectious diseases

6225

29065

1.66

264.04

3.3

2.5

65.41

66.62

g/l

26.74

5736

26673

Other special examinations and investigations of persons without complaint or reported diagnosis

3964

10829

1.94

263.39

2.7

2.4

66.52

66.40

g/l

0.40

3664

9998

Diseases of liver

2708

13647

2.16

262.74

2.2

2.7

66.44

66.35

g/l

0.20

2477

12581

Emergency coronary revascularization (for ACS)

5941

22144

1.70

262.69

2.5

2.8

65.78

66.49

g/l

9.53

5537

20167

Coronary revascularization (ANGIO or CABG)

5381

19691

1.75

261.89

2.6

2.8

65.79

66.61

g/l

11.64

5046

17984

Ischemic heart diseases

5553

20050

1.73

261.80

2.7

2.8

65.87

66.63

g/l

10.21

5182

18325

Certain disorders involving the immune mechanism

1599

6567

2.75

259.17

3.1

2.6

65.50

66.50

g/l

5.19

1530

6053

Disorders of parathyroid gland

1890

8283

2.55

258.86

2.8

2.6

65.59

66.00

g/l

1.54

1709

7450

Diarrhoea and gastroenteritis of presumed infectious origin

4687

24769

1.77

258.86

3.1

2.4

65.44

66.59

g/l

18.74

4315

22710

Disturbances of skin sensation

1981

8866

2.43

258.52

2.2

2.6

67.47

66.68

g/l

5.53

1857

8185

Diseases of the musculoskeletal system and connective tissue

2838

6834

2.17

256.81

2.6

66.88

66.11

g/l

5.08

2650

6300

Insulin, intermediate and long-acting

4067

22602

1.85

255.61

2.6

2.7

65.88

66.30

g/l

2.76

3763

20703

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4394

25352

1.80

255.13

2.5

2.7

65.77

66.42

g/l

6.26

4059

23195

Nerve, nerve root and plexus disorders

7042

27342

1.61

253.95

2.5

2.7

66.57

66.33

g/l

1.72

6489

25093

Other necrotizing vasculopathies (FG)

704

1856

4.87

252.08

1.9

3.1

64.66

65.91

g/l

3.55

651

1689

Other antidepressants

6664

21567

1.64

251.56

2.4

2.8

66.52

66.41

g/l

0.53

6083

19935

Fall on same level

7056

24199

1.61

251.52

2.5

2.7

66.05

66.71

g/l

9.56

6423

22534

Asthma (diagnoses ohter than nonallergic)

5772

29235

1.66

250.26

2.3

2.7

66.07

66.46

g/l

3.49

5318

26835

Ascites

868

2648

4.08

249.69

2.7

2.6

62.71

66.39

g/l

25.85

823

2418

Dermatitis and eczema

7258

28059

1.59

248.89

2.5

2.7

66.74

66.32

g/l

4.43

6733

25713

Myelodysplastic syndrome, including Hilmo

479

960

7.52

248.54

3.1

1.6

66.78

66.17

g/l

0.87

453

857

General examination and investigation of persons without complaint and reported diagnosis

3822

10805

1.92

248.36

2.7

2.4

65.98

66.41

g/l

2.47

3528

9982

Other arrhythmias

3905

16424

1.86

248.06

2.5

2.7

66.15

67.11

g/l

12.79

3586

15111

Seropositive rheumatoid arthritis

1870

8285

2.46

247.89

2.0

2.9

66.10

66.02

g/l

0.17

1760

7514

Hypertensive Heart Disease

2006

6843

2.45

247.88

2.4

2.8

65.58

66.06

g/l

1.78

1827

6155

Pain (limb, back, neck, head abdominally)

4442

12695

1.83

246.28

2.7

2.6

66.47

66.34

g/l

0.50

4100

11658

Diabetes, insulin treatment (Kela reimbursement)

6567

25046

1.62

245.52

2.3

2.8

66.46

66.33

g/l

0.63

6030

22978

Soft tissue disorders

6182

19803

1.66

245.30

2.4

2.7

66.52

66.44

g/l

0.30

5706

18148

Solid cancers, including Hilmo

5106

17892

1.73

244.32

3.0

1.6

65.82

66.96

g/l

19.80

4772

16334

Major coronary heart disease event

5685

21152

1.69

243.39

2.6

2.8

65.76

66.57

g/l

11.84

5310

19317

Type 2 diabetes, definitions combined

5988

21874

1.66

242.41

2.3

2.8

66.70

66.39

g/l

2.22

5496

20061

Concussion

2894

11559

2.03

242.41

2.4

2.9

66.48

66.39

g/l

0.23

2633

10716

Paroxysmal tachycardia

1330

4130

2.88

241.63

2.4

2.7

65.86

67.57

g/l

12.48

1227

3780

Azathioprine

1090

3793

3.20

240.44

2.1

2.8

65.78

66.81

g/l

3.61

1038

3498

Type 2 diabetes, strict (exclude DM1)

6009

22051

1.65

238.80

2.3

2.8

66.69

66.38

g/l

2.29

5514

20222

Hypothyroidism, drug reimbursement

652

1022

4.75

238.47

2.8

1.4

66.35

68.49

g/l

8.88

611

950

Dizziness and giddiness

5142

24701

1.70

237.01

2.3

2.8

66.33

66.40

g/l

0.27

4674

22750

Other dialysis

454

910

7.56

235.84

3.2

3.1

62.74

66.54

g/l

18.76

440

848

Disorders of lens

4583

16915

1.77

234.81

2.9

2.7

65.90

66.53

g/l

6.22

4229

15677

Other functional intestinal disorders

3277

16435

1.92

233.23

2.8

2.6

65.97

66.39

g/l

2.40

2994

15019

Nephrotic syndrome

434

835

7.52

233.06

3.1

3.0

59.14

66.43

g/l

34.20

424

779

Exposure to unspecified factor

6548

29033

1.59

232.43

2.5

2.6

65.96

66.51

g/l

7.02

5951

26762

Diseases of the respiratory system

3755

10376

1.89

232.20

2.8

2.3

66.15

67.37

g/l

16.38

3477

9454

Dorsopathies

6108

19538

1.64

231.97

2.5

2.6

66.74

66.29

g/l

4.33

5596

17994

Solid cancers

4981

17697

1.72

231.97

3.0

1.6

65.74

66.95

g/l

21.53

4650

16149

Asthma-related pneumonia

2868

15299

2.01

231.82

2.6

64.93

66.12

g/l

13.02

2648

13833

Other necrotizing vasculopathies

819

2538

4.08

231.48

2.0

2.9

64.36

66.17

g/l

7.87

756

2316

Benign neoplasm of colon, rectum, anus and anal canal

4802

24999

1.72

231.19

2.7

65.91

66.27

g/l

2.58

4386

22868

Asthma, hospital admissions 3, pneumonia

2868

15325

2.01

230.55

2.6

64.93

66.12

g/l

12.99

2648

13857

Asthma-related pneumonia or sepsis

2868

15325

2.01

230.55

2.6

64.93

66.12

g/l

12.99

2648

13857

7281

24355

1.57

229.95

3.4

2.4

65.90

66.61

g/l

11.14

6672

22326

Thrombocytopenia, unspecified

806

2478

4.05

229.31

2.9

2.7

65.30

66.39

g/l

2.78

763

2285

Hyperkalaemia

723

2083

4.40

228.09

3.0

2.5

63.45

66.20

g/l

16.02

679

1871

Cardiomyopathy

1427

5887

2.71

227.34

2.7

64.51

66.78

g/l

21.91

1342

5343

Chronic lower respiratory diseases

7452

26126

1.55

227.32

2.3

2.7

66.18

66.56

g/l

3.93

6888

24013

Symptoms and signs involving the digestive system and abdomen

6222

19912

1.62

225.90

2.6

66.08

66.66

g/l

6.49

5752

18273

Venous thromboembolism

4045

23205

1.78

225.58

3.2

2.6

65.01

66.35

g/l

22.33

3743

21094

Nausea and vomiting

2057

9647

2.24

223.13

3.0

2.6

65.00

66.34

g/l

10.41

1896

8702

Other disorders of urethra and urinary system

4691

19893

1.72

222.68

2.6

2.7

65.80

66.50

g/l

7.57

4311

18247

Rheumatoid arthritis, including avohilmo

2827

15281

1.99

222.42

2.0

2.7

66.20

66.23

g/l

0.07

2649

13860

Bacterial pneumoniae

2923

13888

1.97

221.40

3.6

2.3

64.55

66.93

g/l

44.29

2735

12599

Insulin, fast-acting

2612

13753

2.04

221.05

2.6

65.33

66.43

g/l

10.42

2442

12595

Care involving use of rehabilitation procedures

4035

21548

1.76

220.48

2.6

2.4

65.84

66.93

g/l

16.27

3814

19650

All influenza

1904

8962

2.30

219.55

5.1

2.3

65.21

66.96

g/l

17.36

1757

8122

Other intervertebral disc disorders

5107

18872

1.68

218.68

2.5

2.6

66.78

66.25

g/l

5.34

4695

17363

Type 2 diabetes, definitions combined, including avohilmo

5883

21781

1.62

218.67

2.3

2.8

66.72

66.38

g/l

2.67

5403

19987

Non-follicular lymphoma

1021

3711

3.36

218.53

2.9

2.7

64.15

66.08

g/l

9.42

977

3377

Diabetes medication

6451

24670

1.58

217.55

2.3

2.7

66.47

66.38

g/l

0.37

5913

22667

Hypercalcemia

597

1584

5.23

217.34

4.5

2.9

65.16

66.44

g/l

2.85

556

1446

Disorders of choroid and retina

5661

25506

1.63

216.79

2.7

65.96

66.34

g/l

3.06

5140

23405

Hypertensive Renal Disease

507

1176

5.78

216.67

3.1

2.9

65.24

65.99

g/l

1.22

488

1057

Secondary and unspecified malignant neoplasm of lymph nodes

835

2710

3.69

214.63

2.6

1.6

64.09

66.61

g/l

12.85

806

2444

Gastro-oesophageal reflux disease

4525

23510

1.70

213.63

2.4

2.7

66.51

66.48

g/l

0.11

4123

21640

Intestinal infectious diseases, including avohilmo, including avohilmo

7307

27441

1.53

212.55

3.1

2.5

65.64

66.61

g/l

20.44

6732

25188

Arthropathies

5070

15788

1.68

211.92

2.4

2.7

66.85

66.29

g/l

5.50

4675

14568

Other nutritional deficiencies

4188

23234

1.72

210.72

2.2

2.7

66.62

66.52

g/l

0.36

3869

21514

Pulmonary heart disease, diseases of pulmonary circulation

2604

14006

2.02

209.85

2.9

2.6

64.82

66.14

g/l

13.95

2423

12648

Use of hypnotics and sedatives

6724

25593

1.56

209.32

2.9

2.6

66.10

66.54

g/l

4.57

6160

23598

Bacterial pneumonia, not elsewhere classified

2768

13196

1.96

207.69

3.5

2.3

64.47

66.92

g/l

45.68

2598

11957

Secondary uncertain malignant neoplasm

1184

4695

2.87

207.23

2.6

1.6

64.33

66.54

g/l

14.04

1125

4190

Presence of other functional implants

4341

18158

1.73

206.68

2.6

66.20

66.38

g/l

0.75

3914

16578

DVT of lower extremities and pulmonary embolism

3219

18425

1.86

206.64

3.4

2.6

64.81

66.29

g/l

21.12

2969

16712

Cerebrovascular diseases

5295

23568

1.64

206.44

2.3

2.8

65.56

66.37

g/l

10.97

4808

21601

Infections of the skin and subcutaneous tissue

3798

22333

1.75

206.22

2.9

2.6

65.61

66.56

g/l

11.17

3554

20592

Other diseases of urinary system

6200

22861

1.58

204.73

2.5

2.7

66.11

66.55

g/l

4.24

5713

21081

Diseases of the digestive system

3435

19978

1.82

204.43

2.5

2.7

65.48

66.22

g/l

5.97

3173

18182

Lung cancer and mesothelioma

1539

5750

2.50

204.30

2.0

2.4

64.75

66.93

g/l

21.60

1452

5176

Suppurative and necrotic conditions of lower respiratory tract

665

1964

4.34

203.28

2.7

2.8

61.67

66.46

g/l

35.13

634

1816

Other disorders involving the immune mechanism, not elsewhere classified

410

842

6.73

203.26

3.8

2.8

65.52

66.83

g/l

2.14

394

787

Gastrointestinal diseases

3040

8189

1.93

201.77

2.8

2.3

66.64

67.08

g/l

2.16

2815

7586

Acute myeloid leukaemia and myelodysplastic syndromes

369

704

7.85

201.50

2.4

1.6

66.24

66.57

g/l

0.32

353

636

Benzodiazepine use

6390

28835

1.55

201.36

2.5

2.7

66.14

66.47

g/l

2.77

5774

26599

Anaemia in chronic diseases classified elsewhere

374

729

7.79

200.30

5.2

2.7

63.64

66.59

g/l

8.52

356

671

Presence of cardiac and vascular implants and grafts

3433

14722

1.83

199.38

2.2

2.6

65.33

66.21

g/l

8.78

3125

13404

Other disorders of kidney and ureter

1219

5027

2.81

199.16

3.6

2.7

65.27

66.18

g/l

3.83

1162

4599

Explicit bacterial Sepsis, including avohilmo

980

3613

3.11

197.81

4.5

2.4

65.24

66.60

g/l

4.98

917

3277

Pyothorax

551

1468

5.01

197.24

2.7

2.8

61.42

66.35

g/l

30.19

526

1355

Other/unspecified dorsalgia

2472

13062

1.98

196.44

3.0

2.6

66.62

66.22

g/l

1.87

2246

11979

Insulin, fast-acting or short human

2618

14330

1.95

196.24

2.6

65.33

66.41

g/l

10.08

2448

13122

Postmenopausal osteoporosis with pathological fracture

765

2530

3.85

196.03

2.4

2.6

66.22

65.98

g/l

0.33

653

2258

Streptococcal septicaemia, including avohilmo

871

3049

3.34

195.13

4.5

2.4

65.33

66.59

g/l

3.91

814

2757

Conduction disorders

2186

8947

2.11

194.63

2.4

2.7

65.57

66.77

g/l

10.16

1973

8109

Vocal cord dysfunction

819

2352

3.31

192.54

2.5

3.2

66.02

67.17

g/l

3.73

751

2210

Other diseases of pericardium

509

1286

5.03

192.35

2.5

2.8

63.35

66.92

g/l

16.73

487

1161

Disorders of gallbladder, biliary tract and pancreas

6372

26699

1.54

192.03

2.7

66.00

66.47

g/l

4.82

5857

24523

Other retinal disorders

4652

22511

1.65

190.35

2.7

65.84

66.21

g/l

2.46

4216

20563

Explicit bacterial Sepsis

954

3539

3.08

190.31

4.5

2.4

65.31

66.61

g/l

4.45

893

3211

Streptococcal septicaemia

847

2970

3.33

189.16

4.5

2.4

65.39

66.56

g/l

3.35

792

2683

Episodal and paroxysmal disorders

6482

22044

1.54

189.12

2.3

2.8

66.69

66.27

g/l

4.19

5956

20264

Senile cataract

4226

15854

1.71

188.45

3.0

2.7

65.89

66.45

g/l

4.66

3889

14672

Cough

2651

13670

1.91

188.05

2.7

66.52

66.53

g/l

0.02

2439

12540

Other joint disorders

4814

15763

1.64

187.94

2.2

2.7

66.99

66.29

g/l

8.07

4429

14545

Sulfasalazine

1813

8875

2.18

187.19

2.0

2.8

66.87

66.68

g/l

0.47

1702

8119

Sciatica+with lumbago

3264

16943

1.79

186.93

2.5

2.6

66.85

66.30

g/l

4.29

3005

15627

Persons encountering health services for examination and investigation

3690

10829

1.77

186.88

2.6

2.4

66.62

66.40

g/l

0.85

3399

9998

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1268

5442

2.62

186.64

3.3

1.6

64.53

66.71

g/l

16.31

1221

4907

Hyperparathyroidism

1566

7276

2.38

185.86

2.9

2.6

65.65

65.98

g/l

0.99

1418

6526

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3951

24563

1.69

184.34

2.4

2.7

65.85

66.34

g/l

3.51

3647

22484

2832

15978

1.85

184.11

2.6

65.91

66.42

g/l

3.13

2607

14646

Bronchitis

6803

28009

1.50

183.67

3.6

2.4

65.82

66.56

g/l

12.12

6264

25689

Coxarthrosis [arthrosis of hip](FG)

3611

14890

1.75

183.33

2.4

2.9

66.37

66.17

g/l

0.86

3290

13637

Fracture of lumbar spine and pelvis

1900

9619

2.17

182.72

2.6

64.93

65.95

g/l

6.13

1640

8666

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

373

773

6.61

182.71

3.5

2.8

65.21

66.88

g/l

3.11

357

723

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

6147

26246

1.53

182.69

2.8

2.6

65.94

66.50

g/l

6.37

5650

24116

Amyloidosis

359

735

7.43

182.60

7.5

2.7

63.15

66.51

g/l

8.32

347

673

Sicca syndrome [Sjögren]

780

2678

3.45

181.80

2.0

2.8

69.32

66.41

g/l

17.52

718

2448

Lymphoid leukaemia

640

1988

4.11

181.18

3.4

2.8

64.24

66.15

g/l

5.88

609

1830

AV-block

1491

5837

2.40

180.72

2.4

2.7

65.53

66.62

g/l

6.13

1343

5229

Injuries to the abdomen, lower back, lumbar spine and pelvis

2910

16584

1.83

180.65

2.6

65.33

66.27

g/l

8.10

2558

15125

Non-invasive ventilation

1384

5245

2.41

180.06

3.0

3.1

64.69

67.31

g/l

26.43

1289

4857

Agranulocytosis

973

3768

2.98

179.93

4.5

2.8

64.99

66.47

g/l

6.25

942

3470

Pulmonary embolism

2328

12703

1.99

179.19

3.0

2.6

64.74

66.16

g/l

14.42

2168

11486

Obesity related asthma

2380

13027

1.95

178.53

2.2

2.8

66.64

66.48

g/l

0.48

2192

12016

Abdominal and pelvic pain

5951

19911

1.55

178.52

2.7

2.6

66.26

66.66

g/l

3.42

5494

18272

Peripheral artery disease

3427

16357

1.77

177.71

2.4

2.8

64.96

66.12

g/l

14.10

3122

14822

Myalgia

1575

7468

2.26

177.09

2.5

2.8

66.74

66.52

g/l

0.57

1452

6857

Isolated proteinuria

365

765

6.61

177.09

3.4

2.9

64.74

66.67

g/l

3.80

358

706

Pulmonary heart disease

2328

12752

1.98

177.03

3.0

2.6

64.74

66.15

g/l

14.21

2168

11534

Amyloidosis, other/unspecified

320

616

8.49

176.24

8.1

2.7

62.98

66.25

g/l

7.21

310

563

Other cataract

3128

13641

1.81

176.06

2.9

2.7

65.96

66.38

g/l

2.34

2885

12580

Disorders of eyelid, lacrimal system and orbit

5621

27715

1.54

175.16

2.7

66.48

66.32

g/l

0.80

5162

25447

Benign neoplasm: Colon

4023

23964

1.67

174.37

2.6

2.8

65.87

66.23

g/l

2.27

3666

21915

Obesity

3824

22440

1.67

174.25

2.1

2.7

66.73

66.54

g/l

0.85

3537

20771

Obesity and other hyperalimentation

3843

22550

1.67

174.07

2.1

2.7

66.72

66.54

g/l

0.79

3554

20873

Viral pneumonia

1037

4182

2.77

173.40

5.2

2.3

64.56

66.91

g/l

16.61

962

3784

Pacemaker

2968

16299

1.82

173.06

2.3

2.7

65.23

65.96

g/l

5.59

2694

14704

Later onset COPD, excluding more controls

1646

6043

2.28

172.53

2.1

2.4

65.00

66.76

g/l

15.28

1477

5374

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1275

5717

2.53

171.34

1.8

2.8

65.74

66.27

g/l

1.27

1180

5277

Injuries to the head

6794

28036

1.48

170.57

2.5

2.7

66.00

66.53

g/l

6.50

6188

25850

Sleep apnoea

5962

25594

1.52

170.42

2.4

2.8

66.99

66.26

g/l

11.55

5473

23622

Implicit fungal Sepsis, including avohilmo

701

2353

3.55

170.24

3.2

2.5

64.43

66.72

g/l

9.52

641

2152

Unspecified haematuria

3139

15264

1.78

169.31

2.7

65.87

66.25

g/l

1.88

2870

13993

Fibrosis and cirrhosis of liver

774

2775

3.35

168.55

1.9

2.9

66.47

66.30

g/l

0.20

729

2556

Polyarthrosis

1574

6869

2.25

166.78

2.3

3.0

66.56

65.81

g/l

3.42

1417

6227

Chronic lymphocytic leukaemia

398

947

5.83

166.61

2.6

1.6

63.92

66.56

g/l

6.88

378

849

Chronic lymphocytic leukaemia, helper endpoint

398

947

5.83

166.61

2.6

1.6

63.92

66.56

g/l

6.88

378

849

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

398

947

5.83

166.61

2.6

1.6

63.92

66.56

g/l

6.88

378

849

Other bacterial intestinal infections

1460

6950

2.31

166.29

3.9

2.4

64.06

66.34

g/l

21.10

1339

6273

Obesity due to excess calories

2849

16748

1.78

165.04

2.1

2.7

66.83

66.59

g/l

0.93

2630

15545

Adjustment and management of implanted device

1533

7483

2.27

164.74

2.5

2.3

65.46

66.26

g/l

3.87

1410

6656

Volume depletion

887

3426

2.96

164.09

2.7

2.5

63.90

66.02

g/l

10.46

807

3052

Persons encountering health services in other circumstances

2581

14629

1.83

163.61

2.7

2.6

66.32

66.52

g/l

0.70

2412

13337

Factors influencing health status and contact with health services

1643

3835

2.24

161.75

2.9

2.1

66.49

67.08

g/l

2.01

1517

3503

Enterocolitis due to Clostridium difficile

986

4052

2.79

161.29

4.1

2.5

63.46

66.03

g/l

16.79

909

3660

Iron deficiency anaemia secondary to blood loss (chronic)

1333

6214

2.38

161.07

2.5

2.6

64.79

65.99

g/l

5.51

1206

5596

Other bacterial intestinal infections, including avohilmo

1742

8924

2.11

160.88

3.7

2.5

64.48

66.44

g/l

19.25

1593

8088

Ischaemic heart disease, wide definition

5029

20643

1.56

160.31

2.6

2.8

65.82

66.49

g/l

7.61

4679

18880

Other disorders of white blood cells

564

1737

4.01

159.79

2.4

2.9

66.14

66.40

g/l

0.30

526

1608

Hernia

5725

26065

1.51

159.54

2.6

65.94

66.53

g/l

6.89

5227

23926

Other acute lower respiratory infections

3505

20854

1.67

159.29

3.5

2.5

65.62

66.36

g/l

6.76

3223

19048

Bacterial pneumonia (organism specified)

3165

17492

1.73

158.64

3.8

2.5

64.51

66.42

g/l

31.22

2963

15864

Diseases of the eye and adnexa

4051

12719

1.64

157.56

2.7

2.5

66.76

66.67

g/l

0.31

3781

11842

Coronary atherosclerosis

4288

17526

1.62

157.11

2.6

2.8

65.63

66.48

g/l

10.21

3995

15931

Other (not insulin) diabetes medications

5938

24014

1.50

156.87

2.3

2.8

66.72

66.34

g/l

3.25

5426

22044

Abnormal weight loss

880

3497

2.93

155.73

2.1

2.7

66.40

66.15

g/l

0.41

806

3208

Abnormalities of gait and mobility

1112

4915

2.59

155.70

2.0

2.7

66.51

65.94

g/l

1.73

1032

4475

Abnormalities of heart beat

2272

12328

1.88

155.60

2.4

2.6

66.17

66.47

g/l

1.08

2058

11232

Undetermined asthma, excluding more controls

849

3248

2.84

154.94

2.4

2.3

65.96

67.55

g/l

7.55

789

2915

Other neurological diseases

4894

25560

1.55

154.84

2.5

2.7

65.99

66.29

g/l

2.01

4474

23358

Diffuse large B-cell lymphoma, including Hilmo

528

1597

4.15

154.79

2.3

1.6

62.64

66.58

g/l

18.35

503

1442

Diffuse large B-cell lymphoma

528

1597

4.15

154.79

2.3

1.6

62.64

66.58

g/l

18.35

503

1442

Diffuse large B-cell lymphoma, helper endpoint

528

1597

4.15

154.79

2.3

1.6

62.64

66.58

g/l

18.35

503

1442

Type 1 diabetes

1534

7558

2.16

154.72

2.5

2.7

64.97

66.49

g/l

11.96

1437

6979

ILD, hospital admission 2, with pulmonary infections

892

3567

2.87

154.55

2.4

2.2

65.51

66.58

g/l

3.41

837

3213

Weight loss

923

3764

2.82

154.04

2.2

2.7

66.28

66.14

g/l

0.21

847

3445

Gonarthrosis [arthrosis of knee](FG)

4402

16453

1.59

153.72

2.4

2.8

66.66

66.27

g/l

2.66

4053

15104

Bacterial intestinal infections, IBD co-morbidities

1459

7174

2.23

152.76

4.0

2.5

64.11

66.19

g/l

17.74

1340

6491

Hypokalaemia

1006

4260

2.65

152.43

2.7

2.5

64.71

66.38

g/l

7.90

923

3823

Cirrhosis of liver, NAS

592

1952

3.78

151.32

2.0

2.9

66.00

66.31

g/l

0.36

562

1801

Atherosclerosis, excluding cerebral and coronary sclerosis

3197

15556

1.72

150.48

2.3

2.8

64.95

66.09

g/l

12.90

2909

14084

Shoulder lesions

4617

18299

1.57

150.17

2.4

2.8

66.49

66.38

g/l

0.43

4276

16762

Non-Hodgkin lymphoma, all

494

1457

4.25

150.17

3.9

1.6

63.82

66.32

g/l

6.27

480

1297

GI-bleeding

2453

14328

1.83

149.13

2.4

2.6

65.27

66.02

g/l

4.51

2269

12956

Other diseases of the digestive system

2446

14285

1.83

148.92

2.4

2.6

65.25

66.03

g/l

4.83

2259

12925

Chronic apical periodontitis

6680

26586

1.45

148.79

2.7

2.6

66.31

66.48

g/l

0.98

6148

24436

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

5477

29547

1.49

147.54

3.1

2.6

66.19

66.47

g/l

1.88

5064

27167

Sleep apnoea, including avohilmo

6090

25838

1.47

147.33

2.4

2.8

67.01

66.26

g/l

12.66

5591

23844

Follow-up examination after treatment for conditions other than malignant neoplasms

2458

9325

1.83

146.47

2.5

66.36

g/l

0.01

2252

8614

Mood disorders, excluding more controls

5545

22452

1.50

146.29

2.3

2.8

66.58

66.54

g/l

0.15

5056

20800

Early onset COPD, excluding more controls

1259

5915

2.28

144.80

2.1

2.4

64.97

67.30

g/l

20.56

1171

5422

Acquired haemolytic anaemia

331

767

6.11

143.94

3.5

2.9

65.11

66.53

g/l

1.98

317

708

Abnormal findings on examination of urine, without diagnosis

466

1359

4.28

143.90

3.3

2.9

65.20

66.42

g/l

2.32

454

1258

Other symptoms and signs involving the nervous and musculoskeletal systems

2670

16037

1.75

143.83

2.4

2.7

67.09

66.31

g/l

6.69

2489

14718

Falls/tendency to fall

5995

20915

1.47

143.71

2.5

2.7

66.24

66.73

g/l

5.09

5473

19521

Hypothyroidism, strict autoimmune

4117

17671

1.58

142.41

2.6

2.8

66.44

66.35

g/l

0.31

3772

16087

Haemolytic anaemias

393

1036

4.89

141.28

3.4

2.8

65.40

66.39

g/l

1.33

377

949

Coxarthrosis

3239

12992

1.68

140.94

2.4

2.9

66.48

66.04

g/l

2.51

2943

11916

Myelodysplastic syndrome

222

371

9.89

140.82

2.6

1.6

66.42

66.54

g/l

0.08

209

333

Arthrosis

4084

14536

1.59

140.79

2.3

2.8

66.87

66.19

g/l

6.61

3756

13369

Dysphagia

1850

10105

1.96

140.68

2.5

2.7

65.69

66.37

g/l

3.26

1677

9197

Benign neoplasms

5564

20949

1.49

140.68

2.7

2.5

66.32

66.60

g/l

1.91

5128

19341

Asthma, hospital admissions , main diagnosis only

4881

29153

1.50

140.24

2.3

2.7

66.16

66.45

g/l

1.95

4492

26765

Calcific aortic valvular stenosis

2418

13807

1.82

140.19

2.5

2.6

65.75

g/l

0.01

2213

12390

Calcific aortic valvular stenosis, operated

2418

13807

1.82

140.19

2.5

2.6

65.75

g/l

0.01

2213

12390

Type 1 diabetes, wide definition, subgroup 1

1229

5783

2.27

140.16

2.7

64.81

66.62

g/l

13.98

1148

5377

Other CVD

1711

9198

2.04

139.75

2.9

2.5

64.81

65.82

g/l

6.12

1521

8250

Operations 2 for CAVS

2414

13794

1.82

139.56

2.5

2.6

65.77

65.75

g/l

0.04

2209

12377

Calcific aortic valvular stenosis, diagnosis (helper)

2414

13794

1.82

139.56

2.5

2.6

65.77

65.75

g/l

0.04

2209

12377

Calcific aortic valvular stenosis, including rheumatic fever

2421

13832

1.82

139.43

2.5

2.6

65.78

65.74

g/l

0.08

2216

12410

Retention of urine

2584

12488

1.78

139.38

2.5

2.7

65.67

66.20

g/l

2.74

2350

11420

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

6072

27615

1.45

139.20

3.0

2.5

65.74

66.60

g/l

13.98

5587

25353

Failure and rejection of transplanted organs and tissues

204

311

10.09

139.01

6.1

3.2

63.03

67.21

g/l

9.14

198

294

Other headache syndromes

2455

14485

1.77

138.11

2.3

2.8

66.90

66.38

g/l

3.09

2269

13323

Fibromyalgia

622

2157

3.19

137.88

2.2

2.7

67.48

66.85

g/l

1.45

581

1999

Seronegative rheumatoid arthritis

852

3490

2.71

137.75

2.2

3.1

65.60

66.04

g/l

0.79

795

3184

IgA nephropathy (IgA glomerulonephritis)

291

622

6.37

137.67

2.2

2.9

65.25

67.36

g/l

4.14

276

580

Convulsions, not elsewhere classified

1305

6234

2.18

137.41

2.0

2.4

65.61

66.95

g/l

6.88

1201

5702

Diaphragmatic hernia

2579

15611

1.76

137.28

2.6

2.7

65.91

66.30

g/l

1.67

2336

14216

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1737

9092

2.00

137.05

3.8

1.7

64.50

66.60

g/l

22.22

1626

8232

Any mental disorder

6435

22992

1.44

135.85

2.4

2.8

66.27

66.51

g/l

1.55

5854

21287

Other respiratory diseases principally affecting the interstitium

1504

7833

2.12

135.68

2.5

2.6

65.75

65.89

g/l

0.29

1415

7065

Sleep disorders (combined)

6579

24665

1.43

135.47

2.3

2.8

66.80

66.23

g/l

7.71

6002

22691

Other arthrosis

3211

13493

1.66

135.22

2.4

2.9

66.61

66.13

g/l

3.24

2959

12420

Fracture of rib(s), sternum and thoracic spine

2269

13330

1.82

135.14

2.8

2.6

65.59

66.25

g/l

3.85

2041

12166

Asthma/COPD (KELA code 203)

5560

26107

1.46

134.89

2.3

2.7

66.01

66.56

g/l

6.09

5111

23996

Cardiomyopathies, Primary/intrinsic

918

3936

2.59

134.70

2.2

2.7

64.28

66.83

g/l

17.95

866

3569

Chronic nephritic syndrome

406

1130

4.53

134.55

3.4

2.9

63.99

66.55

g/l

7.44

393

1047

Injuries to the hip and thigh

3419

19828

1.62

134.25

2.4

2.6

65.01

66.29

g/l

16.82

2976

18125

Other external causes of accidental injury

4545

15218

1.54

134.16

2.5

2.7

66.33

66.76

g/l

3.01

4152

14180

Major coronary heart disease event excluding revascularizations

4030

17660

1.58

133.53

2.5

2.9

65.46

66.38

g/l

10.85

3710

16025

Vasculitis limited to skin, not elsewhere classified

328

797

5.55

132.91

2.3

3.0

66.96

66.79

g/l

0.14

310

735

Hypotension

1525

8060

2.09

131.74

2.8

2.5

64.75

65.78

g/l

5.73

1348

7216

Seropositive rheumatoid arthritis, wide

1869

10476

1.92

131.45

2.0

2.7

66.11

66.19

g/l

0.17

1759

9494

Lumbar disc prolapse

3698

17915

1.58

131.35

2.5

2.6

66.85

66.30

g/l

4.56

3429

16544

Other and unspecified disorders of white blood cells

425

1241

4.30

131.34

2.4

2.9

66.52

66.49

g/l

0.02

400

1145

Undetermined asthma

849

3526

2.61

130.79

2.4

2.2

65.96

67.23

g/l

5.13

789

3183

Acute bronchitis

2713

16430

1.70

130.69

3.5

2.5

65.70

66.25

g/l

3.21

2485

14908

Viral infections characterized by skin and mucous membrane lesions

2644

16222

1.71

130.55

3.7

2.6

65.78

66.40

g/l

3.77

2464

14905

Asthma, including avohilmo

6954

27951

1.40

130.53

2.3

2.7

66.35

66.46

g/l

0.56

6421

25656

ILD, hospital admissions 3, with pneumonia sepsis

776

3155

2.83

130.49

2.4

2.3

65.18

66.55

g/l

4.70

730

2833

Cardiomyopathy (excluding other)

943

4148

2.52

130.46

2.2

2.7

64.32

66.90

g/l

19.06

889

3759

Chronic gastritis

1983

11335

1.88

130.39

2.3

2.7

65.93

66.05

g/l

0.30

1780

10254

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1820

10147

1.93

130.38

2.0

2.7

66.12

66.19

g/l

0.12

1713

9207

Injuries to the thorax

3126

20019

1.64

129.90

2.7

2.6

65.62

66.33

g/l

5.80

2834

18347

Biguanides

5746

24656

1.45

129.21

2.2

2.8

66.80

66.25

g/l

6.02

5242

22645

Other reaction to severe stress, and adjustment disorders

1867

10398

1.87

128.86

2.7

2.5

66.26

66.93

g/l

3.37

1748

9702

COPD

3220

16837

1.64

128.50

2.1

2.8

65.07

66.24

g/l

13.83

2926

15370

Other/unspecified seropositive rheumatoid arthritis

1842

10358

1.91

128.17

2.0

2.7

66.14

66.18

g/l

0.08

1732

9387

Drug-induced osteoporosis with pathological fracture

259

549

7.42

127.93

2.0

3.2

64.08

66.87

g/l

5.65

231

501

Depression or dysthymia

3992

14403

1.57

127.84

2.4

2.9

66.64

66.43

g/l

0.93

3629

13421

Urinary track infection

2930

8947

1.70

127.83

2.4

2.6

66.30

66.94

g/l

4.23

2713

8177

Cystitis

5000

20681

1.48

126.20

2.5

2.7

66.29

66.51

g/l

1.22

4594

19002

SLE (Finngen)

326

809

4.91

124.71

2.1

3.1

66.04

67.04

g/l

1.34

307

743

Diabetic retinopathy, excluding more controls

1830

5606

1.97

124.65

2.5

2.3

65.77

66.87

g/l

7.31

1694

5094

873

3764

2.50

123.91

2.6

65.49

66.85

g/l

5.47

820

3468

Accidents

4483

15218

1.52

123.80

2.5

2.7

66.34

66.76

g/l

2.94

4098

14180

Giant cell arteritis

470

1537

3.88

122.83

1.9

3.0

65.14

66.03

g/l

1.61

426

1396

Other disorders of lacrimal gland

2396

14610

1.73

122.59

3.1

2.7

66.72

66.27

g/l

2.26

2191

13357

Other and unspecified vasculitis limited to skin

296

708

5.66

122.47

2.4

3.0

66.90

66.79

g/l

0.08

280

650

Statin medication

3397

12314

1.60

121.51

2.5

2.9

66.40

66.73

g/l

1.64

3158

11349

Viral hepatitis, IBD co-morbidity

271

575

5.11

121.16

2.2

3.1

67.44

66.58

g/l

0.79

251

542

Missing teeth due to accident, extraction or parodontitis

4120

25303

1.52

120.61

2.8

2.7

66.23

66.29

g/l

0.18

3676

23332

Myocardial infarction

3283

14952

1.61

120.35

2.5

2.8

65.26

66.36

g/l

12.28

3010

13530

Other gastritis (incl. Duodenitis)

1593

8730

1.96

120.35

2.6

2.7

65.72

66.23

g/l

1.73

1455

7927

Gastroduodenal ulcer

1917

11064

1.85

120.23

2.4

2.7

65.22

66.04

g/l

4.30

1771

10018

Anxiety disorders, excluding more controls

4601

20361

1.49

119.76

2.5

2.8

66.50

66.60

g/l

0.34

4220

18895

Type 1 diabetes, wide definition

1259

6344

2.10

119.32

2.7

64.77

66.55

g/l

13.99

1176

5870

Cutaneous abscess, furuncle and carbuncle

1631

8989

1.92

119.11

2.6

65.50

66.66

g/l

7.60

1533

8309

Gonarthrosis

3727

13951

1.56

118.73

2.3

2.8

66.70

66.13

g/l

4.39

3431

12813

Fungal Sepsis

431

1351

3.89

118.44

3.9

2.5

63.16

66.74

g/l

12.11

399

1243

Visual disturbances and blindness

3355

22245

1.57

118.38

2.6

66.40

66.26

g/l

0.49

3056

20323

Immunodeficiency with predominantly antibody defects

286

677

5.46

118.31

4.5

2.8

62.37

67.30

g/l

15.94

278

632

Immunodeficiencies

426

1323

3.85

117.74

4.3

2.9

63.19

66.70

g/l

13.40

411

1226

Periodontitis

5966

27688

1.41

117.67

2.8

2.6

66.42

g/l

0.00

5463

25479

Chronic periodontitis, including avohilmo

5961

27700

1.41

117.51

2.8

2.6

66.41

66.42

g/l

0.00

5455

25494

ILD, hospital admissions

1264

6542

2.15

116.81

2.4

2.6

66.13

65.91

g/l

0.42

1189

5925

Disorders of lacrimal system

2825

17813

1.63

116.71

3.0

2.7

66.73

66.26

g/l

2.79

2585

16256

Substance abuse, excluding more controls

3234

17702

1.58

116.53

1.9

2.8

66.06

66.60

g/l

3.21

2926

16521

Other interstitial pulmonary diseases

1278

6652

2.13

116.04

2.4

2.6

66.15

65.89

g/l

0.53

1202

6013

Other (seronegative) rheumatoid arthritis, wide

1364

7218

2.05

115.81

2.1

2.7

65.50

66.19

g/l

2.38

1265

6545

Interstitial lung disease

1278

6669

2.12

115.19

2.4

2.6

66.15

65.90

g/l

0.52

1202

6032

Interstitial lung disease endpoints

1278

6669

2.12

115.19

2.4

2.6

66.15

65.90

g/l

0.52

1202

6032

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1710

7907

1.91

115.14

2.1

1.7

64.81

66.54

g/l

16.30

1614

7107

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1081

5287

2.24

115.00

2.6

65.62

66.26

g/l

1.75

977

4808

Implicit fungal Sepsis

401

1230

4.00

114.23

4.0

2.5

63.45

66.78

g/l

10.32

371

1131

Non-allergic asthma (mode), excluding more controls

1019

4773

2.24

114.22

2.3

65.92

67.42

g/l

8.08

949

4311

External causes of morbidity and mortality

3523

11584

1.57

113.13

2.6

66.36

66.86

g/l

3.29

3231

10776

Sequelae of external causes of morbidity and mortality

1790

10346

1.85

113.00

2.8

2.6

65.53

66.24

g/l

3.47

1676

9432

Other/unspecified cytomegaloviral diseases

238

509

6.38

112.69

7.0

2.9

61.98

67.26

g/l

14.30

229

480

Rotator cuff syndrome

3759

17545

1.53

112.11

2.5

2.8

66.56

66.35

g/l

0.93

3474

16083

Methotrexate

900

4116

2.37

111.99

2.1

2.9

65.97

66.48

g/l

1.14

848

3744

Cytomegalovirus infection, IBD co-morbidity

262

609

5.69

111.58

6.5

2.9

62.14

67.18

g/l

14.87

250

568

Other symptoms and signs involving cognitive functions and awareness

3227

19034

1.57

111.30

2.3

2.8

65.93

66.19

g/l

1.10

2878

17413

Fracture of femur

2079

11294

1.77

110.92

2.5

2.6

64.51

65.90

g/l

11.03

1743

10156

Rare circulating lymphoid malignancy, including Hilmo

300

771

4.88

110.68

5.4

1.6

64.07

66.45

g/l

4.05

287

704

Psychiatric diseases

5632

20384

1.42

110.43

2.4

2.9

66.37

66.48

g/l

0.46

5128

18927

Malignant neoplasm of skin, including Hilmo

3200

14091

1.58

110.35

2.9

1.6

65.81

66.77

g/l

10.08

2915

12761

Stroke, including SAH

4252

21343

1.49

110.25

2.3

2.8

65.37

66.32

g/l

12.31

3859

19503

Other chronic obstructive pulmonary disease

3043

16389

1.60

110.21

2.1

2.8

64.99

66.21

g/l

14.21

2763

14963

Pruritus

832

3730

2.45

109.54

2.3

2.6

66.62

66.42

g/l

0.32

774

3422

Idiopathic gout

824

3730

2.52

109.33

2.4

2.6

64.94

65.93

g/l

3.10

766

3400

Other diseases of liver

1233

6414

2.07

109.22

2.2

2.7

66.99

66.47

g/l

1.42

1124

5938

Chronic ulcer of skin, not elsewhere classified

626

2505

2.90

109.21

2.5

2.6

65.09

66.24

g/l

2.84

575

2282

Cytomegaloviral disease, including avohilmo

264

629

5.45

108.50

6.5

2.9

62.15

67.07

g/l

14.54

252

588

Cytomegaloviral disease

263

626

5.48

108.35

6.5

2.9

62.16

67.05

g/l

14.28

251

585

Other specified/unspecified systemic involvement of connective tissue

464

1588

3.39

108.05

2.1

3.2

67.66

66.63

g/l

1.91

439

1456

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2988

13136

1.60

107.99

2.9

1.6

65.81

66.69

g/l

8.03

2717

11842

Other autoimmune haemolytic anaemias

199

393

8.15

106.63

3.1

3.2

66.10

66.40

g/l

0.17

192

359

Primary hyperparathyroidism

885

4154

2.39

106.54

3.0

2.7

66.27

66.22

g/l

0.07

798

3773

Mood [affective] disorders

5797

27325

1.39

106.48

2.3

2.7

66.57

66.45

g/l

0.59

5295

25178

Mood disorders

5808

27358

1.39

105.94

2.3

2.7

66.57

66.44

g/l

0.64

5304

25207

Malignant neoplasm of skin

3066

13655

1.58

105.68

2.8

1.6

65.79

66.74

g/l

9.48

2792

12338

Cholelithiasis, broad definition with cholecystitis

5254

25446

1.41

105.09

2.7

66.09

66.45

g/l

2.68

4802

23325

Noninfective enteritis and colitis

2703

17554

1.60

104.09

2.6

66.16

66.45

g/l

1.11

2516

16121

Cardiomyopathy in other diseases

124

155

17.23

104.08

8.4

2.3

63.58

66.75

g/l

3.07

117

139

Hydronephrosis

816

3716

2.41

103.65

2.9

2.5

65.13

66.56

g/l

5.88

763

3374

Mycoses

1802

10682

1.79

103.00

3.1

2.6

65.37

66.40

g/l

6.22

1670

9807

Visual disturbances

3040

20362

1.56

102.80

2.6

66.47

66.29

g/l

0.70

2791

18667

Urticaria and erythema

2034

12406

1.71

102.58

2.7

2.6

66.97

66.47

g/l

2.32

1881

11433

Other diseases of the respiratory system

1530

8718

1.89

102.47

2.3

2.6

64.89

65.92

g/l

5.15

1394

7871

Other respiratory disorders and diseases

1530

8718

1.89

102.47

2.3

2.6

64.89

65.92

g/l

5.15

1394

7871

Endocarditis

342

1011

4.08

102.35

2.6

2.8

64.96

66.96

g/l

4.29

324

920

Temporal arteritis

402

1339

3.80

101.98

1.8

3.0

65.20

66.07

g/l

1.41

366

1209

Dental operations

3822

13476

1.51

101.55

2.7

2.4

66.17

g/l

0.00

3467

12265

Disorders of the thyroid gland

5460

26054

1.39

101.05

2.5

2.7

66.22

66.40

g/l

0.92

5025

23930

Deforming dorsopathies

1634

9449

1.82

100.80

2.6

2.7

66.49

66.28

g/l

0.53

1500

8684

Diseases of oral cavity, salivary glands and jaws

3565

12449

1.52

100.16

2.7

2.4

66.10

66.14

g/l

0.09

3217

11352

Zoster [herpes zoster], including avohilmo

3369

22347

1.51

99.82

3.2

2.6

66.04

66.28

g/l

1.08

3088

20385

Cellulitis

1445

8124

1.89

99.62

3.1

2.6

65.34

66.51

g/l

6.21

1358

7468

Stroke, excluding SAH

4049

20654

1.47

99.47

2.3

2.8

65.29

66.28

g/l

12.62

3673

18850

Systemic lupus erythematosus

326

952

4.13

99.40

2.1

3.1

66.04

66.94

g/l

1.15

307

881

Myeloid leukaemia

308

881

4.53

99.37

2.5

3.1

65.48

66.55

g/l

1.70

300

813

Cardiomyopathy, other and unspecified

583

2341

2.80

99.19

2.5

2.7

64.76

66.93

g/l

8.56

542

2116

Depression

5282

25941

1.39

98.84

2.3

2.7

66.59

66.49

g/l

0.43

4827

23952

Basal cell carcinoma, including Hilmo

2879

12853

1.58

98.72

2.9

1.6

65.77

66.68

g/l

8.15

2613

11578

Osteomyelitis

547

2156

2.92

98.00

3.1

2.6

65.00

66.32

g/l

3.26

501

2004

Diabetic maculopathy, excluding more controls

754

3402

2.43

97.87

2.8

2.7

65.34

66.33

g/l

2.80

707

3128

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2856

12787

1.58

97.75

2.9

1.6

65.78

66.67

g/l

7.70

2598

11517

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

541

2120

2.92

97.72

4.4

1.6

64.59

66.55

g/l

6.92

521

1901

Other and unspecified types of non-Hodgkin lymphoma, hilmo

418

1452

3.53

97.51

3.3

3.0

63.85

66.20

g/l

6.10

400

1333

Amputation

851

4075

2.34

97.17

2.8

2.6

63.80

66.01

g/l

11.70

771

3662

Acute sinusitis

2771

16642

1.56

96.75

3.5

2.4

66.17

66.67

g/l

2.84

2543

15378

Hypoparathyroidism

364

1172

3.83

96.46

2.4

2.9

65.40

66.51

g/l

2.02

329

1068

Abnormal findings on diagnostic imaging of other body structures

1026

5250

2.13

96.14

3.1

2.7

65.60

66.47

g/l

2.78

960

4796

ILD, hospital admissions 1, main diag only

1108

5873

2.09

95.61

2.4

2.6

66.21

65.92

g/l

0.56

1037

5324

Obesity, other/unspecified

1812

10938

1.73

95.00

1.9

2.6

66.50

66.67

g/l

0.44

1699

10120

Other diseases of blood and blood-forming organs

567

2313

2.80

94.51

3.6

2.8

66.62

66.38

g/l

0.29

516

2143

Diseases of pulp and periapical tissues and dental caries

4045

14568

1.47

94.50

2.5

2.6

66.08

66.19

g/l

0.37

3683

13261

Diseases of the myoneural junction and muscle

929

4632

2.21

94.42

2.1

2.6

64.66

66.20

g/l

6.77

828

4223

Diagnoses used for exclusion with ILD

1734

10435

1.77

94.39

2.3

2.6

65.90

66.17

g/l

0.71

1599

9507

Marginal zone B-cell lymphoma, including Hilmo

208

465

6.28

94.35

2.7

1.6

66.16

67.06

g/l

0.72

196

422

Other degenerative diseases of the nervous system

1799

7830

1.76

94.22

2.2

3.0

66.28

66.06

g/l

0.56

1604

7172

Cholelithiasis

5003

25113

1.40

94.14

2.7

66.12

66.43

g/l

2.07

4568

23005

Valvular operations

967

4880

2.14

93.62

2.0

2.7

65.41

66.69

g/l

5.40

902

4405

Candidiasis, including avohilmo

1796

10899

1.73

93.16

2.8

2.6

65.74

66.50

g/l

3.84

1640

9975

Biological medication for rheuma

965

4843

2.11

93.12

2.0

2.7

67.64

66.95

g/l

1.96

916

4538

Rheumatism, unspecified

860

4161

2.24

93.09

2.1

3.0

66.78

66.38

g/l

0.87

801

3799

Other diseases of anus and rectum

1951

12059

1.69

92.93

2.7

2.6

65.86

66.32

g/l

1.82

1745

10972

Malignant neoplasm of respiratory system and intrathoracic organs

1494

7138

1.85

92.74

2.0

1.7

64.89

66.52

g/l

12.92

1406

6412

Paralytic ileus and intestinal obstruction

1721

10355

1.75

92.71

3.1

2.6

65.04

66.24

g/l

7.36

1585

9419

Giant cell arteritis with polymyalgia rheumatica

402

1420

3.56

92.29

1.8

2.9

65.20

66.21

g/l

1.80

366

1287

Other chronic obstructive pulmonary disease, including avohilmo

3632

21057

1.48

91.85

2.1

2.8

65.13

66.28

g/l

15.08

3296

19310

Unspecified fall

3164

21421

1.50

91.55

2.4

2.6

65.57

66.32

g/l

6.23

2793

19635

Soft tissue disorders related to use, overuse and pressure

1711

10314

1.75

91.36

2.5

2.8

66.12

66.37

g/l

0.71

1569

9459

Zoster [herpes zoster]

1343

7621

1.90

91.15

4.0

2.6

65.68

66.13

g/l

1.28

1238

6872

Gastric ulcer

1281

7170

1.92

90.74

2.4

2.7

65.00

66.00

g/l

4.17

1176

6449

3370

20981

1.48

90.48

1.9

2.7

65.99

66.54

g/l

3.43

3061

19495

Ischaemic Stroke, excluding all haemorrhages

3815

19990

1.46

90.44

2.3

2.8

65.29

66.25

g/l

11.34

3465

18203

3504

21384

1.47

90.43

1.9

2.8

66.02

66.54

g/l

3.25

3187

19874

Osteonecrosis

516

2059

2.88

90.18

8.1

2.6

65.20

66.62

g/l

3.79

479

1910

malignant neoplasm of female genital organs, including Hilmo

1106

5619

2.01

90.17

4.7

1.5

65.03

66.53

g/l

8.91

1032

4973

Basal cell carcinoma

2759

12540

1.56

90.05

2.9

1.6

65.71

66.64

g/l

8.20

2503

11281

Disorders of continuity of bone

643

2804

2.50

89.94

3.3

2.5

66.19

66.75

g/l

1.11

597

2605

Anxiety disorders

4800

24198

1.39

89.92

2.4

2.7

66.53

66.54

g/l

0.03

4403

22349

Neurotic, stress-related and somatoform disorders

4737

23934

1.40

89.84

2.5

2.7

66.53

66.56

g/l

0.10

4346

22112

Other abnormal findings of blood chemistry

406

1434

3.30

89.82

3.6

2.8

66.54

66.63

g/l

0.08

390

1330

Dental caries, including avohilmo

4437

16364

1.43

89.76

2.5

2.6

66.11

66.21

g/l

0.35

4037

14941

Acute upper respiratory infections of multiple and unspecified sites

4251

22390

1.42

89.75

3.8

2.4

65.97

66.53

g/l

4.83

3928

20594

Caries of dentine, including avohilmo

4704

17495

1.41

89.51

2.5

2.7

66.13

66.28

g/l

0.58

4280

15996

Other diseases of hard tissues of teeth

3446

12298

1.50

89.48

2.5

66.19

66.15

g/l

0.11

3119

11234

Other noninfective gastroenteritis and colitis

1526

8970

1.79

89.39

2.9

2.6

65.67

66.34

g/l

2.63

1418

8186

Diseases of pulp and periapical tissues, including avohilmo

5939

23161

1.36

89.38

2.6

66.44

66.37

g/l

0.26

5456

21219

Myocardial infarction, without ST-elevation

2875

17707

1.54

89.05

2.4

2.7

65.26

66.04

g/l

6.36

2602

16052

Non-allergic asthma (mode)

1019

5234

2.03

88.89

2.3

65.92

67.10

g/l

5.25

949

4735

Respiratory insufficiency

590

2489

2.60

88.86

1.9

2.1

64.88

66.54

g/l

5.61

537

2217

Polyuria

1567

9346

1.79

88.72

2.3

2.7

66.34

66.19

g/l

0.35

1418

8561

Alcohol use disorder, Swedish definition

3203

20197

1.49

88.69

1.9

2.7

65.96

66.52

g/l

3.43

2914

18768

SLE, strict definition

309

941

3.97

88.63

2.1

2.9

65.98

67.17

g/l

1.75

291

873

SLE, ICD10

309

941

3.97

88.63

2.1

2.9

65.98

67.17

g/l

1.75

291

873

Other and unspecified diseases of blood and blood-forming organs

282

821

4.35

88.07

4.6

2.9

66.55

66.72

g/l

0.13

268

767

Sequelae with surgical and medical care as external cause

1405

8156

1.85

87.96

2.7

65.57

66.22

g/l

2.41

1315

7430

Acute peritonitis

530

2168

2.80

87.95

3.3

2.8

63.06

66.42

g/l

18.13

509

1994

Pain in thoracic spine

904

4530

2.12

87.91

2.9

2.6

66.89

66.45

g/l

1.10

833

4176

Intracranial injury

3486

22929

1.46

87.78

2.4

2.6

66.21

66.43

g/l

0.92

3146

21062

Anxiety (asthma-related co-morbidities)

2931

15098

1.51

87.53

2.2

2.7

66.67

66.80

g/l

0.38

2687

14097

Acute upper respiratory infections

6046

27601

1.34

87.22

3.4

2.4

66.13

66.44

g/l

2.31

5543

25306

Angina pectoris

3506

16383

1.47

86.15

2.7

2.9

65.89

66.40

g/l

3.56

3256

14853

Myocardial infarction, strict

2947

14269

1.53

85.96

2.4

2.8

65.36

66.32

g/l

9.27

2707

12911

Complications of internal orthopaedic prosthetic devices, implants and grafts

1603

9723

1.76

85.43

2.3

2.6

65.73

66.04

g/l

0.82

1444

8784

Other disorders of veins

2484

16316

1.56

85.33

2.4

2.7

66.37

66.49

g/l

0.33

2235

14905

Injury, poisoning and certain other consequences of external causes

2783

9252

1.55

85.13

2.6

2.7

66.54

66.92

g/l

1.65

2558

8586

Acute myeloid leukaemia

172

357

6.77

84.93

2.3

1.5

65.79

66.81

g/l

0.87

167

325

Acute myeloid leukaemia, including Hilmo

172

357

6.77

84.93

2.3

1.5

65.79

66.81

g/l

0.87

167

325

Acute myeloid leukaemia, helper endpoint

172

357

6.77

84.93

2.3

1.5

65.79

66.81

g/l

0.87

167

325

Peripheral artery operations in Hilmo

974

5117

2.07

84.85

2.7

2.6

64.27

66.04

g/l

8.63

879

4607

Other general symptoms and signs

330

1039

3.47

84.82

1.9

2.5

67.08

67.06

g/l

0.02

311

960

Other abnormalities of plasma proteins

203

486

5.76

84.53

4.4

2.9

63.02

66.26

g/l

4.26

193

436

Amputation of toe

622

2795

2.55

84.28

2.8

2.7

63.93

66.08

g/l

8.28

564

2551

Open wound of head

3347

22213

1.46

84.25

2.5

2.7

65.82

66.39

g/l

4.10

3015

20440

Nonischemic cardiomyopathy

748

3587

2.30

84.18

2.6

2.7

64.35

66.24

g/l

7.63

705

3244

Migraine

2374

12091

1.57

84.01

2.3

2.8

66.83

66.60

g/l

0.85

2202

11209

Seropositive rheumatoid arthritis, strict definition

1009

5374

2.03

84.00

1.9

2.7

66.33

66.42

g/l

0.14

946

4919

Injuries to the shoulder and upper arm

5028

29128

1.37

83.93

2.8

2.6

66.19

66.42

g/l

1.31

4571

26799

Irritable bowel syndrome

1506

8966

1.76

83.43

2.5

66.50

66.65

g/l

0.33

1371

8236

Mycoses, including avohilmo

5179

29762

1.36

82.87

2.6

66.27

66.47

g/l

1.09

4743

27419

Peripheral arterial reconstruction

1316

7662

1.86

82.80

2.3

2.6

64.61

65.83

g/l

6.31

1197

6875

Migraine without aura

867

4341

2.08

82.71

2.5

2.6

66.91

66.99

g/l

0.11

808

4063

Other disorders of ear

5358

26216

1.35

82.12

2.7

2.6

66.31

66.39

g/l

0.32

4864

24178

Systemic lupus erythematosus, unspecified

270

793

4.14

82.00

1.9

2.8

66.03

67.28

g/l

1.75

255

741

Spondyloarthritis

1061

5757

1.95

81.59

2.4

2.6

66.67

66.37

g/l

0.58

996

5262

Arthropathies in other diseases classified elsewhere

306

970

3.71

81.57

3.0

3.2

65.68

66.30

g/l

0.68

281

893

Selective serotonin reuptake inhibitors

5498

21612

1.35

81.12

2.4

2.8

66.55

66.40

g/l

0.68

5000

19978

Malignant neoplasm of mesothelium and soft tissue

355

1237

3.38

81.00

4.0

1.6

64.49

66.69

g/l

5.50

346

1122

Secondary right heart disease

401

1504

3.19

80.82

2.1

2.8

65.45

66.25

g/l

1.20

379

1374

Haemorrhage, not elsewhere classified

342

1173

3.40

79.76

2.5

2.4

64.27

66.46

g/l

5.01

319

1068

All anxiety disorders

2966

15949

1.48

79.27

2.2

2.6

66.69

66.78

g/l

0.24

2721

14830

Hypothyroidism, other/unspecified

4930

24382

1.36

79.03

2.6

2.7

66.37

66.39

g/l

0.08

4523

22361

Other viral diseases

1442

8575

1.74

78.73

4.0

2.5

65.19

66.78

g/l

11.34

1369

7976

Exclusions for E4_PCOS_BROAD

1007

5438

1.97

78.69

2.9

2.7

65.57

66.66

g/l

4.57

945

5041

Idiopathic thrombocytopenic purpura

279

860

3.92

78.63

3.5

2.7

66.33

66.49

g/l

0.11

265

792

malignant neoplasm of female genital organs

977

5130

2.00

78.57

4.9

1.5

64.99

66.50

g/l

8.11

912

4540

Other anxiety disorders

2149

11924

1.58

78.47

2.1

2.6

66.79

66.89

g/l

0.25

1981

11103

Mental and behavioural disorders due to psychoactive substance use

3342

21863

1.44

78.47

1.9

2.7

66.07

66.55

g/l

2.71

3023

20306

Other diseases of intestine

1050

5778

1.95

78.42

2.6

64.88

66.32

g/l

7.35

1000

5285

Alcoholic liver disease

737

3631

2.24

77.61

1.7

2.8

65.32

66.32

g/l

2.24

664

3366

COPD related to multimorbidity

2761

16219

1.51

77.24

2.1

2.8

64.85

66.15

g/l

14.76

2492

14781

Elevated blood glucose level

589

2658

2.44

76.94

2.9

2.6

65.33

66.25

g/l

2.07

549

2450

Pericarditis

295

950

3.61

76.33

2.8

2.6

64.29

67.22

g/l

8.23

279

862

Persons encountering health services for specific procedures, not carried out

541

2350

2.50

76.20

2.3

2.4

66.17

67.22

g/l

2.48

504

2174

Other diseases of arteries and capillaries

664

3163

2.31

76.14

2.5

2.7

65.31

66.34

g/l

2.77

600

2892

COPD, early/later onset

3071

18298

1.47

76.01

2.1

2.8

64.98

66.19

g/l

14.00

2786

16720

Malignant neoplasm of urinary organs, including Hilmo

800

4085

2.13

75.67

3.0

1.6

65.54

66.55

g/l

2.94

740

3659

Meniscus derangement

2966

13731

1.48

75.44

2.7

2.8

66.67

66.13

g/l

3.59

2728

12641

Other viral diseases, including avohilmo

1800

11341

1.62

75.44

3.6

2.4

65.58

66.84

g/l

9.56

1708

10549

Allergic asthma (mode), excluding more controls

926

4763

1.96

75.37

2.1

2.2

66.80

67.78

g/l

4.10

864

4363

Substance abuse

3234

21523

1.44

74.82

1.9

2.7

66.06

66.55

g/l

2.84

2926

19995

Demyelinating diseases of the central nervous system

489

2051

2.59

74.44

1.8

2.6

68.19

67.13

g/l

2.60

465

1914

Hypothyreosis and Thyroxine purchase for inclusion criteria

5118

25579

1.34

74.27

2.6

66.36

g/l

0.01

4698

23469

Sub-endpoint used in defining T1D endpoints

1626

10008

1.67

74.09

2.5

64.94

66.37

g/l

11.67

1517

9128

Other pulmonary heart/vessel disease

421

1688

2.93

73.97

2.0

2.7

65.41

66.11

g/l

0.99

394

1539

Charcot foot

187

459

5.19

73.83

3.4

3.1

65.34

67.21

g/l

2.43

174

423

Other or unspecified ileus, impaction or obstruction

1234

7243

1.81

73.50

3.1

2.5

65.07

66.17

g/l

4.38

1138

6552

COPD, hospital admissions

3027

18169

1.46

73.41

2.1

2.8

65.00

66.17

g/l

13.16

2748

16599

Oesophageal varices

362

1351

3.15

73.09

1.8

2.9

65.15

66.59

g/l

2.20

342

1246

Malignant neoplasm of bronchus and lung, including Hilmo

1420

7183

1.75

73.01

2.0

1.7

64.77

66.49

g/l

13.23

1332

6441

Cervicalgia

1205

7024

1.80

72.78

2.3

2.6

66.85

66.23

g/l

2.28

1094

6437

Gingivitis and periodontal diseases

5655

22524

1.32

72.70

2.6

66.40

66.31

g/l

0.33

5159

20663

Disorders of synovium and tendon

2838

16893

1.46

72.48

2.3

2.8

66.39

66.47

g/l

0.23

2611

15523

Functional dyspepsia

1539

9574

1.68

72.38

2.7

66.65

66.48

g/l

0.39

1422

8775

Spondylopathies (FG)

703

3449

2.16

72.17

2.0

2.8

67.60

66.58

g/l

2.82

658

3205

Urticaria

1541

9576

1.67

72.15

2.7

2.6

66.95

66.60

g/l

1.06

1420

8843

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

704

3499

2.20

72.00

3.0

1.6

65.38

66.47

g/l

3.04

659

3131

Abnormal involuntary movements

881

4719

2.01

71.78

2.6

2.8

66.44

66.21

g/l

0.41

798

4330

Other complications of surgical and medical care, not elsewhere classified

641

3071

2.27

71.61

2.8

2.6

65.73

66.60

g/l

2.07

597

2831

Carpal tunnel syndrome

3485

22047

1.41

71.48

2.5

2.7

66.70

66.36

g/l

1.98

3224

20230

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

601

2818

2.33

71.14

3.7

2.6

65.97

66.67

g/l

1.39

563

2606

Need for other prophylactic measures

431

1764

2.76

70.97

2.5

2.9

64.49

66.69

g/l

6.45

417

1631

Fentanyl

709

3529

2.16

70.86

5.7

2.2

64.96

65.83

g/l

1.95

638

3159

Other disorders of adrenal gland

345

1268

3.10

70.47

2.8

2.9

64.54

66.69

g/l

5.29

330

1182

Decubitus ulcer and pressure area

525

2364

2.51

70.30

2.0

2.6

63.94

66.12

g/l

6.68

471

2146

Personality disorders, excluding more controls

1098

6243

1.82

70.22

2.0

2.7

66.52

67.12

g/l

1.94

1016

5895

All influenza (not pneumonia)

819

4293

2.02

69.92

4.5

2.3

65.67

67.23

g/l

6.54

757

3932

Cardiodefibrillation

2415

16725

1.51

69.88

2.5

2.7

65.28

66.12

g/l

6.09

2222

15257

Adrenocortical insufficiency

299

1033

3.38

68.98

2.8

3.0

64.15

66.81

g/l

6.88

284

959

Myeloproliferative diseases

634

3100

2.28

68.82

2.7

66.58

66.25

g/l

0.48

585

2829

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1205

7001

1.76

68.65

2.0

2.6

66.14

66.92

g/l

3.08

1117

6583

Other symptoms and signs involving the digestive system and abdomen

1005

5664

1.87

68.46

3.6

2.6

65.76

66.50

g/l

2.38

914

5163

L01XX Other antineoplastic agents

501

2253

2.56

68.28

4.2

2.7

65.46

66.29

g/l

1.42

466

2073

Eosinophilic disease (BM)

147

314

5.84

68.27

2.3

2.2

65.17

66.93

g/l

1.55

134

290

Artrosis, including avohilmo

4494

18595

1.35

67.51

2.2

2.8

66.76

66.27

g/l

4.28

4110

17188

Vascular disorders of the intestines

554

2586

2.39

67.47

2.3

2.4

65.43

65.99

g/l

0.84

517

2325

Non-small cell lung cancer, including Hilmo

1022

5473

1.87

66.99

1.9

1.6

64.94

66.55

g/l

8.83

957

4882

Renal tubulo-interstitial disorders in diseases classified elsewhere

125

242

7.35

66.82

6.5

2.5

63.72

66.66

g/l

3.44

120

226

Tumor necrosis factor alpha inhibitors

805

4259

1.99

66.62

2.0

2.7

67.92

67.02

g/l

2.70

761

3985

Nonalcoholic fatty liver disease

630

3085

2.21

66.42

2.1

2.9

67.98

66.76

g/l

3.25

574

2873

Diseases of peritoneum

699

3577

2.13

65.93

3.0

2.7

63.90

66.30

g/l

13.20

660

3276

Diabetic retinopathy

2346

10053

1.53

65.59

2.4

2.3

65.79

66.47

g/l

4.01

2154

9225

Non-selective monoamine reuptake inhibitors

2146

14072

1.52

65.27

2.4

2.8

66.11

66.28

g/l

0.51

1946

12903

Somatoform disorder

894

4941

1.91

64.88

2.4

2.7

66.74

66.84

g/l

0.16

813

4577

Drug-induced neutropenia

522

2420

2.41

64.84

4.0

2.9

64.22

66.52

g/l

8.11

505

2232

Pneumonia due to other infectious organisms, not elsewhere classified

273

930

3.42

64.49

5.7

2.4

62.82

66.87

g/l

10.23

264

848

Disorder of lipoprotein metabolism, unspecified

890

4962

1.93

64.22

2.3

2.6

66.11

66.30

g/l

0.29

819

4470

Cervical disc disorders

1998

13542

1.53

63.68

2.4

2.7

66.67

66.26

g/l

1.80

1851

12516

Sarcoidosis

831

4545

1.97

63.63

2.1

2.7

66.54

66.60

g/l

0.09

792

4197

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1773

11737

1.57

63.51

2.5

2.6

65.63

66.45

g/l

4.33

1594

10789

Disorders of sclera, cornea, iris and ciliary body

3049

22288

1.41

63.46

2.6

66.88

66.37

g/l

3.35

2820

20488

Subjective visual disturbances

1503

9614

1.64

63.35

2.6

2.7

66.82

66.37

g/l

1.67

1380

8797

Hypothyroidism, strict autoimmune, 3 medication purchases required

4572

23614

1.33

63.25

2.6

66.50

66.35

g/l

0.64

4172

21630

Other skin changes

1304

8093

1.71

63.22

3.6

2.7

65.36

66.17

g/l

3.17

1196

7354

Symptoms and signs involving speech and voice

2007

13676

1.53

62.98

2.5

2.6

66.26

66.23

g/l

0.06

1848

12479

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

674

3467

2.12

62.69

3.2

2.8

65.07

66.38

g/l

4.10

634

3194

Allergic asthma (mode)

926

5054

1.84

62.60

2.1

2.2

66.80

67.50

g/l

2.32

864

4641

Chronic sinusitis

2291

15971

1.48

62.21

2.7

66.21

66.47

g/l

0.90

2119

14738

Other and unspecified myopathies

651

3328

2.15

62.09

2.2

2.6

64.46

66.19

g/l

5.87

568

3032

Chronic periodontitis, complicated

3346

24287

1.38

62.06

2.8

66.19

66.40

g/l

0.84

3087

22419

Coxibs

1570

5183

1.64

61.87

2.2

2.6

66.49

65.60

g/l

4.15

1430

4764

Recurrent or chronic depression

1880

8646

1.55

61.80

2.3

2.9

66.91

66.80

g/l

0.24

1719

8144

Benign neoplasm of other and ill-defined parts of digestive system

1175

7160

1.75

61.74

2.7

65.57

66.17

g/l

1.96

1089

6515

Diseases of spleen

185

518

4.50

61.13

2.1

2.8

64.74

66.57

g/l

1.89

178

484

Gout due to impairment of renal function

147

356

5.90

61.08

3.2

3.1

64.02

65.96

g/l

1.91

139

328

Psoriatic and enteropathic arthropathies

626

3138

2.12

61.04

2.0

2.9

67.44

66.45

g/l

2.88

589

2915

Degeneration of macula and posterior pole

3253

18637

1.40

60.56

2.7

65.89

65.96

g/l

0.18

2916

16884

Other extrapyramidal and movement disorders in other diseases

1549

10100

1.61

60.55

2.1

2.7

66.81

66.17

g/l

3.16

1404

9230

Other/unspecified rheumatoid arthritis

837

4672

1.94

60.53

2.0

2.6

65.24

66.13

g/l

2.24

769

4222

Pyogenic arthritis

450

2005

2.46

60.49

2.8

3.0

65.73

65.86

g/l

0.11

425

1838

Motor neuron disease ALS

189

537

4.28

60.40

1.6

3.0

67.86

65.97

g/l

3.39

176

501

Viral pneumonia (unknown virus, not influenza)

452

2020

2.46

60.38

4.6

2.8

64.80

66.63

g/l

5.11

424

1876

Type of accident

1658

10942

1.58

60.37

2.5

2.6

65.67

66.44

g/l

3.59

1484

10049

Motor neuron disease (with DMD)

191

546

4.22

60.36

1.6

3.0

67.83

65.90

g/l

3.58

178

510

Problems related to lifestyle

569

2764

2.19

60.31

2.0

2.7

66.28

66.96

g/l

1.23

525

2564

Malignant neoplasm of ovary, including Hilmo

425

1858

2.54

60.20

6.2

1.5

64.43

66.70

g/l

7.35

404

1653

COPD, hospital admission 2, with asthma infections

2171

13024

1.50

60.04

2.2

2.7

64.51

66.11

g/l

17.32

1962

11855

DVT of lower extremities

1204

7427

1.72

59.72

4.0

2.6

65.02

66.20

g/l

5.44

1097

6750

Phlebitis and thrombophlebitis (not including DVT)

1347

8532

1.66

59.46

3.5

2.6

65.31

66.38

g/l

5.47

1251

7792

Migraine with aura

1072

6360

1.74

59.40

2.1

2.7

66.79

66.72

g/l

0.11

995

5900

Malignant neoplasm of urinary organs

660

3441

2.08

58.88

2.9

1.6

65.62

66.42

g/l

1.67

612

3072

Benign neoplasm: Colon, unspecified

1687

11296

1.57

58.86

2.7

65.85

66.06

g/l

0.57

1519

10293

Unspecified acute lower respiratory infection

915

5254

1.84

58.80

3.7

2.4

65.15

66.46

g/l

5.64

853

4836

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1692

11284

1.56

58.67

2.0

2.9

67.37

66.51

g/l

5.20

1572

10532

Glucagon-like peptide-1 (GLP-1) analogues

1692

11284

1.56

58.67

2.0

2.9

67.37

66.51

g/l

5.20

1572

10532

Extrapyramidal and movement disorders

2426

17356

1.45

58.67

2.1

2.7

66.39

66.13

g/l

0.96

2176

15834

Papulosquamous disorders

2234

15728

1.47

58.59

2.3

2.7

66.99

66.38

g/l

3.42

2074

14496

Chronic rhinitis, nasopharyngitis and pharyngitis

1727

11548

1.55

58.58

2.3

2.7

66.66

66.50

g/l

0.41

1586

10656

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1145

7008

1.73

58.56

3.5

1.7

64.43

66.64

g/l

17.18

1085

6316

Other coagulation defects

473

2179

2.37

58.53

2.8

2.7

65.92

66.63

g/l

1.23

447

2008

Intestinal stricture

1976

13640

1.51

58.44

3.1

2.6

65.03

66.13

g/l

7.16

1825

12377

Lichen simplex chronicus and prurigo

449

2036

2.44

58.44

2.4

2.9

66.90

66.31

g/l

0.91

418

1868

Injuries to the knee and lower leg

6484

28254

1.26

58.31

2.4

2.7

66.01

66.51

g/l

5.80

5945

26004

Nonorganic sleeping disorders, excluding more controls

980

5717

1.78

58.29

2.1

2.6

66.45

66.79

g/l

0.74

909

5336

Other and unspecified drugs and medicaments

558

2750

2.21

58.26

3.7

2.7

66.01

66.56

g/l

0.94

524

2527

Persons with potential health hazards related to communicable diseases

1564

10134

1.57

57.93

2.6

2.4

65.89

66.92

g/l

6.04

1485

9474

Use of pramipexole

1397

9003

1.64

57.91

2.2

2.7

66.51

66.04

g/l

1.68

1250

8179

Diabetic neuropathy

861

4923

1.91

57.82

2.6

2.4

65.90

66.34

g/l

0.96

797

4495

Conductive and sensorineural hearing loss

4673

24226

1.31

57.79

2.8

2.7

66.17

66.31

g/l

0.58

4209

22297

Budesonide

726

3899

1.96

57.50

2.2

2.8

66.43

66.79

g/l

0.55

668

3572

Misadventures to patients during surgical and medical care

905

5230

1.84

57.43

3.2

2.6

64.80

66.32

g/l

6.77

835

4782

Other infectious diseases, including avohilmo

624

3221

2.11

57.43

3.3

2.6

64.76

66.29

g/l

4.99

583

2960

Abnormal results of function studies

554

2731

2.19

57.42

2.8

2.9

66.20

66.76

g/l

0.93

519

2542

Malignant neoplasm of bronchus and lung

1217

6313

1.70

57.31

1.9

1.7

64.85

66.48

g/l

10.47

1137

5645

Other disorders of bone

990

5837

1.77

57.22

4.1

2.4

66.46

66.77

g/l

0.68

919

5433

COPD, hospital admissions 3, with asthma pneumonia sepsis

1882

11049

1.53

57.13

2.2

2.7

64.28

65.99

g/l

16.58

1704

10016

Abnormal findings on diagnostic imaging of central nervous system

341

1385

2.74

56.65

2.4

3.0

67.14

66.78

g/l

0.36

316

1291

Other diseases of upper respiratory tract

6117

25596

1.27

56.59

2.6

66.38

66.33

g/l

0.17

5618

23469

Malignant neoplasm of kidney, except renal pelvis

602

3090

2.12

56.29

3.0

1.6

65.49

66.47

g/l

2.23

564

2763

Prurigo nodularis

229

771

3.58

56.21

2.3

3.2

67.29

66.43

g/l

0.89

213

710

Spondylopathies in diseases classified elsewhere

149

384

5.18

56.18

19.4

2.3

64.78

66.61

g/l

1.87

141

357

Other and unspecified aplastic anaemias

126

283

5.85

56.07

3.1

65.28

66.60

g/l

1.01

119

260

Discitis, unspecified

177

511

4.35

56.00

3.0

2.7

64.94

66.38

g/l

1.49

172

477

Insulin, fast-acting (human)

714

3850

1.95

55.86

2.8

2.4

64.19

66.88

g/l

18.80

674

3574

Noninfectious colitis NAS

809

4557

1.88

55.68

3.1

2.6

65.38

66.49

g/l

3.54

760

4176

Chronic tubulo-interstitial nephritis

275

1016

3.07

55.55

2.5

2.6

64.70

67.03

g/l

4.31

252

925

Mental and behavioural disorders due to alcohol

2768

19373

1.40

55.26

1.9

2.7

66.04

66.54

g/l

2.49

2517

18025

Sensorineural hearing loss

4519

23572

1.31

55.21

2.7

66.17

66.27

g/l

0.38

4059

21671

Trochanteric bursitis

867

4997

1.84

55.11

2.3

2.9

66.31

66.27

g/l

0.05

786

4560

Marginal zone B-cell lymphoma

119

261

6.25

55.07

2.3

1.6

67.28

66.88

g/l

0.19

112

238

Vitreous haemorrhage

684

3693

2.01

55.05

2.7

65.00

66.28

g/l

4.49

636

3386

Paracetamol or NSAID medication

746

1958

1.98

54.90

2.8

2.3

66.51

65.94

g/l

0.99

686

1839

Viral pneumonia (known virus, not influenza)

253

911

3.28

54.84

8.0

2.9

64.27

66.32

g/l

3.43

233

836

Protozoal diseases

263

970

3.22

54.75

6.5

3.0

63.30

66.61

g/l

7.24

253

901

Myeloproliferative diseases (CML excluded)

554

2807

2.19

54.60

2.9

2.7

66.82

66.24

g/l

0.93

508

2565

Bipolar affective disorders

839

4773

1.83

54.55

2.0

2.7

66.30

66.94

g/l

1.58

771

4473

Fracture of shoulder and upper arm

2112

14889

1.47

54.53

3.1

2.6

65.82

66.26

g/l

1.69

1881

13579

Open wound of lower leg

930

5486

1.79

54.50

2.4

2.6

64.61

66.38

g/l

9.51

847

4991

Exposure to other specified factors

4233

28345

1.31

54.17

2.4

2.7

66.35

66.50

g/l

0.69

3875

26195

Unspecified privation

666

3574

2.00

54.10

2.4

2.6

65.25

66.46

g/l

3.95

616

3295

Candidiasis

837

4804

1.85

54.08

3.3

2.6

64.90

66.56

g/l

7.10

770

4420

Postprocedural disorders of nervous system

359

1512

2.55

53.92

2.0

2.5

67.50

67.72

g/l

0.24

338

1417

Other disorders of glucose regulation and pancreatic internal secretion

526

2606

2.18

53.84

2.3

2.7

64.66

66.46

g/l

5.21

482

2407

Injuries to the elbow and forearm

3809

25150

1.33

53.79

2.5

2.7

65.97

66.51

g/l

4.54

3433

23135

Other embolism and thrombosis

807

4618

1.86

53.12

3.5

2.6

64.60

66.29

g/l

6.59

755

4198

Disorders of skin appendages

2451

17692

1.41

52.91

2.5

2.6

66.64

66.58

g/l

0.15

2291

16368

Substance use, excluding alcohol

973

5829

1.74

52.89

1.9

2.7

66.11

66.87

g/l

2.06

869

5461

Drug-induced adrenocortical insufficiency

177

530

4.12

52.75

3.1

3.0

63.91

66.95

g/l

5.19

167

496

Cerebral palsy and other paralytic syndromes

670

3627

1.97

52.72

2.2

2.6

65.97

66.37

g/l

0.63

613

3349

Other and unspecified coagulation defects

324

1329

2.69

52.57

2.8

2.9

66.16

67.03

g/l

1.29

312

1239

MS-disease / Multiple Sclerosis

378

1650

2.46

52.57

1.7

2.6

68.31

67.41

g/l

1.77

362

1543

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1828

12652

1.50

52.55

2.6

65.82

66.44

g/l

3.14

1699

11620

Other peripheral vascular diseases

516

2568

2.18

52.33

2.0

2.7

67.10

66.59

g/l

1.00

475

2370

Asthma and allergy, excluding more controls

464

2152

2.20

52.32

2.3

2.1

67.05

68.00

g/l

2.29

434

1992

Crystal arthropathies, rheuma endpoint

191

604

3.88

52.27

2.4

3.5

65.02

65.92

g/l

0.85

175

548

Non-small cell lung cancer, adenocarcinoma

457

2190

2.31

52.07

1.9

1.6

64.17

66.53

g/l

8.82

429

1957

Protozoal diseases, including avohilmo

264

1000

3.10

52.05

6.5

3.1

63.31

66.63

g/l

7.36

254

928

Spondylolisthesis/Spondylolysis

1013

6182

1.72

51.87

2.9

2.7

66.52

66.34

g/l

0.32

937

5689

Internal derangement of knee

1840

12615

1.48

51.84

2.4

2.9

66.74

66.21

g/l

2.63

1680

11660

Congenital malformations of the urinary system, including avohilmo

381

1691

2.47

51.74

2.4

2.9

64.57

66.52

g/l

5.28

363

1574

Chronic pancreatitis

792

4550

1.86

51.71

2.0

2.7

64.92

66.39

g/l

5.34

735

4185

Collagenous colitis

598

3151

2.05

51.68

2.8

2.7

65.77

66.39

g/l

1.03

551

2902

Diseases of the ear and mastoid process

5944

24071

1.26

51.43

2.7

2.6

66.50

66.46

g/l

0.16

5451

22259

Transient ischemic attack

3288

19948

1.35

51.35

2.4

2.8

65.64

66.27

g/l

5.05

2991

18148

Heart failure and hypertrophic cardiomyopathy

194

633

3.88

51.24

3.0

3.1

64.23

66.22

g/l

2.82

184

580

Oxicams

1360

4947

1.62

51.15

2.4

2.6

66.52

65.51

g/l

4.61

1233

4536

Congenital malformations, deformations and chromosomal abnormalities

2696

18896

1.38

51.03

2.4

2.6

66.23

66.70

g/l

2.63

2519

17486

Other metabolic disorders

691

3803

1.91

50.87

3.5

2.5

66.02

66.87

g/l

2.32

651

3487

Other symptoms and signs involving the circulatory and respiratory systems

413

1904

2.35

50.79

2.5

2.6

65.62

66.54

g/l

1.42

375

1743

Hypocalcemia

211

719

3.52

50.71

4.6

3.1

64.42

66.92

g/l

4.03

192

669

2778

18696

1.39

50.62

2.9

2.7

65.60

65.98

g/l

1.83

2505

16870

Other demyelinating diseases of the central nervous system

226

785

3.20

50.58

1.9

2.8

68.29

68.03

g/l

0.21

215

746

Phobic anxiety disorders

524

2613

2.08

50.46

2.4

2.6

67.05

67.57

g/l

0.75

492

2470

Epilepsy

1652

11254

1.51

50.39

2.3

2.7

65.94

66.15

g/l

0.47

1499

10316

Disorders of muscles

585

3075

2.02

50.05

2.1

2.7

66.02

66.47

g/l

0.77

546

2829

Acute pancreatitis

1171

7487

1.64

49.86

2.4

2.6

65.73

66.35

g/l

1.72

1080

6847

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2401

17413

1.41

49.82

1.8

2.7

65.96

66.55

g/l

2.88

2184

16205

Folate deficiency anaemia

128

323

5.34

49.79

2.7

3.0

64.75

66.75

g/l

1.56

123

294

Reactive arthropathies

482

2372

2.17

49.78

2.8

3.0

66.65

66.20

g/l

0.66

448

2198

Cystic kidney disease

243

897

3.12

49.70

2.6

3.0

64.05

66.88

g/l

6.75

232

834

Hodgkin lymphoma, hilmo

213

731

3.36

49.63

2.5

3.1

66.07

66.64

g/l

0.40

206

680

Congenital malformations of the urinary system

357

1570

2.49

49.58

2.5

2.9

64.48

66.47

g/l

5.20

343

1462

Polycystic kidney disease

209

713

3.43

49.58

2.8

3.1

64.09

67.07

g/l

6.47

199

667

Viral and other specified intestinal infections, including avohilmo

1193

7316

1.61

49.40

2.8

2.3

65.84

67.02

g/l

5.83

1128

6754

Dilated cardiomyopathy

798

4673

1.84

49.33

2.1

2.7

64.18

66.14

g/l

9.87

751

4275

Gonarthrosis,primary

5243

25469

1.27

49.24

2.5

2.8

66.56

66.24

g/l

2.37

4797

23362

Malignant neoplasm of digestive organs, including Hilmo

2375

12700

1.42

49.18

2.5

1.6

64.48

66.66

g/l

29.33

2166

11458

Non-small cell lung cancer

701

3893

1.90

49.12

1.8

1.6

64.69

66.40

g/l

6.95

657

3454

Psoriasis

1555

10583

1.53

48.96

2.2

2.7

67.05

66.49

g/l

2.16

1452

9757

Infection of intervertebral disc (pyogenic)

146

407

4.58

48.90

2.7

2.9

64.38

66.36

g/l

1.91

138

379

Raynaud syndrome

510

2585

2.12

48.85

1.8

2.7

67.37

66.68

g/l

1.51

469

2386

Other and unspecified urticaria

977

5992

1.70

48.70

2.5

2.6

66.81

66.64

g/l

0.30

896

5545

Sequelae of cerebrovascular disease

2380

14921

1.41

48.55

2.2

2.7

65.32

66.07

g/l

4.54

2110

13532

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

821

4670

1.79

48.34

2.3

2.8

64.87

66.62

g/l

8.47

781

4339

Cystic kidney disease, including avohilmo

254

972

2.98

48.33

2.6

2.9

64.09

66.79

g/l

6.49

242

903

Malignant neoplasm of ovary

328

1413

2.59

48.33

6.2

1.5

64.07

66.69

g/l

7.70

311

1259

Poisoning by drugs, medicaments and biological substances

1068

6693

1.65

48.31

2.1

2.6

66.14

66.91

g/l

2.61

978

6252

Vitamin deficiency

330

1422

2.57

48.30

2.4

2.9

65.83

66.55

g/l

0.96

298

1308

Vitamin deficiency, wide

330

1422

2.57

48.30

2.4

2.9

65.83

66.55

g/l

0.96

298

1308

Primary biliary cholangitis, wide definition

183

586

3.65

48.16

1.6

3.0

67.32

67.26

g/l

0.03

171

544

Serous carcinoma of ovary, including Hilmo

261

1020

2.96

48.10

7.2

1.5

64.48

66.75

g/l

4.71

251

912

Other specified/unspecified necrotizing vasculopathies

139

378

4.65

48.04

2.1

3.1

64.79

66.67

g/l

1.88

133

352

Myocarditis

246

912

2.91

48.04

3.0

2.4

65.03

67.73

g/l

5.49

230

833

Other crystal arthropathies

191

637

3.66

47.96

2.4

3.2

65.02

65.81

g/l

0.72

175

576

Coxarthrosis, primary

3739

24286

1.31

47.95

2.4

2.8

66.34

66.12

g/l

1.08

3372

22154

Delirium, not induced by alcohol and other psychoactive substances

904

5500

1.75

47.78

2.4

2.6

64.76

65.75

g/l

3.01

807

4942

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

875

5092

1.75

47.65

2.3

2.8

65.01

66.60

g/l

7.65

827

4716

Other enthesopathies

1492

10100

1.52

47.59

2.5

2.8

66.73

66.57

g/l

0.40

1370

9312

Alcohol use disorder, ICD-based

2217

16158

1.41

47.33

1.8

2.7

66.01

66.53

g/l

2.17

2021

15044

Polyarthritis, unspecified

254

979

2.91

47.25

2.5

3.1

65.87

66.09

g/l

0.16

236

902

L01XE Protein kinase inhibitors

401

1918

2.36

46.82

3.8

3.0

64.06

66.44

g/l

7.01

385

1778

Superficial injury of head

1386

9292

1.55

46.71

2.1

2.6

65.85

66.25

g/l

1.24

1255

8452

Radiculopathy

937

5767

1.71

46.65

2.6

66.54

65.98

g/l

1.52

851

5252

In situ neoplasms

2376

17585

1.40

46.55

2.7

2.6

65.56

66.16

g/l

3.43

2159

15954

Exclusions for E4_PCOS_CONSORTIUM

3347

16018

1.33

46.44

2.8

2.5

66.27

66.67

g/l

2.27

3042

14686

Drug-induced osteoporosis

147

429

4.45

46.44

2.0

3.1

64.01

67.18

g/l

4.72

138

400

Actinic keratosis

2590

17691

1.38

46.35

3.0

2.6

65.50

65.92

g/l

2.09

2338

15932

Skin changes due to chronic exposure to nonionizing radiation

2642

18009

1.38

46.31

3.0

2.7

65.52

65.94

g/l

2.07

2384

16231

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

227

848

3.15

46.04

6.5

1.5

63.61

66.82

g/l

7.44

219

758

Panic disorder

601

3252

1.92

45.96

2.0

2.7

66.66

67.38

g/l

1.56

547

3053

Hepatic failure, not elsewhere classified

285

1185

2.73

45.91

2.4

3.0

63.84

66.60

g/l

4.57

258

1091

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

3005

20875

1.34

45.88

2.3

2.6

66.24

66.67

g/l

2.41

2793

19323

L04AC Interleukin inhibitors

361

1642

2.37

45.83

2.0

2.8

67.37

67.27

g/l

0.08

344

1541

Other diseases of pancreas

573

3111

2.00

45.64

2.8

65.03

66.31

g/l

3.30

534

2851

Other and unspecified acquired haemolytic anaemias

113

277

5.48

45.60

3.0

2.3

65.28

66.15

g/l

0.39

106

259

Asthma and allergy

464

2269

2.09

45.52

2.3

2.1

67.05

67.75

g/l

1.41

434

2098

Acetic acid derivatives and related substances

1492

5144

1.54

45.46

2.4

2.6

66.38

65.59

g/l

3.29

1366

4726

Reactive arthropathies, FINNGEN

379

1763

2.31

45.39

2.8

3.1

66.75

66.38

g/l

0.46

352

1620

Invasive ventilation

487

2508

2.12

45.38

2.8

63.58

66.37

g/l

9.40

456

2314

Diseases of salivary glands

1738

12251

1.47

45.29

2.4

2.7

66.64

66.42

g/l

0.54

1588

11253

Other viral diseases, not elsewhere classified, including avohilmo

1211

7874

1.58

45.26

3.3

2.5

65.56

66.78

g/l

6.45

1141

7315

Unspecified nephritic syndrome

187

633

3.50

45.25

4.2

2.9

63.43

66.70

g/l

5.71

179

585

Amiodarone users

703

4081

1.87

45.22

2.3

2.7

64.05

66.02

g/l

9.35

659

3725

Iridocyclitis

1241

8203

1.58

45.21

2.8

2.6

67.07

66.38

g/l

2.43

1155

7534

Unstable angina pectoris

2267

13098

1.41

44.99

2.4

2.8

65.80

66.13

g/l

1.26

2070

11795

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

214

770

3.06

44.82

2.4

2.7

64.39

68.11

g/l

10.95

201

745

Poisoning by medicine

958

5959

1.67

44.76

2.1

2.6

66.18

66.95

g/l

2.35

876

5574

Systemic atrophies primarily affecting the central nervous system

328

1472

2.52

44.64

2.3

3.0

67.74

66.35

g/l

3.36

308

1350

Oter anti-inflammatory and antirheumatic agents, non-steroids

1318

4758

1.58

44.29

2.4

2.6

66.04

65.45

g/l

1.79

1189

4355

Disorders of adult personality and behaviour

1171

7641

1.58

44.20

1.9

2.5

66.44

67.03

g/l

2.01

1075

7168

Tubulo-interstitial nephritis, not specified as acute or chronic

410

1995

2.21

44.02

2.8

2.4

65.25

66.59

g/l

2.46

374

1812

Haemorrhoids and perianal venous thrombosis

1908

13633

1.43

43.99

2.6

66.28

66.38

g/l

0.24

1740

12441

Adalimumab

483

2481

2.06

43.99

2.0

2.8

68.30

67.05

g/l

3.17

458

2329

Herpesviral [herpes simplex] infections

649

3675

1.87

43.95

3.3

2.6

65.55

66.62

g/l

2.78

610

3386

Hypoglycaemia, other or unspecified

414

2028

2.21

43.84

2.2

2.7

64.43

66.57

g/l

6.36

379

1879

Nonhereditary hypogammaglobulinemia

111

274

5.18

43.76

4.3

2.8

61.42

67.52

g/l

10.20

106

261

Other infectious diseases

507

2679

2.05

43.74

3.4

2.6

64.51

66.27

g/l

5.28

471

2461

Hypertrophic cardiomyopathy

318

1421

2.54

43.74

3.0

64.64

66.43

g/l

4.12

303

1316

Other viral diseases, not elsewhere classified

893

5488

1.69

43.52

3.8

2.5

65.00

66.68

g/l

8.12

840

5082

Essential (haemorrhagic) thrombocythaemia

268

1108

2.73

43.49

2.5

1.6

66.47

67.02

g/l

0.52

244

1005

Cervicobrachial syndrome

1082

6986

1.61

43.35

2.5

2.7

67.04

66.45

g/l

2.08

1013

6440

Postprocedural endocrine and metabolic disorders, not elsewhere classified

625

3505

1.87

43.34

3.5

2.5

66.23

66.86

g/l

1.44

587

3214

Diabetic retinopathy, strict definition

1079

6222

1.64

43.28

2.6

2.4

65.28

66.56

g/l

6.15

993

5706

Superficial injury of hip and thigh

936

5872

1.68

43.24

2.2

2.5

65.28

66.13

g/l

2.80

833

5322

Viral and other specified intestinal infections

863

5131

1.69

43.21

3.0

2.3

65.45

67.01

g/l

6.66

813

4742

Eosinophilia

148

449

4.03

43.20

2.3

3.0

65.09

66.54

g/l

1.32

135

417

Fracture of lower leg, including ankle

2954

22319

1.33

43.15

2.3

2.7

66.07

66.53

g/l

2.52

2694

20529

Inflammatory bowel disease

1552

10819

1.48

42.72

2.3

2.7

66.63

66.62

g/l

0.03

1456

10018

Autoimmune hepatitis, wide definition

277

1163

2.61

42.65

2.4

2.9

67.08

66.92

g/l

0.10

257

1058

Dermatitis due to substances taken internally

337

1541

2.38

42.63

4.6

2.9

65.59

66.40

g/l

1.05

312

1424

Covid-19 suspected case

979

6197

1.64

42.59

3.0

2.5

66.41

66.95

g/l

1.44

921

5746

Voice disturbances

1490

10355

1.49

42.37

2.7

66.26

66.32

g/l

0.12

1380

9461

Generalized anxiety disorder

633

3560

1.83

42.35

2.0

2.6

66.97

67.30

g/l

0.55

585

3335

Benign neoplasm: Sigmoid colon

1207

8082

1.57

42.33

2.8

2.7

65.92

66.09

g/l

0.31

1107

7361

Enthesopathies of lower limb, excluding foot

1113

7270

1.58

42.30

2.5

2.6

66.39

66.44

g/l

0.08

1020

6723

Microscopic polyangiitis

196

7.02

42.28

1.7

2.8

62.82

66.56

g/l

3.50

181

Hernia of abdominal wall

2577

19570

1.35

42.26

2.6

2.7

65.99

66.35

g/l

1.53

2383

17992

Migraine without aura and triptan purchases

633

3572

1.83

42.17

2.0

2.5

67.00

67.26

g/l

0.41

592

3343

Hyperplasia of prostate

2118

8688

1.42

41.94

2.8

65.82

66.41

g/l

2.94

1959

8088

Follicular lymphoma, hilmo

331

1536

2.45

41.89

3.0

63.75

66.38

g/l

7.59

317

1414

Other and unspecified local infections of skin and subcutaneous tissue

579

3222

1.92

41.88

3.5

2.8

65.40

66.55

g/l

2.82

535

2974

Rash and other nonspecific skin eruption

565

3122

1.93

41.86

2.4

2.7

66.81

66.37

g/l

0.74

530

2865

Etanercept

357

1678

2.29

41.84

2.0

2.8

67.51

66.97

g/l

0.63

337

1578

Systemic sclerosis (FG)

174

587

3.41

41.80

2.1

3.6

65.05

66.27

g/l

1.09

162

541

Other local infections of skin and subcutaneous tissue

610

3454

1.88

41.61

3.4

2.7

65.61

66.49

g/l

1.90

562

3182

Drug-induced cataract

189

675

3.28

41.51

3.3

3.0

64.56

67.15

g/l

4.85

181

624

Scoliosis

434

2194

2.09

41.45

2.2

2.7

65.96

66.22

g/l

0.28

395

2013

Herpesviral [herpes simplex] infections, including avohilmo

1207

8059

1.55

41.32

2.9

2.5

66.25

66.76

g/l

1.49

1124

7433

Other diseases of lip and oral mucosa

2253

16827

1.38

41.25

2.9

2.7

66.86

66.40

g/l

2.30

2067

15502

Myositis

193

698

3.17

40.99

2.0

3.1

65.27

66.69

g/l

1.94

186

640

5-aminosalicylic acid

912

5727

1.64

40.90

2.2

2.7

66.93

66.88

g/l

0.07

860

5291

Diplopia

785

4792

1.73

40.84

2.6

66.07

66.18

g/l

0.16

725

4394

COPD-related respiratory insufficiency

805

4972

1.73

40.64

2.2

2.7

64.16

66.04

g/l

9.09

719

4493

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2706

20006

1.33

40.52

2.6

2.7

66.59

66.46

g/l

0.43

2493

18509

Malignant neoplasm of other connective and soft tissue, including Hilmo

284

1242

2.54

40.52

5.8

1.6

64.71

66.93

g/l

4.75

272

1134

Acute pancreatitis (for exclusion)

1171

7843

1.56

40.49

2.4

2.6

65.73

66.28

g/l

1.42

1080

7179

Psoriatic arthropathies

521

2827

1.95

40.41

2.1

3.0

67.46

66.26

g/l

3.28

486

2635

Artificial joint operation, meniscal resection

5152

27086

1.24

40.29

2.5

2.7

66.47

66.30

g/l

0.89

4719

24865

Stomatitis and related lesions

1047

6845

1.59

40.09

3.0

2.6

66.32

66.47

g/l

0.26

969

6292

Abnormal serum enzyme levels

1823

12798

1.43

40.05

2.5

2.7

65.87

66.15

g/l

0.81

1700

11800

Diseases of male genital organs

2597

9841

1.36

40.05

2.7

66.16

66.57

g/l

1.83

2420

9201

Mixed connective tissue disease

147

464

3.76

39.92

2.1

3.3

67.73

67.09

g/l

0.39

142

430

Benign neoplasm: Transverse colon

731

4432

1.77

39.89

2.9

2.8

65.51

66.19

g/l

1.56

672

4046

Localized swelling, mass and lump of skin and subcutaneous tissue

1716

12345

1.43

39.87

2.7

66.07

66.31

g/l

0.63

1582

11309

Bullous disorders

411

2097

2.16

39.81

2.3

2.8

66.18

66.17

g/l

0.00

386

1919

Mantle cell lymphoma, including Hilmo

130

383

4.17

39.77

2.6

1.6

64.75

66.48

g/l

1.49

125

350

Other and unspecified effects of external causes

1272

8649

1.52

39.76

2.6

2.5

66.61

66.64

g/l

0.05

1189

8016

Benign neoplasm: Stomach

633

3695

1.85

39.64

2.8

2.7

65.36

66.19

g/l

1.97

578

3385

Cardiac arrest

354

1416

2.26

39.64

2.2

2.6

64.14

67.38

g/l

9.74

327

1275

Early onset COPD

1259

8595

1.53

39.63

2.1

2.8

64.97

66.44

g/l

9.03

1171

7925

Migraine with aura and triptan purchases

623

3568

1.81

39.55

2.0

2.5

66.85

67.23

g/l

0.74

588

3327

Bronchiectasis

546

3060

1.94

39.53

2.9

2.7

65.49

66.06

g/l

0.93

495

2780

Thyroiditis, ILD-related definition

564

3157

1.88

39.44

2.5

2.7

67.34

66.60

g/l

1.67

520

2902

Secondary thrombocytopenia

124

358

4.34

39.38

5.2

2.9

63.82

67.11

g/l

4.57

117

338

Disease of hard tissues of teeth, NOS

2941

11838

1.33

39.30

2.6

2.5

66.71

66.21

g/l

3.04

2696

10843

Ankylosing spondylitis

453

2377

2.02

39.01

1.9

2.7

67.57

66.70

g/l

1.48

426

2211

Disorders of vitreous body and globe

3024

22416

1.31

38.87

2.8

66.11

66.27

g/l

0.61

2779

20532

Adverse effects, not elsewhere classified

937

6010

1.62

38.80

2.7

2.6

66.82

66.65

g/l

0.28

884

5571

Clear cell adenocarcinoma of kidney

318

1487

2.37

38.77

3.0

1.7

65.50

66.95

g/l

2.53

296

1353

Other symptoms and signs involving the urinary system

645

3800

1.81

38.56

2.6

2.8

65.24

66.22

g/l

2.62

614

3482

Fissure and fistula of anal and rectal regions

1221

8299

1.52

38.54

2.6

66.40

66.58

g/l

0.35

1108

7634

Pneumonia derived septicemia

247

1041

2.66

38.44

6.2

2.9

66.53

66.58

g/l

0.03

220

957

Cholecystectomy

3909

26785

1.26

38.10

2.7

66.16

66.32

g/l

0.66

3576

24491

Pneumonia due to Streptococcus pneumoniae

259

1112

2.55

38.08

4.8

2.3

66.54

66.94

g/l

0.25

229

1009

Other encephalitis

197

748

2.98

38.05

2.3

3.0

65.63

66.71

g/l

0.87

182

700

Personality disorders

1098

7306

1.54

37.96

2.0

2.5

66.52

67.01

g/l

1.42

1016

6848

Lesion of ulnar nerve

763

4708

1.70

37.73

2.4

2.7

66.55

66.48

g/l

0.09

709

4372

Disorders of conjunctiva

4209

26477

1.25

37.72

2.7

2.6

66.68

66.46

g/l

1.24

3885

24354

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

807

5012

1.69

37.62

2.6

1.6

64.86

66.15

g/l

5.12

738

4424

Other abnormal immunological findings in serum

146

472

3.54

37.60

2.1

2.9

68.37

66.70

g/l

2.30

136

438

Intestinal malabsorption

299

1376

2.38

37.58

2.2

2.9

64.91

66.93

g/l

4.16

276

1270

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1070

7007

1.55

37.50

2.5

2.4

66.22

66.95

g/l

2.37

997

6528

Other disorders of eyelid

2673

19568

1.32

37.33

2.4

2.7

66.05

66.06

g/l

0.03

2429

17789

Disorders of optic nerve and visual pathways

501

2760

1.93

37.29

2.2

2.7

66.62

66.70

g/l

0.09

472

2564

Acute and subacute iridocyclitis

1014

6696

1.58

37.26

3.0

2.6

67.06

66.44

g/l

1.80

947

6161

Traumatic subdural haemorrhage

835

4938

1.66

37.11

2.5

2.8

65.65

65.75

g/l

0.12

751

4498

Other disorders of bladder

750

4646

1.71

37.10

2.2

2.7

66.24

66.23

g/l

0.01

668

4233

Duodenal ulcer

695

4222

1.75

37.05

2.2

2.7

65.70

65.90

g/l

0.27

647

3814

Restless leg syndrome

821

5192

1.66

36.94

2.0

2.7

67.03

66.33

g/l

2.16

750

4776

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1205

8216

1.51

36.94

2.0

2.5

66.14

66.92

g/l

3.13

1117

7682

Abscess of lung

141

459

3.69

36.72

2.1

3.2

62.35

66.80

g/l

6.57

133

429

Encephalitis

204

803

2.86

36.62

2.3

3.0

65.73

66.78

g/l

0.87

188

748

Psoriasis vulgaris

993

6560

1.58

36.47

2.1

2.7

67.15

66.47

g/l

1.95

920

6084

Superficial injury of lower leg

1323

9227

1.48

36.47

2.2

2.6

65.76

66.55

g/l

3.73

1191

8456

Neuromuscular dysfunction of bladder

551

3155

1.86

36.46

2.1

2.8

65.83

66.51

g/l

1.23

503

2889

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

690

4166

1.72

36.42

2.1

2.7

66.36

67.11

g/l

1.76

634

3911

Other inflammatory liver diseases

396

2047

2.09

36.36

2.5

3.0

66.57

66.35

g/l

0.19

361

1889

Other abnormal uterine and vaginal bleeding

1148

5552

1.54

36.21

2.4

2.6

66.21

66.26

g/l

0.08

997

5040

Respiratory disorders in diseases classified elsewhere

132

420

3.87

36.04

2.2

3.1

65.46

66.65

g/l

0.77

124

392

Disorders of vitreous body

2928

21957

1.30

36.04

2.8

66.12

66.28

g/l

0.56

2692

20131

Faecal incontinence

560

3232

1.84

36.00

2.1

2.6

65.88

66.34

g/l

0.77

510

2912

Other shoulder lesions

481

2643

1.92

35.82

1.8

2.8

66.55

66.57

g/l

0.02

453

2442

Pleural plaque

640

3860

1.78

35.71

2.2

2.7

66.80

66.01

g/l

1.84

575

3470

Malignant neoplasm of breast, HER2-negative

1831

8633

1.40

35.71

2.6

1.5

66.23

66.88

g/l

2.96

1659

7763

Vitamin D deficiency

139

452

3.52

35.50

1.9

2.6

65.82

67.53

g/l

1.73

128

423

Malnutrition

174

647

3.12

35.47

2.4

3.0

61.56

66.34

g/l

7.18

165

593

Malignant neoplasm of breast, HER2-negative, including Hilmo

1855

8713

1.40

35.45

2.6

1.5

66.26

66.90

g/l

2.93

1683

7839

Malignant neoplasm of breast, including Hilmo

1855

8712

1.40

35.45

2.6

1.5

66.26

66.90

g/l

2.90

1683

7838

Amputation of foot

220

923

2.77

35.44

3.9

3.0

63.66

66.04

g/l

4.12

198

854

Adhesive capsulitis of shoulder

882

5723

1.61

35.13

2.1

2.9

66.29

66.34

g/l

0.06

823

5252

Anterior Iridocyclitis

1067

7212

1.54

35.09

2.9

2.6

67.03

66.42

g/l

1.75

993

6637

Nonorganic sleeping disorders

980

6488

1.56

35.03

2.1

2.6

66.45

66.75

g/l

0.63

909

6030

Disorders of vestibular function (Vertigo)

2678

20417

1.31

34.93

2.5

2.7

66.58

66.20

g/l

1.95

2416

18593

Malignant neoplasm of breast

1827

8640

1.40

34.93

2.6

1.5

66.24

66.88

g/l

2.91

1655

7769

Other diseases of oesophagus

583

3433

1.81

34.93

2.4

2.7

65.59

66.02

g/l

0.71

530

3126

Familial hypercholesterolemia

897

5868

1.61

34.92

3.0

2.5

65.47

66.18

g/l

1.98

836

5266

Thyrotoxicosis, other and/or unspecified

1012

6771

1.55

34.74

2.4

2.7

65.51

66.52

g/l

4.14

934

6198

Benign neoplasm: Ascending colon

908

5984

1.61

34.71

2.8

2.7

65.96

66.08

g/l

0.18

840

5439

Primary biliary cholangitis (PBC)

158

562

3.22

34.65

1.8

2.8

68.17

67.40

g/l

0.45

143

520

Specific personality disorders

940

6177

1.57

34.55

1.9

2.6

66.33

67.08

g/l

2.52

865

5784

Drug-induced polyneuropathy

266

4.85

34.55

11.2

3.1

64.68

66.39

g/l

1.44

251

Recurrent aphthous stomatitis , including avohilmo

783

4969

1.65

34.52

3.1

2.6

66.16

66.38

g/l

0.33

726

4562

Other disorders of eye and adnexa

733

4574

1.67

34.50

2.6

2.7

66.14

66.63

g/l

1.04

675

4227

Benign neoplasm of other and unspecified endocrine glands

756

4775

1.67

34.36

2.5

2.7

66.04

66.38

g/l

0.63

695

4402

Cramp and spasm

287

1346

2.32

34.35

2.8

66.55

66.63

g/l

0.07

266

1257

Malignant neoplasm, without specification of site, including Hilmo

309

1490

2.25

34.34

2.8

1.5

64.36

66.36

g/l

3.48

290

1321

Dermatophytosis

807

5175

1.64

34.34

2.7

65.78

66.41

g/l

1.40

746

4752

Ventral hernia

1359

9660

1.46

34.32

2.7

65.61

66.30

g/l

2.70

1250

8821

Fitting and adjustment of other devices

2102

14038

1.36

34.31

2.7

2.4

65.95

66.52

g/l

2.69

1867

12586

Polycystic ovarian syndrome, consortium definition

3184

14452

1.28

34.24

2.5

66.44

66.56

g/l

0.40

2857

13223

Pneumococcal septicemia

234

1015

2.58

34.24

6.3

2.9

66.69

66.40

g/l

0.15

208

936

Lesion of lateral popliteal nerve

306

1475

2.26

34.19

2.7

2.6

67.09

66.18

g/l

1.38

284

1382

Chronic myeloproliferative disease

137

463

3.69

34.19

2.7

3.3

66.22

66.23

g/l

0.01

127

429

Polyarteritis nodosa and related conditions

114

338

4.01

34.17

2.3

2.8

64.72

66.94

g/l

2.00

104

312

Acute posthaemorrhagic anaemia

239

1045

2.53

34.12

2.9

64.56

66.39

g/l

2.48

213

954

Other specified/unspecified inflammatory spondylopathies

232

997

2.49

33.55

2.1

2.8

68.29

66.91

g/l

2.08

214

943

Late syphilis

121

380

3.86

33.52

4.0

3.0

65.66

67.15

g/l

1.41

113

351

Other hammer toe(s) (acquired)

942

5689

1.57

33.41

2.2

3.0

65.89

65.75

g/l

0.22

825

5145

Lung diseases due to external agents

867

5691

1.60

33.33

2.5

2.6

65.26

65.91

g/l

1.40

772

5146

Lung transplantation

191

5.45

33.16

1.6

3.0

61.22

67.10

g/l

6.31

186

Fracture of forearm

2855

20298

1.29

33.14

2.5

2.7

65.94

66.43

g/l

3.03

2572

18579

Morphin

180

703

2.92

33.13

2.0

2.1

65.89

66.44

g/l

0.41

171

645

Carcinoma in situ of skin of other and unspecified parts of face

637

3925

1.75

33.12

2.6

65.09

65.77

g/l

1.36

580

3513

Coeliac disease

619

3744

1.73

33.09

3.1

2.7

66.79

66.61

g/l

0.23

571

3447

Allergic purpura

187

740

2.80

32.98

2.0

2.7

66.78

66.87

g/l

0.05

179

685

Inflammatory diseases of the central nervous system

458

2555

1.91

32.96

2.7

2.8

65.70

66.47

g/l

1.17

426

2377

Thyrotoxicosis

1298

9208

1.46

32.91

2.3

2.6

65.56

66.42

g/l

3.97

1196

8400

Metatarsalgia

487

2758

1.86

32.91

2.3

2.8

66.85

66.52

g/l

0.46

447

2545

Acute generalized exanthematous pustulosis

284

1353

2.30

32.84

5.0

3.0

65.72

66.73

g/l

1.20

263

1250

Injuries to the ankle and foot

3401

23435

1.26

32.76

2.5

2.6

66.55

66.58

g/l

0.08

3164

21712

Alcohol abuse, main dg, excluding more controls

711

4453

1.66

32.73

1.7

2.9

66.08

66.68

g/l

1.18

648

4183

Other inflammation of eyelid

797

5154

1.62

32.49

3.2

2.6

66.58

66.33

g/l

0.40

715

4724

Crohn disease

615

3725

1.72

32.46

2.0

2.7

66.17

66.83

g/l

1.24

584

3455

Conjunctivitis

3641

23845

1.25

32.25

2.7

2.6

66.81

66.48

g/l

1.89

3352

21931

Lung transplant status

191

5.37

32.23

1.6

3.0

61.22

67.10

g/l

6.19

186

Systemic sclerosis

174

678

2.92

32.19

2.1

3.0

65.05

66.94

g/l

2.27

162

624

Fracture of foot, except ankle

1165

8122

1.48

32.19

2.8

2.6

66.29

66.67

g/l

0.99

1081

7539

Pneumothorax

416

2276

1.96

32.13

2.5

2.6

64.42

66.60

g/l

6.19

388

2087

Acidosis

168

646

3.00

32.12

2.3

2.8

64.53

66.58

g/l

1.86

156

597

Diseases of external ear

1915

14508

1.36

32.05

2.7

2.6

66.38

66.31

g/l

0.16

1664

13348

Squamous cell neoplasms and carcinomas of the skin

644

3984

1.71

32.01

2.6

1.6

64.90

66.13

g/l

3.86

593

3503

Guillain-Barre syndrome

133

453

3.46

31.97

3.1

2.8

66.74

66.80

g/l

0.03

124

422

Diseases of inner ear

3049

23421

1.27

31.93

2.5

2.7

66.52

66.23

g/l

1.48

2754

21405

Other diseases of stomach and duodenum

413

2265

1.96

31.86

2.4

2.7

65.27

66.30

g/l

1.92

386

2073

Leisure time condition

969

6553

1.54

31.83

2.3

2.6

65.54

66.39

g/l

2.65

839

6007

Inflammatory diseases of female pelvic organs

2769

14937

1.29

31.74

2.3

2.6

66.62

66.54

g/l

0.23

2488

13672

Aortic aneurysm

1425

10166

1.43

31.55

2.5

2.7

65.61

66.21

g/l

2.18

1297

9296

Gingival hyperplasia

237

1072

2.44

31.32

2.8

3.2

64.98

66.53

g/l

1.96

220

997

Other disorders of nervous system

420

2330

1.94

31.30

2.8

65.75

66.50

g/l

1.13

390

2147

Sequelae of other external causes

342

1772

2.08

31.19

3.1

2.9

65.16

66.59

g/l

2.93

325

1633

Hyperhidrosis

161

602

2.88

31.19

1.9

2.5

66.85

67.62

g/l

0.72

144

556

Persistent mood disorders

939

6327

1.54

31.13

2.2

2.6

66.66

66.50

g/l

0.26

857

5827

Suicide or other Intentional self-harm

1055

7263

1.49

31.09

2.1

2.6

65.99

66.80

g/l

2.92

974

6790

Vitamin B12 deficiency anaemia

627

3882

1.71

31.03

2.5

2.6

65.42

65.96

g/l

0.95

573

3509

Acute nephritic syndrome

154

576

3.07

30.94

3.4

2.8

62.48

66.84

g/l

6.72

145

534

Other enthesopathy of foot (+metatarsalgia)

511

2986

1.79

30.92

2.3

2.8

66.87

66.51

g/l

0.54

468

2755

Other problems related to primary support group, including family circumstances

428

2297

1.88

30.89

2.7

2.6

65.18

67.28

g/l

6.06

409

2160

Cardiomyopathy, Hypertrophic obstructive

137

482

3.27

30.78

2.3

3.1

64.64

67.40

g/l

4.00

130

444

Late syphilis, including avohilmo

133

464

3.36

30.61

3.8

2.9

65.84

67.01

g/l

1.11

125

426

Conjunctivitis (acute, non atopic)

1333

9561

1.43

30.56

3.4

2.6

66.60

66.49

g/l

0.21

1239

8825

Coronary artery bypass grafting

1575

8628

1.40

30.52

2.0

2.8

65.54

66.05

g/l

1.78

1446

7753

Gastrointestinal stromal tumor and sarcoma

110

347

3.88

30.43

5.7

1.6

64.11

67.02

g/l

4.12

103

318

Other inflammation of eyelid, including avohilmo

2030

15573

1.33

30.43

2.8

2.6

66.92

66.52

g/l

1.73

1854

14412

Other and unspecified nerve root and plexus disorders, also in other diseases

1038

7172

1.50

30.38

2.5

2.6

67.10

66.58

g/l

1.62

950

6657

Generalized skin eruption due to drugs and medicaments

248

1156

2.35

30.37

5.3

3.0

65.41

66.67

g/l

1.57

229

1069

Fibroblastic disorders

1261

9032

1.44

30.34

2.3

2.8

66.18

66.23

g/l

0.09

1163

8259

Malignant neoplasm of breast, HER-positive

1475

8002

1.41

30.34

2.6

1.5

66.57

66.86

g/l

0.76

1325

7177

Malignant neoplasm of breast, ER-positive, including Hilmo

1477

8009

1.41

30.24

2.6

1.5

66.57

66.86

g/l

0.77

1327

7183

Infective dermatitis

617

3825

1.69

30.16

2.2

2.7

66.54

66.34

g/l

0.26

574

3505

Other obstructive and reflux uropathy

227

1016

2.40

30.12

2.4

2.5

64.48

66.90

g/l

4.35

207

940

Speech therapy

1423

10447

1.41

29.72

2.5

2.6

66.13

66.24

g/l

0.21

1367

9491

Extreme obesity with alveolar hypoventilation

265

1282

2.27

29.67

2.0

3.0

66.40

66.61

g/l

0.17

236

1185

Acute gastritis

441

2516

1.87

29.66

2.5

2.8

66.23

66.16

g/l

0.07

402

2297

Atopic dermatitis, strict definition with reimbursement

1105

7411

1.46

29.61

2.2

2.4

67.03

66.94

g/l

0.16

1036

6929

Artificial opening status

352

1885

2.03

29.47

3.1

2.6

64.82

66.46

g/l

3.11

328

1730

Other bursopathies

706

4542

1.62

29.43

2.8

65.73

66.31

g/l

1.20

651

4143

Speech and linguistic disorders, excluding more controls

292

1347

2.11

29.36

2.4

2.8

65.84

66.87

g/l

1.40

266

1266

Disorders of ocular muscles, binocular movement, accommodation and refraction

2213

17105

1.31

29.29

2.6

66.63

66.56

g/l

0.18

2059

15802

Benign thyroid growths and nodules

1742

12244

1.36

29.28

2.5

2.7

65.96

66.19

g/l

0.63

1590

11080

Malignant neoplasm of digestive organs

2060

12143

1.33

29.26

2.5

1.6

64.33

66.64

g/l

27.91

1870

10938

Other condition

727

4709

1.61

29.26

2.8

2.6

66.08

66.67

g/l

1.27

684

4354

Parkinson's disease, excluding more controls

781

4722

1.59

29.24

2.0

3.1

65.87

65.97

g/l

0.14

689

4337

Other disorders of the musculoskeletal system and connective tissue

842

5654

1.56

29.08

2.6

2.7

65.87

66.28

g/l

0.88

777

5168

Emotionally unstable personality disorder

440

2497

1.82

29.00

1.8

2.4

66.51

67.57

g/l

2.49

404

2359

Other noninfective disorders of lymphatic vessels and lymph nodes

232

1073

2.37

28.97

2.2

2.8

64.46

66.91

g/l

4.37

225

985

Intestinal adhesions without obstruction

505

3014

1.78

28.87

3.3

2.6

65.08

66.26

g/l

2.54

455

2745

Benign neoplasm: Caecum

694

4503

1.64

28.74

2.9

2.7

65.85

66.08

g/l

0.33

649

4112

Neuralgia and neuritis, unspecified

284

1417

2.15

28.66

2.7

3.0

66.40

66.71

g/l

0.31

260

1308

Spontaneous rupture of synovium and tendon

467

2732

1.81

28.64

2.3

2.8

66.05

66.29

g/l

0.28

423

2499

Unspecified misadventure during surgical and medical care

361

1967

1.99

28.63

3.2

2.9

65.38

66.50

g/l

2.00

334

1821

Cerebral cysts

302

1540

2.09

28.59

2.3

2.7

66.14

66.89

g/l

0.92

283

1434

Special screening examination for infectious and parasitic diseases

783

3706

1.57

28.58

2.2

2.4

67.28

67.19

g/l

0.12

717

3512

malignant neoplasm of male genital organs, including Hilmo

1541

6831

1.39

28.54

2.9

1.7

65.80

66.78

g/l

5.43

1420

6278

Agoraphobia

136

486

2.98

28.54

1.6

2.3

67.35

68.59

g/l

0.96

120

461

KRA_PSY_EATING, excluding more controls

234

1059

2.26

28.53

1.6

2.5

65.90

67.96

g/l

4.34

214

1009

Gonarthrosis, primary, with knee surgery

3434

21970

1.24

28.35

2.4

2.8

66.36

66.11

g/l

1.15

3098

20081

Non-small cell lung cancer, adenocarcinoma, helper endpoint

457

2689

1.84

28.31

1.9

2.8

64.17

66.11

g/l

6.30

429

2453

Temporomandibular joint disorders, including avohilmo

1856

13749

1.33

28.22

2.6

67.24

66.73

g/l

2.70

1731

12739

Ulcerative colitis

1148

8181

1.44

28.21

2.4

2.6

66.80

66.63

g/l

0.31

1079

7580

Chronic laryngitis and laryngotracheitis

769

5093

1.58

28.19

2.2

2.6

66.42

66.33

g/l

0.12

682

4668

Umbilical hernia

1402

10344

1.40

28.15

2.6

2.7

66.28

66.61

g/l

0.93

1305

9619

Benign neoplasm: Rectum, anus and anal canal

1199

8665

1.44

28.00

2.7

66.01

66.06

g/l

0.08

1109

7883

Emphysema

477

2837

1.80

27.94

2.6

2.8

65.24

65.92

g/l

1.08

442

2583

Post-traumatic stress disorder

281

1394

2.09

27.86

1.6

2.4

67.68

68.02

g/l

0.33

258

1328

Organic, including symptomatic, mental disorders

3250

18709

1.25

27.86

2.4

2.7

65.71

66.04

g/l

1.54

2847

17055

Hallux valgus (acquired)

1561

8309

1.37

27.82

2.5

2.9

66.40

66.02

g/l

1.15

1404

7588

Diabetic maculopathy

744

4653

1.60

27.74

2.7

2.4

65.35

66.55

g/l

4.01

698

4247

Systemic sclerosis, icd10

173

724

2.71

27.73

2.1

2.8

65.10

67.20

g/l

2.72

161

667

Open wound of ankle and foot

539

3297

1.71

27.71

2.7

65.65

66.63

g/l

2.15

500

3055

Mixed hyperlipidaemia

256

1253

2.23

27.70

1.9

2.6

66.47

66.59

g/l

0.08

235

1146

Ovarian cyst

1473

6175

1.39

27.69

2.4

2.5

66.59

66.47

g/l

0.25

1360

5647

Nummular dermatitis

487

2914

1.77

27.66

2.6

2.8

66.60

66.23

g/l

0.51

447

2672

Xerosis cutis

143

549

3.03

27.65

2.2

3.3

65.20

66.81

g/l

2.03

132

508

Cervicocranial syndrome

534

3256

1.71

27.64

2.2

2.6

67.11

66.35

g/l

1.79

494

2989

Injuries to the neck

1075

7601

1.45

27.61

2.5

2.6

66.48

66.63

g/l

0.27

988

7042

Varicose veins

3330

20631

1.24

27.59

2.6

2.7

66.25

66.37

g/l

0.39

3017

18835

Parkinson's disease, strict definition, excluding more controls

731

4480

1.59

27.54

2.0

3.1

65.97

65.94

g/l

0.04

643

4116

Other chondrocalcinosis

128

472

3.34

27.45

2.5

2.8

64.78

66.30

g/l

1.44

120

432

Explicit fungal Sepsis, including avohilmo

174

5.09

27.42

1.9

2.4

59.80

67.06

g/l

6.03

164

1980

13244

1.33

27.25

2.6

65.86

65.65

g/l

0.57

1746

11880

Monoarthritis, not elsewhere classified

231

1091

2.28

27.03

1.8

3.2

67.05

66.26

g/l

0.86

222

1008

Thoracic aortic aneurysm

860

5897

1.53

27.02

2.6

2.9

65.80

66.32

g/l

1.25

784

5440

Alcohol-induced chronic pancreatitis

364

2023

1.93

26.93

1.9

2.9

65.25

66.72

g/l

2.51

334

1888

Cyst of kidney

461

2753

1.80

26.85

2.9

2.8

66.20

66.32

g/l

0.13

426

2529

Juvenile arthritis (FINNGEN)

173

718

2.54

26.84

2.9

3.2

67.40

66.92

g/l

0.32

165

671

Ankylosing spondylitis, ICD10

434

2536

1.80

26.59

1.9

2.8

67.62

66.84

g/l

1.22

407

2371

Speech disturbances, not elsewhere classified

550

3435

1.70

26.54

2.1

2.7

66.23

66.09

g/l

0.14

499

3131

Mixed and other personality disorders

335

1808

1.94

26.44

2.3

2.7

66.57

67.55

g/l

1.51

312

1705

Other/unspecified enthesopathies of lower limb, excluding foot

344

1876

1.93

26.40

2.4

2.7

66.44

66.57

g/l

0.12

319

1742

Left bundle-branch block

413

2389

1.83

26.39

1.9

2.7

66.29

66.78

g/l

0.59

361

2147

Pemphigoid

216

1021

2.40

26.33

1.6

2.7

65.67

66.16

g/l

0.43

201

933

Cardiac murmurs and other cardiac sounds

416

2369

1.81

26.28

2.9

2.5

67.06

66.44

g/l

0.91

387

2172

Hyperkinetic disorders, excluding more controls

305

1476

1.97

26.02

1.4

2.5

67.45

68.12

g/l

1.01

284

1422

Other follicular disorders

356

1973

1.90

25.99

2.5

2.8

67.32

66.84

g/l

0.59

341

1842

Malignant neoplasm of other connective and soft tissue

168

714

2.63

25.84

5.5

1.6

64.67

66.95

g/l

2.87

163

655

Explicit fungal Sepsis

173

4.94

25.82

2.0

2.4

59.65

67.06

g/l

6.13

163

Visual impairment including blindness (binocular or monocular)

425

2500

1.81

25.82

2.4

2.6

65.88

66.12

g/l

0.24

362

2258

Injuries to unspecified part of trunk, limb or body region

559

3518

1.67

25.82

2.4

2.7

65.22

66.43

g/l

3.01

509

3243

Dissociative [conversion] disorders

173

734

2.51

25.80

1.9

3.0

67.46

67.64

g/l

0.11

153

687

Complications of cardiac and vascular prosthetic devices, implants and grafts

162

684

2.71

25.66

2.8

3.1

63.39

66.12

g/l

3.31

152

630

Retinal vascular occlusion

748

5046

1.56

25.63

2.8

2.7

66.24

65.89

g/l

0.64

682

4543

Transport accidents

2080

13577

1.30

25.60

2.3

2.7

66.58

66.82

g/l

0.77

1926

12692

Cholecystitis

813

5561

1.52

25.57

2.4

2.6

65.54

65.95

g/l

0.76

731

5001

Disorders of oesophagus in diseases classified elsewhere

164

698

2.68

25.50

3.6

3.0

62.96

66.35

g/l

5.99

148

645

Hypopituitarism

343

1891

1.91

25.50

2.5

2.9

65.95

66.80

g/l

1.29

325

1786

Barrett oesophagus

320

1745

1.99

25.45

2.8

3.0

65.34

66.22

g/l

1.16

293

1616

Other lack of coordination

128

483

3.05

25.43

2.0

3.5

67.11

66.58

g/l

0.35

119

446

Mental and behavioural disorders due to tobacco

458

2753

1.75

25.42

2.2

3.0

65.76

66.57

g/l

1.27

405

2567

Primary gonarthrosis, bilateral

3014

20727

1.24

25.36

2.3

2.8

66.40

66.10

g/l

1.41

2736

18933

Syphilis

163

688

2.63

25.32

3.3

2.7

65.73

67.11

g/l

1.56

153

641

Syphilis, including avohilmo

163

688

2.63

25.32

3.3

2.7

65.73

67.11

g/l

1.56

153

641

Polycythaemia vera

215

1022

2.32

25.27

2.7

1.6

66.30

66.79

g/l

0.40

204

922

Other nonthrombocytopenic purpura

267

3.97

25.15

2.2

2.7

66.01

66.07

g/l

0.02

246

Heartburn

558

3523

1.65

25.10

2.3

2.6

66.97

66.71

g/l

0.37

498

3236

Tobacco use

292

1544

2.02

25.08

1.9

2.8

66.40

66.95

g/l

0.57

276

1452

Dermatographic urticaria

316

1707

1.95

25.08

2.4

2.9

67.21

66.93

g/l

0.30

297

1594

Pain associated with micturition

641

4191

1.60

25.00

2.8

2.7

66.63

66.37

g/l

0.40

583

3845

Retinal detachments and breaks

2019

15948

1.30

24.96

2.9

2.7

66.22

66.19

g/l

0.06

1842

14591

Benign neoplasm: Adrenal gland

465

2834

1.75

24.94

2.4

2.9

65.69

66.43

g/l

1.37

425

2616

Chronic hepatitis, not elsewhere classified

205

959

2.34

24.93

1.7

3.2

69.01

67.06

g/l

2.21

191

896

Arterial embolism and thrombosis

367

2094

1.88

24.91

2.3

2.7

63.79

66.19

g/l

6.46

328

1909

Keratitis

1751

13559

1.32

24.90

2.5

2.6

66.59

66.37

g/l

0.62

1609

12473

Disorders of magnesium metabolism

231

4.29

24.82

2.6

2.9

64.13

66.21

g/l

0.99

215

Benign neoplasm: Rectum

1066

7716

1.44

24.81

2.7

65.95

66.06

g/l

0.18

984

7023

Retinal vascular disorders

755

5136

1.54

24.80

2.8

2.7

66.22

65.89

g/l

0.58

687

4616

Smoking dependency

458

2772

1.74

24.78

2.2

2.9

65.76

66.55

g/l

1.23

405

2584

Other hearing loss

1731

13006

1.33

24.68

2.7

2.6

65.89

65.94

g/l

0.10

1545

11779

Other disorders of optic [2nd] nerve and visual pathways

349

1964

1.89

24.66

2.3

2.9

65.95

66.43

g/l

0.55

328

1825

Atopic dermatitis

2432

15525

1.26

24.64

2.1

2.6

67.22

66.65

g/l

3.47

2251

14388

Excessive, frequent and irregular menstruation

1572

6314

1.35

24.61

2.4

2.5

66.73

66.45

g/l

0.77

1419

5765

Dermatophytosis, including avohilmo

3288

26761

1.22

24.57

2.5

2.6

66.53

66.50

g/l

0.08

3006

24709

Idiopathic pulmonary fibrosis

515

3243

1.70

24.47

2.0

2.5

66.44

65.81

g/l

1.02

474

2939

Fracture of skull and facial bones

1041

7486

1.43

24.41

2.8

2.7

65.99

66.52

g/l

1.45

944

6934

malignant neoplasm of male genital organs

1491

6760

1.36

24.32

2.9

1.7

65.71

66.78

g/l

6.04

1374

6209

Anosmia

269

3.44

24.26

2.8

1.4

66.19

68.26

g/l

1.66

241

COPD, hospital admissions 1, only main diagnosis

2070

14121

1.29

24.23

2.1

2.7

65.00

66.05

g/l

7.46

1857

12853

Malignant neoplasm of prostate, including Hilmo

1502

6684

1.36

24.21

2.9

1.7

65.79

66.74

g/l

5.02

1381

6134

Other epidermal thickening

274

1441

2.05

24.17

2.5

2.9

65.04

66.60

g/l

3.16

256

1333

Superficial injury of abdomen, lower back and pelvis

760

5176

1.52

24.06

2.4

2.6

66.15

66.50

g/l

0.67

686

4775

Ulcerative colitis, NAS

636

4179

1.58

23.96

2.2

2.7

66.83

66.74

g/l

0.11

605

3872

Disorders of psychological development

387

2069

1.78

23.82

2.2

2.4

65.93

67.14

g/l

2.18

355

1949

Combinations of oral blood glucose lowering drugs

1548

11897

1.34

23.82

2.1

2.9

66.91

66.09

g/l

3.81

1426

10997

Other disorders of patella

668

4429

1.55

23.79

2.2

2.9

67.01

66.56

g/l

0.95

610

4161

Impingement syndrome of shoulder

1156

8504

1.40

23.72

2.6

2.9

66.75

66.45

g/l

0.74

1059

7868

Other or ill-defined heart diseases

266

1384

2.03

23.67

3.2

2.6

64.68

67.13

g/l

4.39

240

1264

Left ventricular outflow tract obstruction (LVOTO), broad definition

481

2981

1.69

23.59

2.2

2.9

65.99

66.82

g/l

1.44

449

2799

Other and unspecified visual disturbances

565

3645

1.62

23.50

2.5

2.7

66.43

66.39

g/l

0.05

525

3364

Thiazolidinediones

663

4445

1.57

23.46

2.2

2.8

66.54

65.93

g/l

1.25

612

4065

Other localized connective tissue disorders

134

538

2.81

23.38

3.1

2.9

65.57

67.48

g/l

1.64

123

493

Benign paroxysmal vertigo

1605

12423

1.33

23.36

2.6

2.7

66.84

66.11

g/l

3.87

1444

11286

Corns and callosities

374

2185

1.82

23.29

3.5

2.7

64.93

66.59

g/l

3.86

334

2018

Other/unspecified synovitis and tenosynovitis

543

3469

1.63

23.25

2.5

2.8

66.31

66.46

g/l

0.19

505

3190

Ocular pain

412

2462

1.75

23.23

2.6

2.9

66.53

66.75

g/l

0.26

378

2269

Infections with a predominantly sexual mode of transmission

1092

7939

1.40

23.17

2.5

2.4

66.61

67.08

g/l

1.25

1013

7430

Other renal tubulo-interstitial diseases

138

560

2.70

23.16

2.6

65.42

67.15

g/l

1.65

130

518

Erosion of teeth , including avohilmo

1125

8260

1.39

23.02

2.5

66.84

66.76

g/l

0.13

1047

7702

Vasomotor and allergic rhinitis

1563

11750

1.32

22.94

2.4

2.6

66.98

66.67

g/l

0.97

1427

10899

Hypermobility syndrome

202

960

2.21

22.86

2.0

2.6

67.57

67.34

g/l

0.20

187

904

Status post-ami

1524

8878

1.34

22.80

2.3

2.7

65.54

66.06

g/l

1.71

1380

7971

Fall on and from stairs and steps

1348

10219

1.35

22.68

2.4

2.6

66.07

66.34

g/l

0.63

1208

9369

Bullous pemphigoid

173

797

2.48

22.65

1.5

2.9

65.49

65.94

g/l

0.33

161

726

Other specified/unspecified soft tissue disorders

265

1405

2.01

22.59

2.7

2.8

66.21

66.23

g/l

0.01

247

1279

Emotional disorders starting during childhood or adolecense, excluding more controls

111

387

2.87

22.53

2.0

2.5

66.82

67.83

g/l

0.64

100

375

Synovial cyst of popliteal space [Baker]

399

2391

1.76

22.51

2.4

2.8

65.87

66.25

g/l

0.45

361

2179

Carcinoma in situ of skin of scalp and neck

226

1159

2.21

22.46

2.5

2.8

64.62

65.86

g/l

1.66

205

1052

Diseases of tongue

336

1920

1.85

22.45

2.6

2.4

66.31

66.23

g/l

0.07

310

1750

Iridocyclitis in diseases classified elsewhere

132

537

2.77

22.44

2.2

3.1

66.65

66.83

g/l

0.09

121

498

Other postsurgical states

350

2026

1.83

22.41

2.5

2.7

65.36

66.85

g/l

3.35

328

1872

Malignant neoplasm of prostate

1468

6608

1.35

22.37

2.9

1.7

65.70

66.73

g/l

5.53

1349

6060

Viral infections of the central nervous system

348

2009

1.82

22.34

2.7

65.47

66.71

g/l

2.08

316

1863

Trigger finger

683

4625

1.53

22.31

2.0

2.8

66.27

66.48

g/l

0.32

634

4267

Olecranon bursitis

346

2002

1.84

22.29

3.0

2.8

65.26

66.53

g/l

2.34

324

1848

Childhood asthma (age<16), excluding more controls

279

1146

1.93

22.15

2.0

67.09

68.72

g/l

2.85

261

1092

Overexertion and strenuous or repetitive movements

479

3013

1.66

22.12

3.0

2.7

65.47

66.75

g/l

3.38

445

2806

6-mercaptopurine

140

579

2.56

22.03

2.4

3.4

66.21

67.53

g/l

0.90

133

545

Cryoglobulinemia

14.04

21.92

5.4

2.3

66.16

66.65

g/l

0.10

Other juvenile arthritis

144

605

2.50

21.83

2.7

3.3

67.52

66.64

g/l

0.67

136

573

Other viral hepatitis, including avohilmo

271

1456

1.95

21.81

2.4

2.7

67.37

67.49

g/l

0.08

251

1384

Cholangitis (primary sclerosing, PSC), with reimbursement 202

111

418

2.95

21.79

2.1

3.2

67.14

66.75

g/l

0.17

106

390

Malignant neoplasm of bladder, including Hilmo

656

4386

1.54

21.73

2.4

1.7

65.47

66.41

g/l

2.41

592

3934

Arthropathic psoriasis

551

3600

1.60

21.61

2.0

2.9

67.17

66.61

g/l

1.03

515

3339

Attention to artificial openings

256

1371

2.02

21.53

2.6

2.5

64.32

66.70

g/l

3.97

228

1250

Other viral hepatitis

259

1378

1.97

21.51

2.4

2.6

67.41

67.55

g/l

0.09

241

1308

Bacterial, viral and other infectious agents, including avohilmo

409

2488

1.72

21.51

3.1

2.7

65.81

66.92

g/l

2.09

388

2339

Fall involving bed

240

1266

2.09

21.49

2.3

2.9

65.02

65.97

g/l

1.10

208

1153

Sequelae of injuries, of poisoning and of other consequences of external causes

1112

8257

1.38

21.48

2.6

2.7

66.40

66.62

g/l

0.47

1022

7674

Malignant neoplasm, without specification of site

205

1017

2.18

21.42

2.7

1.6

64.89

66.09

g/l

1.01

190

908

IBD patients in KELA-register

969

7034

1.41

21.40

2.4

2.6

66.90

66.78

g/l

0.19

924

6562

Unknown and unspecified causes of morbidity

309

1740

1.85

21.38

2.5

2.4

66.46

66.98

g/l

0.55

292

1590

Gangrene, not elsewhere classified

223

4.01

21.37

3.3

2.7

64.27

66.72

g/l

1.57

204

Other/unspecified reactive arthropathies

332

1920

1.83

21.34

2.8

66.82

66.71

g/l

0.10

309

1788

Viral hepatitis

309

1743

1.86

21.32

2.3

2.7

67.38

67.16

g/l

0.18

284

1644

Amputation of ankle bones

156

703

2.48

21.22

3.6

3.0

62.91

65.91

g/l

4.16

141

646

Sulfonylureas

2038

13026

1.27

21.07

2.2

2.8

65.84

65.65

g/l

0.51

1832

11769

Viral hepatitis, including avohilmo

322

1845

1.82

21.04

2.3

2.7

67.39

67.13

g/l

0.21

295

1740

Later onset COPD

1832

11721

1.29

20.97

2.1

2.7

64.97

65.88

g/l

5.27

1632

10568

Childhood asthma (age<16)

280

1174

1.89

20.93

2.0

1.9

67.09

68.54

g/l

2.35

262

1119

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

697

4788

1.49

20.87

2.4

66.99

66.95

g/l

0.05

630

4425

Alcohol induced polyneuropathy

278

3.54

20.74

1.7

3.0

65.13

66.75

g/l

0.95

257

Disorders of myoneural junction and muscle in diseases classified elsewhere

217

3.99

20.74

1.8

2.9

65.35

67.31

g/l

1.05

204

Vascular diseases of the intestine

261

1429

1.98

20.64

2.3

2.6

64.16

66.22

g/l

3.30

244

1304

Psychotic depression

277

1528

1.90

20.57

2.3

3.0

66.81

66.51

g/l

0.25

245

1426

Malignant melanoma

789

5591

1.46

20.54

3.3

1.6

65.72

66.61

g/l

2.64

715

5025

Focal epilepsy

1048

7769

1.39

20.53

2.3

2.6

65.81

66.25

g/l

0.98

950

7122

Coxarthrosis, primary, with hip surgery

2751

21254

1.23

20.53

2.5

2.8

66.36

66.05

g/l

1.42

2478

19331

Colonic or urogenital fistula

1317

10096

1.34

20.49

2.7

2.6

66.44

66.43

g/l

0.02

1195

9296

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2376

18642

1.24

20.37

2.4

2.6

66.91

66.55

g/l

1.67

2173

17152

Other sleep disorders

546

3602

1.57

20.36

2.3

2.7

66.38

66.30

g/l

0.08

497

3323

ILD-related respiratory insufficiency

236

1267

2.06

20.18

2.5

2.9

65.10

66.06

g/l

0.93

223

1151

Sacroiliitis, not elsewhere classified

184

886

2.17

20.18

1.8

2.6

68.14

67.30

g/l

0.79

168

833

Crohn's disease NAS

298

1694

1.85

20.17

1.9

2.7

65.74

66.92

g/l

1.70

282

1581

Inguinal hernia

3012

16733

1.21

20.17

2.8

2.6

65.91

66.47

g/l

3.64

2774

15420

Speech and linguistic disorders

302

1638

1.82

20.14

2.4

2.6

65.87

66.83

g/l

1.33

276

1533

Need for immunization against other single viral diseases

121

497

2.72

20.12

2.8

2.7

63.63

67.00

g/l

4.65

115

465

Aortic valve malfunction, age under 60 years

444

2811

1.65

20.07

2.2

2.9

66.09

66.85

g/l

1.20

412

2642

Postzoster neuralgia

123

515

2.72

19.93

3.5

2.5

65.32

66.19

g/l

0.57

112

471

Alcohol dependence

1311

10082

1.33

19.93

1.8

2.9

65.89

66.48

g/l

1.75

1190

9386

Psoriatic arthropathies, ICD10

507

3317

1.59

19.84

2.1

2.9

67.51

66.71

g/l

1.75

473

3079

Injury of unspecified body region

411

2566

1.68

19.83

2.0

2.7

65.53

66.39

g/l

1.31

373

2363

Viral warts

444

2813

1.64

19.81

2.8

2.7

65.36

66.68

g/l

2.85

420

2608

Algoneurodystrophy

157

721

2.33

19.77

2.0

2.7

66.86

67.48

g/l

0.54

147

679

Cluster headache, wide

178

858

2.20

19.70

1.8

3.1

67.26

67.13

g/l

0.07

172

803

Malignant melanoma, including Hilmo

877

6375

1.42

19.65

3.2

1.6

65.81

66.65

g/l

2.63

794

5731

Paraplegia, diplegia of upper limbs

140

621

2.50

19.64

2.2

2.7

65.10

66.59

g/l

1.26

131

576

therapeutic use

208

1078

2.12

19.62

2.3

2.9

65.53

66.57

g/l

1.07

177

995

Alcohol abuse, main dg

711

4978

1.47

19.61

1.7

2.7

66.08

66.66

g/l

1.14

648

4662

Membranous nephropathy

109

5.63

19.51

6.7

2.8

62.20

66.94

g/l

2.80

102

Personal history of other diseases and conditions

381

2311

1.69

19.51

3.5

2.5

65.35

67.39

g/l

4.98

351

2148

Iron deficiency

127

533

2.52

19.45

1.9

3.0

66.51

67.65

g/l

0.92

116

510

Viral infections of the central nervous system, including avohilmo

361

2187

1.73

19.44

2.6

2.7

65.61

66.70

g/l

1.75

328

2033

Social phobias

265

1460

1.87

19.35

2.1

2.6

67.22

68.00

g/l

0.95

253

1387

Adenocarcinoma and Papillary adenocarcinoma of kidney

311

3.26

19.32

3.7

1.6

66.01

67.19

g/l

0.65

289

Papilloedema, unspecified

129

553

2.55

19.32

1.6

2.8

65.43

66.90

g/l

1.25

121

516

Polyarteritis nodosa

152

4.42

19.30

2.1

2.8

63.94

66.05

g/l

0.99

139

Idiopathic urticaria

119

492

2.63

19.21

2.5

2.7

68.17

67.35

g/l

0.70

109

461

Mucosal proctocolitis

537

3570

1.55

19.20

2.3

2.7

67.27

66.94

g/l

0.45

520

3336

Fall on same level involving ice and snow

2922

24587

1.21

19.16

2.4

2.7

66.29

66.39

g/l

0.28

2641

22594

Allergic conjunctivitis

2475

19713

1.22

19.13

2.4

2.6

66.90

66.54

g/l

1.74

2264

18162

Bacterial, viral and other infectious agents

377

2317

1.70

19.12

3.1

2.8

65.57

66.99

g/l

2.87

356

2181

Inflammatory bowel disease, strict (require KELA)

969

7168

1.38

19.09

2.4

2.6

66.90

66.76

g/l

0.24

924

6684

Asthma and opportunity respiratory infection

295

1719

1.85

19.05

2.7

2.9

65.21

66.25

g/l

1.48

272

1558

Focal epilepsy, strict definition

979

7273

1.38

19.02

2.3

2.6

65.69

66.24

g/l

1.25

885

6668

Brachial plexus disorders

370

2261

1.70

19.02

2.4

2.8

67.26

66.97

g/l

0.33

342

2134

Other and unspecified disorders of skin and subcutaneous tissue

340

2048

1.76

19.01

2.6

2.8

66.23

66.50

g/l

0.23

288

1883

Other psoriatic arthropathies

491

3221

1.59

19.00

2.1

2.9

67.52

66.71

g/l

1.74

459

2987

Glaucoma

3238

23372

1.20

18.90

2.6

2.7

66.39

66.09

g/l

1.42

2935

21268

Special screening examination for other diseases and disorders

518

3424

1.56

18.86

2.4

2.6

66.80

66.43

g/l

0.56

490

3169

Calculus of kidney and ureter

1582

12565

1.29

18.80

2.5

2.7

66.51

66.33

g/l

0.43

1447

11570

Acute suppurative otitis media

855

5769

1.40

18.72

3.4

2.4

66.59

67.17

g/l

1.37

800

5420

Right bundle-branch block

213

1122

2.03

18.72

2.5

2.7

65.61

66.88

g/l

1.40

197

1013

Other and unspecified rosacea

448

2890

1.62

18.71

2.5

2.8

67.18

66.60

g/l

0.96

412

2668

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

548

3174

1.53

18.67

1.8

2.2

67.00

67.71

g/l

1.49

511

3030

Obsessive-compulsive disorder

214

1117

1.98

18.54

1.7

2.6

66.39

68.03

g/l

2.32

194

1063

Conjunctivitis (acute, non atopic), including avohilmo

5081

26860

1.15

18.50

2.6

2.7

66.75

66.35

g/l

3.46

4695

24718

1388

10163

1.31

18.43

2.6

2.5

65.89

65.55

g/l

0.89

1212

9047

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

245

1345

1.89

18.34

1.6

2.5

66.34

67.54

g/l

1.37

223

1281

Pneumonitis due to solids and liquids

489

3242

1.58

18.28

2.3

2.5

64.56

65.91

g/l

2.56

433

2953

Familial hypercholesterolemia, with ischemic heart disease

557

3802

1.54

18.27

2.3

2.7

65.12

65.85

g/l

1.43

521

3396

Cholangitis (primary sclerosing, PSC)

348

2132

1.72

18.25

2.3

2.6

65.72

66.22

g/l

0.52

320

1948

Oesophagitis

304

1799

1.79

18.23

2.2

2.8

64.73

66.27

g/l

2.76

284

1658

Other and unspecified haemorrhagic conditions

107

436

2.76

18.21

4.0

2.6

65.59

66.67

g/l

0.71

100

406

Cutaneous lupus erythematosus

151

714

2.33

18.18

2.3

3.1

67.29

67.39

g/l

0.06

141

660

Exfoliative dermatitis

299

3.22

18.18

1.9

3.0

66.98

65.87

g/l

0.79

272

Striking against or struck by other objects

1448

11382

1.29

18.08

2.5

2.6

66.45

66.67

g/l

0.55

1319

10586

Ulcer of oesophagus

393

2493

1.67

18.00

2.6

2.8

65.54

66.08

g/l

0.70

360

2275

Atopic dermatitis, strict definition

1012

7419

1.36

17.91

2.3

2.4

67.04

67.03

g/l

0.01

955

6962

Menorrhagia

1400

6060

1.31

17.91

2.5

66.65

66.35

g/l

0.77

1230

5522

Strabismus

1166

8923

1.33

17.91

2.5

2.6

66.53

66.51

g/l

0.04

1085

8226

Pre-eclampsia or eclampsia

779

5624

1.42

17.83

2.5

2.6

66.32

67.10

g/l

2.01

724

5218

Other blood glucose lowering drugs, excl. Insulins

876

6483

1.40

17.82

2.1

2.8

66.29

65.81

g/l

1.04

812

5865

Malignant neoplasm of corpus uteri, including Hilmo

470

3105

1.58

17.79

3.6

1.5

65.97

66.36

g/l

0.56

427

2743

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1458

11345

1.29

17.79

2.5

66.99

66.87

g/l

0.28

1361

10590

Propionic acid derivatives

1359

5276

1.32

17.75

2.7

2.6

66.45

65.58

g/l

3.57

1246

4856

Total colectomy

214

1149

1.99

17.74

3.0

65.91

66.73

g/l

0.73

206

1071

Total colectomy operation

214

1149

1.99

17.74

3.0

65.91

66.73

g/l

0.73

206

1071

Postprocedural disorders of digestive system, not elsewhere classified

196

1027

2.06

17.69

2.5

3.1

65.06

66.48

g/l

1.61

183

951

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

219

1193

1.98

17.59

2.7

2.9

66.37

66.59

g/l

0.15

204

1104

Macular pucker

942

7078

1.38

17.58

2.6

2.8

65.81

65.95

g/l

0.23

849

6435

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

274

1592

1.83

17.55

2.1

1.7

65.64

66.47

g/l

0.82

248

1420

Congenital malformations of the circulatory system

607

4095

1.48

17.41

2.2

2.8

65.43

66.61

g/l

3.18

574

3818

Paralytic strabismus

391

2499

1.65

17.33

2.5

2.7

66.54

66.25

g/l

0.31

359

2310

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

408

2630

1.63

17.32

3.3

2.7

64.35

66.54

g/l

5.82

370

2413

Rosacea

597

4148

1.49

17.30

2.4

2.6

67.26

66.65

g/l

1.22

552

3836

Cluster headache, strict

160

779

2.17

17.29

1.9

3.2

67.38

67.27

g/l

0.06

154

734

Schizophrenia or delusion, excluding more controls

1187

9046

1.32

17.24

2.3

2.7

65.85

66.72

g/l

3.33

1075

8419

Amenorrhoea

223

1212

1.90

17.17

2.1

2.3

67.01

67.30

g/l

0.23

204

1128

Kyphosis

371

2.87

17.16

2.6

2.8

66.30

66.86

g/l

0.33

347

Other specified and unspecified personality disorders

350

2167

1.67

17.15

1.9

2.7

65.90

67.16

g/l

2.43

324

2030

Panniculitis, unspecified

263

3.26

17.12

2.2

3.0

66.44

67.03

g/l

0.24

249

Open wound of forearm

471

3135

1.56

17.02

2.4

2.6

65.79

66.47

g/l

1.08

426

2892

Mental and behavioural disorders due to opioids

141

657

2.25

16.94

2.0

2.4

66.63

68.00

g/l

1.09

129

625

Abscess of anal and rectal regions

373

2357

1.64

16.89

2.3

2.7

66.05

67.05

g/l

1.57

351

2206

Other specified/unspecified bacterial intestinal infections

354

2223

1.68

16.85

3.7

2.7

65.33

66.45

g/l

1.91

322

2047

Golimumab

157

769

2.16

16.76

1.9

2.9

68.17

67.68

g/l

0.39

149

735

Lack of expected normal physiological development

130

3.79

16.69

2.3

2.1

65.43

66.99

g/l

0.61

125

Crohn's disease of small intestine

297

1780

1.74

16.66

2.0

2.7

64.96

67.00

g/l

4.11

282

1662

Infection due to other mycobacteria, including avohilmo

112

486

2.56

16.62

1.8

2.5

64.37

66.60

g/l

1.84

440

Viral warts, including avohilmo

905

6771

1.37

16.61

2.7

2.6

65.96

66.74

g/l

2.36

851

6277

Urolithiasis

1701

13819

1.26

16.58

2.5

2.7

66.42

66.29

g/l

0.30

1557

12726

Focal epilepsy, mode (most common among epilepsy diagnosis)

910

6831

1.37

16.57

2.4

2.6

66.06

66.28

g/l

0.34

820

6262

Mental and behavioural disorders due to sedatives or hypnotics

287

1707

1.75

16.56

1.6

2.7

66.04

67.09

g/l

1.31

260

1601

Pleural plaque with presence of asbestos

469

3169

1.57

16.50

2.3

2.7

66.80

65.55

g/l

3.04

420

2875

Cachexia

136

4.36

16.48

3.3

2.6

63.85

66.79

g/l

1.42

125

Fracture of neck

356

2257

1.67

16.45

2.9

2.6

65.72

66.41

g/l

0.92

329

2079

Other nutritional anaemias

287

3.13

16.40

2.0

2.8

65.65

65.99

g/l

0.14

260

Other and unspecified injuries of head

390

2518

1.62

16.36

1.9

2.8

64.96

66.43

g/l

3.27

347

2309

Seborrhoeic dermatitis

501

3411

1.53

16.31

2.6

2.8

67.15

66.35

g/l

1.56

453

3131

Superficial injury of thorax

742

5415

1.41

16.27

2.3

2.6

65.81

66.40

g/l

1.36

676

4985

Acute alcohol intoxication, ICD10

907

6819

1.36

16.27

1.8

2.7

66.25

66.63

g/l

0.72

828

6374

CR(E)ST syndrome

105

449

2.63

16.24

2.4

2.8

64.51

67.26

g/l

2.57

100

417

Hypersensitivity angiitis

134

4.49

16.23

1.7

2.8

60.41

66.78

g/l

6.31

122

Procreative management

1251

8043

1.30

16.22

2.6

2.5

66.71

66.97

g/l

0.62

1176

7524

Hepatocellular carcinoma, including Hilmo

172

889

2.09

16.20

2.5

1.6

66.32

66.47

g/l

0.08

158

801

Cerebral aneurysm, nonruptured

439

2919

1.57

16.15

2.0

2.9

66.12

66.43

g/l

0.37

406

2688

Infection due to other mycobacteria

107

462

2.59

16.12

1.8

2.5

64.44

66.52

g/l

1.60

417

Viral encephalitis, not elsewhere classified/unspecified

123

563

2.40

16.07

3.6

2.9

65.77

66.74

g/l

0.63

108

524

Autoimmune hyperthyroidism

257

1495

1.79

16.05

2.4

2.8

65.48

66.87

g/l

2.31

241

1371

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

402

2593

1.59

16.03

2.0

2.7

67.49

66.86

g/l

0.90

378

2424

Congenital malformations and deformations of the musculoskeletal system

312

1897

1.69

15.99

2.1

2.7

67.51

66.83

g/l

0.83

298

1776

Malignant neoplasm of corpus uteri

430

2855

1.58

15.99

3.7

1.5

66.06

66.33

g/l

0.33

393

2521

Moderate visual impairment, binocular

192

1036

2.00

15.97

1.9

2.6

66.37

65.86

g/l

0.39

154

932

Pain and other conditions associated with female genital organs and menstrual cycle

719

4339

1.41

15.94

2.1

2.4

66.93

g/l

0.01

650

4032

Congenital malformations of heart and great arteries

528

3527

1.50

15.92

2.4

2.8

65.11

66.61

g/l

4.22

497

3292

Other diseases of biliary tract

486

3314

1.53

15.89

2.4

2.7

64.55

66.09

g/l

3.81

450

3003

Carcinoma in situ of skin

520

3608

1.52

15.83

2.6

2.7

65.28

66.03

g/l

1.43

469

3267

Pre-eclampsia or poor fetal growth

972

7352

1.34

15.83

2.4

66.59

67.19

g/l

1.63

905

6845

Allergic rhinitis

1116

8532

1.31

15.80

2.5

67.25

66.86

g/l

1.11

1023

7979

Artificial joint re-operation

414

2746

1.60

15.80

2.1

2.7

66.19

66.13

g/l

0.05

378

2503

Disorders of refraction and accommodation

1146

8882

1.31

15.78

2.6

66.73

g/l

0.00

1065

8270

Malignant neoplasm of small intestine, including Hilmo

176

926

2.06

15.78

3.3

1.6

64.79

67.02

g/l

2.81

160

841

Otitis externa

1062

8204

1.32

15.70

2.7

2.6

66.63

66.46

g/l

0.31

943

7592

Necrosis of pulp, including avohilmo

2572

21525

1.19

15.66

2.7

2.6

66.56

66.69

g/l

0.38

2405

20010

Appendectomy

2856

23213

1.18

15.62

3.0

2.6

66.50

66.60

g/l

0.32

2650

21490

Other and unspecified tonsillitis

1093

6999

1.31

15.58

2.4

2.3

66.94

67.21

g/l

0.54

1036

6606

Carrier of infectious disease

132

627

2.27

15.53

2.3

2.8

65.35

66.92

g/l

1.36

123

583

Plantar fascial fibromatosis

431

2869

1.55

15.51

2.5

2.7

67.07

66.61

g/l

0.69

397

2651

Allergic urticaria

343

2170

1.64

15.50

3.3

2.8

66.85

66.58

g/l

0.27

316

2012

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

124

578

2.35

15.49

3.6

2.9

65.72

66.77

g/l

0.70

109

538

Other erythematous conditions

198

1088

1.95

15.45

2.5

3.0

66.64

66.54

g/l

0.06

191

1005

Excessive attrition of teeth

2701

22760

1.19

15.44

2.6

2.7

66.91

66.62

g/l

1.27

2492

21146

Biomechanical lesions, not elsewhere classified

281

1708

1.75

15.39

2.3

2.9

66.74

66.61

g/l

0.11

259

1578

Anti-inflammatory and antirheumatic products, non-steroids

1335

5276

1.29

15.27

2.8

2.6

66.41

65.58

g/l

3.18

1231

4856

Psoriasis (vulgaris), strict definition

174

918

2.02

15.26

1.7

3.0

68.40

67.06

g/l

1.26

159

861

Flat foot [pes planus] (acquired)

424

2824

1.55

15.24

2.0

3.1

66.63

66.05

g/l

0.89

381

2600

Other and unspecified follicular disorders

204

1135

1.90

15.11

2.7

2.9

67.18

66.77

g/l

0.37

193

1056

Infections with a predominantly sexual mode of transmission, including avohilmo

1328

9646

1.27

15.11

2.4

66.77

67.15

g/l

1.05

1236

9035

Colectomy operation

908

6928

1.35

15.09

2.9

2.7

65.51

66.07

g/l

1.26

843

6282

Pre-eclampsia

694

5057

1.40

15.09

2.7

2.5

66.36

67.11

g/l

1.67

648

4699

Pollen allergy

590

4118

1.44

15.03

2.6

67.40

67.13

g/l

0.40

531

3889

Chronic viral hepatitis

196

1074

1.90

14.98

2.2

2.5

67.94

67.46

g/l

0.32

181

1023

Nontoxic multinodular goitre

977

7530

1.33

14.94

2.5

2.7

65.81

66.14

g/l

0.67

886

6806

Redundant prepuce, phimosis and paraphimosis

897

6703

1.34

14.92

3.0

2.7

66.88

66.73

g/l

0.24

835

6279

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

106

472

2.49

14.90

4.0

1.6

64.46

67.10

g/l

2.54

101

427

Other Crohn's disease

283

1725

1.70

14.90

1.9

2.6

65.79

67.27

g/l

2.45

269

1613

Other disorders of bone density and structure

128

610

2.25

14.87

2.0

2.6

68.13

67.19

g/l

0.84

117

568

Thrombotic microangiopathy

151

3.95

14.85

2.9

2.3

60.63

66.35

g/l

4.03

140

Excessive earwax

3383

26645

1.17

14.85

2.7

66.62

66.23

g/l

2.35

3043

24487

Thyrotoxicosis with diffuse goitre

589

4196

1.44

14.84

2.3

2.6

65.91

66.73

g/l

1.88

545

3872

Complications of other internal prosthetic devices, implants and grafts

241

1421

1.81

14.83

2.7

66.57

66.27

g/l

0.26

224

1304

Entropion and trichiasis of eyelid

517

3624

1.49

14.82

2.7

2.6

66.14

65.81

g/l

0.41

468

3271

Other and unspecified vascular occlusions

544

3848

1.48

14.78

2.9

2.7

66.34

65.87

g/l

0.77

493

3464

Hemiplegia

254

1515

1.77

14.77

2.0

2.8

66.00

66.66

g/l

0.65

223

1399

Endometriosis

1332

6131

1.28

14.74

2.3

2.5

66.45

66.44

g/l

0.01

1218

5606

Neovascular glaucoma

235

1380

1.81

14.68

2.3

2.7

66.92

66.39

g/l

0.46

218

1261

Drug-induced hypoglycaemia without coma

102

449

2.51

14.66

2.4

2.7

64.84

66.43

g/l

0.73

414

Glaucoma secondary to other eye disorders

236

1388

1.81

14.66

2.3

2.9

66.88

66.29

g/l

0.54

219

1273

Allergic contact dermatitis

539

3787

1.46

14.64

2.3

2.7

67.42

66.69

g/l

1.57

497

3501

Pediculosis, acariasis and other infestations, including avohilmo

661

4804

1.41

14.64

2.3

2.6

66.81

66.91

g/l

0.12

621

4495

Spirochaetal infections, other/unspecified

456

3124

1.52

14.58

2.6

2.8

66.81

66.35

g/l

0.76

411

2892

Erythema multiforme

130

632

2.23

14.54

2.8

2.9

66.38

66.92

g/l

0.29

123

584

Benign neoplasm: Small intestine

246

1475

1.80

14.50

2.9

3.0

65.25

66.51

g/l

1.96

230

1358

Deficiency of other B group vitamins

132

648

2.22

14.47

3.2

2.9

66.55

66.43

g/l

0.07

118

599

Other and unspecified mood [affective] disorders

242

1421

1.76

14.47

2.0

2.7

66.03

67.35

g/l

1.95

223

1335

Primary coxarthrosis, bilateral

1642

13506

1.24

14.46

2.4

2.8

66.47

65.93

g/l

2.34

1481

12226

Chronic iridocyclitis

243

1443

1.78

14.41

2.2

2.8

67.75

66.56

g/l

1.41

220

1334

Ptosis of eyelid

618

4486

1.43

14.39

2.7

66.08

66.03

g/l

0.06

571

4085

Other specified disorders of kidney and ureter

182

998

1.96

14.39

2.5

3.0

65.48

66.65

g/l

1.14

176

923

Monoplegia

435

2.53

14.37

2.4

3.4

67.29

66.94

g/l

0.17

404

Nail disorders

390

2590

1.56

14.35

2.6

2.8

65.37

66.59

g/l

2.62

367

2399

Other arterial embolism and thrombosis

170

916

2.00

14.24

2.5

3.0

64.38

66.18

g/l

2.08

152

834

Benign neoplasm: Descending colon

405

2733

1.56

14.21

2.4

2.9

65.71

66.32

g/l

0.87

365

2520

Other specified/unspecified spondylopathies

146

749

2.11

14.13

2.8

2.7

66.73

66.56

g/l

0.09

130

687

Scabies, including avohilmo

533

3756

1.45

14.12

2.3

2.6

66.83

67.04

g/l

0.25

500

3523

Aneurysms, operations, SAH

833

6334

1.35

14.11

2.1

2.7

65.92

66.26

g/l

0.63

755

5767

Postprocedural musculoskeletal disorders, not elsewhere classified

396

2662

1.56

14.10

2.9

2.8

65.56

66.39

g/l

1.45

364

2440

Other disorders of pigmentation

242

1447

1.77

14.09

2.9

2.8

66.86

66.59

g/l

0.21

225

1325

Special screening examination for neoplasms

310

1963

1.64

14.08

3.0

2.6

65.84

66.30

g/l

0.46

281

1819

Malignant neoplasm of thymus, including Hilmo

4.86

13.97

2.8

1.9

65.55

67.43

g/l

0.74

Scleritis and episcleritis

275

1697

1.69

13.95

2.2

2.7

67.76

66.88

g/l

1.17

255

1580

Other/unspecified crystal arthropathies

207

3.46

13.95

2.8

3.1

65.46

66.25

g/l

0.36

188

Irregular menses

1731

10696

1.23

13.93

2.5

66.74

66.90

g/l

0.42

1583

9926

Symptoms and signs involving emotional state

139

699

2.11

13.92

2.0

3.0

67.18

66.67

g/l

0.40

128

652

Inflammatory disease of uterus

489

3407

1.47

13.83

1.9

2.5

66.87

66.93

g/l

0.05

437

3160

Respiratory conditions due to other external agents

137

697

2.17

13.83

4.0

2.7

65.06

66.55

g/l

1.37

125

637

Background retinopathy and retinal vascular changes

129

640

2.20

13.78

2.3

3.1

66.33

66.40

g/l

0.04

115

593

Superficial injury of wrist and hand

842

6412

1.34

13.75

2.4

2.6

66.75

66.74

g/l

0.02

776

5963

Status epilepticus

188

1053

1.89

13.72

1.9

2.8

65.06

66.10

g/l

0.82

170

966

Other secondary coxarthrosis

190

1072

1.90

13.70

1.8

2.9

66.40

66.58

g/l

0.11

175

989

Acute pharyngitis

512

3564

1.45

13.65

3.3

2.5

67.35

67.25

g/l

0.11

475

3363

Exposure to other and unspecified inanimate mechanical forces

334

2168

1.60

13.63

2.8

66.06

66.67

g/l

0.76

319

2029

Suggestive for eosinophilic asthma

458

3181

1.50

13.61

2.3

2.8

65.50

66.49

g/l

2.01

428

2933

Protein-energy malnutrition of moderate and mild degree

288

2.93

13.61

2.9

2.5

64.35

65.91

g/l

0.69

262

Traumatic subarachnoid haemorrhage

194

1099

1.87

13.61

2.4

2.9

66.25

66.03

g/l

0.14

171

1014

Optic neuritis

176

965

1.92

13.60

1.9

2.8

68.38

67.55

g/l

0.82

167

905

Periapical abscess

2147

18161

1.20

13.57

2.5

2.7

66.79

66.55

g/l

0.79

1990

16852

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

388

2611

1.55

13.55

2.3

2.7

65.83

65.97

g/l

0.14

358

2372

Other disorders starting during childhood or adolecense, excluding more controls

107

462

2.27

13.51

3.2

2.6

65.94

67.36

g/l

0.91

102

446

Carcinoma in situ of skin of upper limb, including shoulder

186

1059

1.94

13.49

2.5

3.0

63.61

66.04

g/l

4.27

173

963

Early complications of trauma

224

1326

1.78

13.48

3.0

2.8

65.72

66.70

g/l

1.06

200

1231

!Aliquae complicationes praecoces traumatis

224

1326

1.78

13.48

3.0

2.8

65.72

66.70

g/l

1.06

200

1231

Specific development disorders of scholastic skills

123

581

2.14

13.43

3.1

2.5

65.96

67.38

g/l

1.19

113

558

Eating disorder

234

1385

1.73

13.41

1.6

2.3

65.90

67.68

g/l

3.51

214

1317

Biological medicines for asthma

107

496

2.31

13.38

2.1

2.7

67.67

67.59

g/l

0.04

102

472

Bell's palsy

551

3963

1.43

13.34

2.6

2.7

66.19

66.39

g/l

0.26

507

3650

Crohn's disease of large intestine

220

1296

1.78

13.32

1.9

2.8

66.24

67.20

g/l

0.98

210

1215

Portal vein thrombosis

103

476

2.39

13.29

2.6

3.0

64.87

66.93

g/l

1.63

447

Other and unspecified erythematous conditions

176

980

1.92

13.24

2.5

3.0

66.66

66.71

g/l

0.03

170

904

Other aneurysm

307

1981

1.63

13.22

2.6

2.8

65.88

66.22

g/l

0.31

286

1820

Orchitis and epididymitis

463

3238

1.48

13.20

2.8

2.7

66.32

66.43

g/l

0.11

430

2989

Testicular dysfunction

182

1020

1.88

13.17

2.1

2.9

67.56

67.07

g/l

0.46

172

971

Type 1 diabetes, definitions combined

287

1800

1.63

13.10

2.3

2.5

65.09

67.31

g/l

6.02

270

1708

Thyroiditis

317

2055

1.61

13.10

2.4

2.8

67.06

66.81

g/l

0.26

287

1903

Benign neoplasm: Duodenum

166

918

1.98

13.09

2.9

3.0

65.52

66.31

g/l

0.68

155

849

Other/unspecified enthesopathies, not elsewhere classified

393

2666

1.53

13.08

2.6

2.8

65.95

66.29

g/l

0.45

360

2438

Erythema nodosum

152

811

2.00

13.03

3.0

67.33

67.00

g/l

0.23

143

748

Hyperfunction of pituitary gland

191

1086

1.83

13.03

2.9

2.7

66.21

67.20

g/l

1.02

176

1023

Other and unspecified injuries of lower leg

326

2125

1.59

13.02

2.2

2.8

65.61

66.86

g/l

2.24

300

1976

Tongue abnormality

317

2067

1.61

13.00

2.6

2.9

66.25

66.45

g/l

0.19

291

1892

Visual field defects

439

3057

1.50

12.96

2.4

2.6

65.66

66.22

g/l

0.80

397

2801

Dislocation, sprain and strain of joints and ligaments at neck level

580

4215

1.41

12.96

2.3

2.7

67.10

66.99

g/l

0.13

538

3933

Third [oculomotor] nerve palsy

121

603

2.22

12.95

1.9

3.3

66.41

66.42

g/l

0.01

110

563

Unspecified urinary incontinence

458

3217

1.48

12.88

2.0

2.7

66.16

66.13

g/l

0.03

375

2917

Seborrhoeic keratosis

1325

10788

1.26

12.85

3.0

2.7

65.62

66.21

g/l

2.10

1229

9808

Bronchitis, not specified as acute or chronic

401

2742

1.51

12.82

2.6

2.7

66.39

66.58

g/l

0.19

363

2513

Hereditary motor and sensory neuropathy

208

3.17

12.81

1.9

2.6

67.68

66.92

g/l

0.36

196

Type 1 diabetes, strict (exclude DM2)

285

1795

1.62

12.81

2.3

2.5

65.04

67.27

g/l

6.05

268

1703

Hereditary ataxia

375

2.56

12.79

1.7

3.1

67.44

66.55

g/l

0.58

348

Secondary parkinsonism, excluding more controls

136

703

2.07

12.78

2.2

2.7

64.60

65.76

g/l

0.94

113

650

Monoamine oxidase A inhibitors

533

3841

1.43

12.77

2.1

2.9

66.69

66.46

g/l

0.28

479

3541

Wet age-related macular degeneration

1074

8254

1.29

12.76

2.6

2.5

65.74

65.48

g/l

0.53

945

7326

Alzheimer disease, excluding more controls

967

4878

1.31

12.75

2.4

3.1

65.42

65.85

g/l

0.96

833

4459

Disorders of orbit

215

1279

1.77

12.74

3.3

2.9

66.68

66.81

g/l

0.09

202

1180

Disorders in reading

199

3.03

12.70

2.5

3.2

65.46

66.66

g/l

0.44

192

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

729

5518

1.36

12.69

2.9

2.7

65.78

66.38

g/l

1.30

694

5083

Fenamates

666

3357

1.38

12.59

2.6

2.7

66.49

65.68

g/l

1.97

612

3073

Other and unspecified nonorganic psychotic disorders

684

5120

1.36

12.59

2.0

2.6

65.96

67.09

g/l

3.22

628

4794

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

825

6361

1.33

12.56

2.9

2.7

65.79

66.41

g/l

1.53

785

5847

Nonsuppurative otitis media

798

5280

1.33

12.55

2.8

2.4

66.52

66.77

g/l

0.39

753

4902

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

334

2217

1.57

12.53

2.0

1.7

65.72

66.36

g/l

0.68

305

1980

Palmar fascial fibromatosis [Dupuytren]

797

6129

1.34

12.52

2.2

2.7

65.82

66.02

g/l

0.30

737

5582

Acute bronchiolitis

171

851

1.86

12.49

5.6

2.6

65.06

66.29

g/l

1.01

158

793

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

158

862

1.93

12.49

2.1

2.9

66.98

67.01

g/l

0.01

152

805

Adult respiratory distress syndrome

386

2.52

12.48

3.3

2.7

61.92

66.13

g/l

3.49

351

Hallux rigidus

638

4754

1.38

12.41

2.3

3.0

66.97

65.86

g/l

3.52

567

4354

Degenerative macular diseases

665

5002

1.38

12.40

2.5

2.6

66.05

65.90

g/l

0.19

611

4500

Testicular hypofunction

163

901

1.91

12.39

2.2

3.0

67.50

66.99

g/l

0.46

155

857

Malignant neoplasm of endocrine gland, including Hilmo

343

2288

1.55

12.38

3.3

1.6

66.26

67.02

g/l

1.04

321

2068

Other noninflammatory disorders of uterus, except cervix

1005

5276

1.30

12.35

2.8

2.7

66.42

66.19

g/l

0.41

912

4781

Scleritis

323

2.62

12.34

1.7

3.0

67.72

g/l

0.00

303

Specific development disorders of speech and language

208

1182

1.75

12.32

2.3

2.8

65.91

66.40

g/l

0.39

192

1100

Causalgia

359

2.51

12.32

1.5

2.7

66.27

67.85

g/l

1.20

341

Pediculosis, acariasis and other infestations

260

1633

1.66

12.31

2.9

2.7

66.62

66.82

g/l

0.14

243

1528

Alcohol-induced acute pancreatitis

184

1063

1.84

12.22

2.2

2.8

66.17

66.62

g/l

0.29

159

998

Benign neoplasm of mouth and pharynx

530

3852

1.42

12.22

3.9

2.7

66.36

g/l

0.00

480

3550

Other and unspecified mononeuropathies, also in other diseases

158

873

1.93

12.22

2.5

2.8

66.39

66.66

g/l

0.18

140

806

Pregnancy hypertension

1394

10195

1.24

12.21

2.5

66.50

67.00

g/l

1.64

1306

9438

Gluteal tendinitis

204

1209

1.77

12.20

2.0

2.8

66.43

66.38

g/l

0.04

186

1122

Certolizumab pegol

347

2.49

12.15

1.6

2.6

69.70

68.04

g/l

1.47

332

Other benign neoplasms of skin

1886

15952

1.20

12.15

3.0

2.6

66.34

66.16

g/l

0.50

1685

14557

Cluster headache, wide,, including avohilmo

215

1291

1.73

12.14

1.7

2.9

67.40

67.28

g/l

0.08

206

1212

Otalgia

370

2518

1.52

12.13

2.8

2.7

67.06

66.55

g/l

0.69

330

2331

Viral meningitis, including avohilmo

152

826

1.93

12.12

2.0

2.6

66.05

67.41

g/l

1.33

143

771

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

635

4736

1.37

12.11

2.5

2.6

67.38

66.81

g/l

1.09

608

4415

Superficial injury of forearm

416

2892

1.48

12.10

2.1

2.6

66.22

66.86

g/l

1.07

371

2688

Viral meningitis

147

791

1.95

12.10

2.0

2.6

65.90

67.38

g/l

1.49

138

738

Salpingitis and oophoritis

718

5460

1.35

12.08

2.1

2.8

66.09

66.66

g/l

1.22

650

5029

Lateral epicondylitis

519

3751

1.42

12.08

2.3

2.8

67.41

66.69

g/l

1.64

478

3486

Unspecified mental disorder

1634

13626

1.21

12.05

2.1

2.6

66.08

66.74

g/l

2.94

1488

12602

Other specified disorders of muscle

144

774

1.97

12.03

2.1

3.1

65.87

66.98

g/l

0.97

135

708

Other secondary gonarthrosis

281

1817

1.63

12.02

2.3

3.0

65.78

66.46

g/l

0.70

267

1674

Superficial injury of shoulder and upper arm

546

3991

1.41

11.99

2.4

2.6

66.12

66.57

g/l

0.75

493

3694

Ankylosing spondylitis, strict definition

175

997

1.84

11.96

1.8

2.9

68.51

67.49

g/l

0.89

168

950

Ulcerative colitis (strict definition, require KELA)

655

4918

1.36

11.95

2.5

2.7

67.40

66.77

g/l

1.31

627

4591

Hyperaldosteronism

159

889

1.92

11.94

2.9

3.1

66.57

66.67

g/l

0.06

143

825

Malignant neoplasm of small intestine

128

667

2.07

11.93

3.8

1.6

64.92

67.29

g/l

2.41

116

609

Sequelae of injuries of lower limb

402

2791

1.49

11.90

2.2

2.8

66.43

66.77

g/l

0.43

373

2597

Emotional disorders and disorders of social functioning with onset specific to childhood

118

574

2.06

11.86

1.9

2.6

67.11

67.25

g/l

0.07

106

549

Atypical facial pain

243

1520

1.67

11.83

2.6

2.7

67.33

66.70

g/l

0.76

221

1404

Inflammatory diseases of prostate (prostatitis)

640

4814

1.37

11.81

2.5

2.8

66.50

66.46

g/l

0.05

592

4472

Scabies

197

1165

1.77

11.81

3.2

2.7

66.49

66.98

g/l

0.36

183

1093

Other and unspecified psoriasis

336

2263

1.55

11.80

2.1

2.9

66.72

66.52

g/l

0.19

318

2091

Pure hyperglyceridaemia

128

669

2.06

11.79

1.9

2.5

66.57

66.44

g/l

0.07

120

620

Acute alcohol intoxication

1173

9503

1.26

11.78

1.8

2.8

66.02

66.44

g/l

1.00

1060

8823

Glucosamine medication

2618

18161

1.17

11.72

2.6

2.7

65.93

65.99

g/l

0.14

2340

16430

Corticotropin deficiency

243

2.92

11.70

2.1

3.3

65.49

67.11

g/l

0.99

233

Viral agents as the cause of diseases classified to other chapters, including avohilmo

128

670

2.04

11.66

4.0

2.9

65.62

66.85

g/l

0.97

121

627

Chondropathies

623

4666

1.37

11.64

2.7

2.6

66.73

66.72

g/l

0.02

571

4335

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1335

10972

1.24

11.63

2.6

66.49

66.51

g/l

0.03

1228

10143

Panniculitis affecting regions of neck and back

166

941

1.85

11.63

2.0

2.8

66.75

66.82

g/l

0.04

155

874

Carbimazole or st.post thyroidectomy, condition for graves disease

899

7077

1.30

11.62

2.7

2.6

65.72

66.61

g/l

3.14

836

6500

Sixth [abducent] nerve palsy

189

1120

1.80

11.61

3.1

3.0

66.33

66.25

g/l

0.04

171

1032

D07AA Corticosteroids, weak (group I)

577

4260

1.38

11.61

2.1

2.7

66.95

66.69

g/l

0.38

525

3954

Ganglion

808

6269

1.31

11.56

2.4

2.8

66.68

66.63

g/l

0.07

740

5783

Crohn disease (strict definition, require KELA)

249

1570

1.64

11.55

2.0

2.7

65.88

67.13

g/l

1.82

233

1473

Malignant melanoma of skin, including Hilmo

674

5121

1.35

11.53

2.9

1.6

65.72

66.67

g/l

2.65

613

4605

Nontoxic goitre/thyroid nodule

1432

11881

1.23

11.52

2.5

2.7

66.07

66.16

g/l

0.17

1307

10758

Acne

275

1755

1.59

11.51

2.2

67.55

67.66

g/l

0.08

264

1665

Congenital malformations of cardiac septa

261

1612

1.62

11.51

2.2

3.0

65.01

66.67

g/l

2.43

242

1512

Benign neoplasm: Rectosigmoid junction

237

1494

1.69

11.50

2.8

3.0

66.01

66.32

g/l

0.26

210

1375

Other other unspecified disorders of the circulatory system

198

1191

1.77

11.46

3.6

2.8

65.44

66.51

g/l

1.26

183

1098

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

728

3468

1.34

11.45

1.9

2.1

67.37

67.79

g/l

0.87

688

3278

Colorectal cancer, including Hilmo

1301

9958

1.24

11.44

2.7

1.6

65.10

66.54

g/l

8.35

1181

8934

Other disorders of central nervous system

304

2.60

11.41

3.8

2.5

67.72

67.66

g/l

0.03

285

Crohn disease (strict definition, require KELA, min 2 HDR)

245

1544

1.64

11.40

2.0

2.7

65.87

67.12

g/l

1.79

229

1447

Other obstetric conditions, not elsewhere classified

753

3615

1.33

11.37

2.0

2.1

67.42

67.76

g/l

0.67

713

3412

Arterial embolism and thrombosis of lower extremity artery

203

1232

1.75

11.35

2.1

2.9

62.79

66.11

g/l

6.04

180

1121

Other ulcerative colitis

242

1526

1.65

11.31

2.1

2.8

67.10

66.93

g/l

0.13

235

1426

Melanocytic naevi of trunk

535

3938

1.40

11.29

3.1

2.7

66.17

66.56

g/l

0.66

504

3652

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

263

1689

1.61

11.29

1.9

2.8

65.89

67.18

g/l

1.98

247

1583

Lichen simplex chronicus

174

1013

1.82

11.27

2.9

3.1

66.68

66.55

g/l

0.09

163

936

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

705

5397

1.33

11.26

2.5

2.6

67.27

66.75

g/l

1.05

676

5025

Implicit parasitic Sepsis

131

3.72

11.24

4.2

2.6

64.52

67.04

g/l

1.51

126

Abnormal blood-pressure reading, without diagnosis

208

1266

1.71

11.23

2.7

2.6

66.33

66.57

g/l

0.19

195

1155

Malignant neoplasm of liver and intrahepatic bile ducts

168

970

1.84

11.23

2.0

1.6

65.65

66.28

g/l

0.40

149

875

Malignant neoplasm of head and neck, including Hilmo

458

3295

1.43

11.18

2.7

1.7

65.35

66.55

g/l

2.63

427

2956

Eating disorders

305

2016

1.54

11.17

1.9

2.4

66.14

67.34

g/l

2.32

278

1898

Other/unspecified soft tissue disorders related to use, overuse and pressure

131

699

1.98

11.14

2.4

3.3

66.09

67.18

g/l

1.03

126

649

Crohn disease (strict definition, all UC cases excluded)

207

1260

1.71

11.14

2.1

2.8

65.84

67.08

g/l

1.61

193

1182

Somnolence, stupor and coma

212

1304

1.70

11.09

1.9

3.0

64.79

66.36

g/l

2.22

197

1199

Chorioretinal inflammation

147

819

1.91

11.08

2.5

2.8

66.81

g/l

0.00

136

754

Otitis externa, unspecified

483

3507

1.41

11.07

2.7

66.84

66.68

g/l

0.18

444

3259

Secondary polycythaemia

125

662

2.02

11.07

2.6

2.9

64.96

66.76

g/l

1.60

112

614

Other congenital malformations

305

2029

1.54

11.05

2.5

2.8

66.13

66.94

g/l

0.99

292

1901

Astigmatism

262

1690

1.60

11.02

2.5

2.9

66.76

66.54

g/l

0.18

239

1574

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

259

1663

1.60

11.00

2.1

2.9

66.90

66.74

g/l

0.13

238

1556

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

264

1709

1.60

10.96

2.0

2.7

65.62

66.88

g/l

2.16

243

1593

Other specified and unspecified retinal disorders

194

1175

1.75

10.96

3.2

2.9

66.67

66.54

g/l

0.08

174

1084

Cluster headache, strict, including avohilmo

197

1190

1.72

10.92

1.7

2.8

67.51

67.46

g/l

0.04

188

1121

Hypotension due to drugs

100

497

2.23

10.90

3.2

2.9

65.59

65.76

g/l

0.08

457

Disorders of optic nerve, not elsewhere classified

126

677

2.02

10.87

2.6

3.1

65.37

66.58

g/l

1.01

118

626

Other specified and unspecified disorders of eye and adnexa

185

1106

1.76

10.86

2.3

3.0

66.06

66.80

g/l

0.62

169

1023

Superficial injury of ankle and foot

460

3318

1.42

10.84

1.9

2.6

66.06

66.93

g/l

1.83

427

3105

Progressive vascular leukoencephalopathy

254

1653

1.64

10.84

2.2

2.6

66.01

65.79

g/l

0.19

223

1472

Congenital iodine-deficiency syndrome/hypothyroidism

154

877

1.87

10.84

2.6

2.7

64.66

66.60

g/l

2.22

135

804

Blepharochalasis

1527

12830

1.21

10.81

2.4

2.8

66.02

66.06

g/l

0.07

1380

11640

Other disorders of iris and ciliary body

153

871

1.87

10.80

2.4

3.1

66.43

66.50

g/l

0.04

142

803

Disturbance of activity and attention

301

1949

1.53

10.77

1.4

2.1

67.48

67.75

g/l

0.31

280

1872

Impacted cerumen

614

4665

1.36

10.73

2.6

2.7

66.04

66.07

g/l

0.04

482

4265

Presbycusis

852

6671

1.30

10.69

2.8

2.4

65.37

65.54

g/l

0.26

739

5942

Melanocytic naevi

1330

11022

1.22

10.68

3.1

2.6

66.32

66.52

g/l

0.47

1253

10162

Hydrocele

590

4452

1.36

10.68

2.5

2.7

65.36

66.29

g/l

2.26

537

4108

Carcinoma in situ of skin of trunk

215

1355

1.71

10.64

3.6

2.7

63.79

65.91

g/l

3.16

197

1231

Contact with and exposure to communicable diseases

923

7310

1.27

10.64

2.8

2.5

66.70

67.15

g/l

1.04

873

6878

Implicit parasitic Sepsis, including avohilmo

151

3.36

10.62

4.0

2.6

64.58

67.18

g/l

1.64

145

Other congenital malformations, including avohilmo

465

3372

1.41

10.62

2.3

2.8

65.93

66.74

g/l

1.43

436

3136

Benign neoplasm of urinary organs

254

1657

1.61

10.54

2.6

2.9

66.04

66.45

g/l

0.39

234

1521

Malignant neoplasm of oesophagus, including Hilmo

186

1125

1.75

10.53

1.9

1.7

60.10

66.66

g/l

15.25

178

1016

Malignant melanoma of skin

556

4169

1.37

10.50

3.0

1.6

65.52

66.60

g/l

2.88

503

3757

Varicella [chickenpox]

176

1043

1.76

10.49

5.7

2.6

65.75

67.13

g/l

1.37

166

988

Impotence

295

1987

1.55

10.49

2.1

2.7

66.16

66.45

g/l

0.27

276

1830

Other mental disorders due to brain damage and dysfunction and to physical disease

667

5146

1.34

10.48

2.4

2.6

66.28

65.87

g/l

0.73

578

4656

Sudden idiopathic hearing loss

507

3757

1.39

10.47

2.5

2.7

66.51

66.21

g/l

0.38

451

3456

Malignant neoplasm of bladder

345

2391

1.50

10.43

2.2

1.6

65.34

66.17

g/l

1.16

315

2115

Autonomic disorders

125

675

1.97

10.43

2.4

3.1

65.78

67.22

g/l

1.38

114

625

Chondrocostal junction syndrome [Tietze]

181

1088

1.75

10.42

2.5

2.9

66.74

66.93

g/l

0.13

168

1006

Pigmented purpuric dermatosis

313

2.54

10.42

2.6

3.5

67.27

66.91

g/l

0.13

290

Other keratitis

470

3435

1.40

10.37

2.4

2.6

67.16

66.71

g/l

0.65

435

3178

Unspecified/other endometriosis

291

1900

1.53

10.36

2.2

67.04

66.96

g/l

0.07

270

1760

Other and unspecified disorders of vitreous body

2188

18553

1.17

10.35

2.7

2.8

66.47

66.27

g/l

0.64

2008

17021

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

253

1653

1.60

10.31

1.9

1.6

65.23

66.36

g/l

1.20

229

1473

Malignant neoplasm of anus and anal canal, including Hilmo

352

2.41

10.30

2.0

1.6

66.28

67.05

g/l

0.44

319

Ingrowing nail

228

1453

1.63

10.26

2.5

2.8

65.48

66.83

g/l

2.13

214

1347

Paralytic ileus

200

1241

1.70

10.24

3.6

2.5

64.42

66.51

g/l

2.51

184

1140

Acne vulgaris

205

1261

1.65

10.24

2.1

2.2

67.59

67.88

g/l

0.21

198

1200

Open wound of abdomen, lower back and pelvis

134

741

1.90

10.22

2.0

2.8

66.07

66.94

g/l

0.56

120

698

Manic episode

127

691

1.93

10.19

2.2

3.3

66.39

67.31

g/l

0.57

117

648

Disorders of tooth development and eruption

609

3752

1.34

10.17

2.7

2.4

66.55

66.68

g/l

0.17

561

3462

Event of undetermined intent

258

1692

1.58

10.16

2.7

66.58

66.88

g/l

0.27

240

1591

Pulmonary oedema

115

613

2.04

10.16

3.2

2.8

64.29

65.78

g/l

1.12

106

553

Atypical mycobacterium lung infection

382

2.37

10.16

1.9

3.0

64.21

66.20

g/l

1.29

348

Other diseases of spinal cord

150

864

1.84

10.14

3.3

3.0

65.46

67.07

g/l

1.68

140

804

Other misadventures during surgical and medical care

135

757

1.91

10.12

2.5

3.3

64.46

66.47

g/l

2.19

127

698

Fracture at wrist and hand level

1483

12433

1.20

10.11

2.6

66.28

66.62

g/l

1.02

1345

11513

Other symptoms and signs involving general sensations and perceptions

207

1298

1.67

10.09

2.1

2.9

65.93

66.09

g/l

0.09

177

1194

Behavioural disorders, excluding more controls

236

2.59

10.07

1.8

2.9

66.04

67.95

g/l

1.11

229

Acquired absence of organs, not elsewhere classified

369

2.37

10.06

5.0

2.9

65.51

66.74

g/l

0.60

336

Viral agents as the cause of diseases classified to other chapters

111

584

2.03

10.05

4.0

2.8

65.01

66.97

g/l

1.66

104

550

Assault

440

3191

1.41

10.04

2.0

2.5

66.92

67.28

g/l

0.42

399

3033

Varicella [chickenpox], including avohilmo

194

1192

1.68

10.03

5.5

2.6

65.41

67.07

g/l

1.98

184

1131

N06DA Anticholinesterases

1637

14806

0.84

10.02

2.0

2.6

65.69

65.66

g/l

0.04

1379

13303

Use of anticholinesterases

1637

14806

0.84

10.02

2.0

2.6

65.69

65.66

g/l

0.04

1379

13303

Malignant neoplasm of colon, including Hilmo

894

7141

1.27

10.01

2.8

1.6

65.05

66.45

g/l

5.52

809

6375

Other and unspecified glaucoma

394

2832

1.45

9.98

2.2

2.7

65.97

65.89

g/l

0.07

353

2541

Other bullous disorders

145

833

1.86

9.97

3.5

3.0

66.92

66.59

g/l

0.21

139

770

Other specified congenital malformation syndromes affecting multiple systems

270

2.52

9.96

1.9

3.4

64.91

66.54

g/l

0.90

260

Post-traumatic wound infection, not elsewhere classified

137

773

1.88

9.93

3.0

2.9

66.94

66.97

g/l

0.02

121

719

Primary adrenocortical insufficiency

287

2.54

9.91

2.0

3.0

64.60

67.09

g/l

2.15

272

Other female pelvic inflammatory diseases

642

4948

1.33

9.90

2.5

2.8

66.32

66.56

g/l

0.35

554

4527

Pustular psoriasis

220

1407

1.64

9.89

2.3

3.0

66.89

66.78

g/l

0.07

205

1298

Nystagmus and other irregular eye movements

330

2.39

9.88

2.5

2.9

65.40

66.97

g/l

0.84

313

Radial styloid tenosynovitis [de Quervain]

209

1313

1.64

9.88

2.7

3.0

66.17

66.93

g/l

0.86

192

1217

Granulomatous disorders of skin and subcutaneous tissue

125

686

1.93

9.88

3.3

2.8

67.40

67.45

g/l

0.03

115

631

150

877

1.85

9.88

2.2

2.9

64.43

66.17

g/l

1.76

132

797

Dystonia

245

1605

1.59

9.84

2.0

2.9

66.86

66.49

g/l

0.29

226

1491

Use of teriflunomide

172

2.96

9.84

2.0

2.3

68.61

68.58

g/l

0.02

164

Other surgical follow-up care

148

853

1.82

9.84

2.1

2.6

65.36

67.22

g/l

1.94

141

790

Hyperosmolality and hypernatraemia

426

2.23

9.79

2.9

2.5

64.33

66.26

g/l

1.01

387

347

2.29

9.78

2.7

3.0

66.53

68.17

g/l

1.24

328

Acute laryngitis and tracheitis

349

2403

1.45

9.70

2.0

2.5

66.13

67.27

g/l

2.11

326

2266

severe traumatic brain injury, does not include concussion

1185

9829

1.23

9.70

2.5

65.77

65.97

g/l

0.42

1070

8892

Other and unspecified pemphigoid

327

2.48

9.61

1.6

3.0

65.57

66.35

g/l

0.38

299

Herpesviral keratitis and keratoconjunctivitis

214

1372

1.64

9.57

2.8

66.08

66.72

g/l

0.65

203

1265

Sequelae of injuries of neck and trunk

143

826

1.83

9.57

3.0

66.07

66.96

g/l

0.69

132

773

Nonsuppurative otitis media, including avohilmo

1129

8024

1.23

9.56

2.7

2.4

66.70

66.80

g/l

0.17

1072

7443

Behavioural syndromes associated with physiological disturbances and physical factors

4435

27165

1.11

9.56

2.2

2.7

66.68

66.44

g/l

1.39

4057

25043

Atrial septal defect

153

892

1.78

9.55

2.1

3.1

64.99

66.61

g/l

1.43

142

835

Deviated nasal septum

1510

12783

1.20

9.55

2.8

2.7

66.77

66.44

g/l

1.01

1392

11888

Malignant neoplasm of endocrine gland

289

1969

1.52

9.53

3.1

1.6

66.22

67.15

g/l

1.25

272

1785

Other specific arthropathies, wide

502

2.07

9.53

2.1

3.5

65.69

66.68

g/l

0.68

461

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

470

2.14

9.52

3.3

1.6

63.65

66.73

g/l

3.22

426

Sacrococcygeal disorders, not elsewhere classified

130

729

1.87

9.49

2.1

3.0

67.88

66.95

g/l

0.77

120

681

Episcleritis

219

1409

1.61

9.49

2.4

2.8

67.77

66.94

g/l

0.88

203

1319

Follicular cysts of skin and subcutaneous tissue

826

6607

1.28

9.49

2.5

2.6

66.35

66.54

g/l

0.28

765

6097

Retinal haemorrhage

148

870

1.82

9.48

3.5

3.0

65.59

66.38

g/l

0.50

130

800

Achilles tendinitis

437

3207

1.40

9.47

2.8

2.7

66.24

66.47

g/l

0.27

397

2986

Suppurative and unspecified otitis media

1246

9171

1.22

9.43

3.2

2.4

66.76

66.80

g/l

0.07

1169

8523

Emotional disorders starting during childhood or adolescence

111

582

1.93

9.43

2.0

2.5

66.82

67.27

g/l

0.23

100

558

Orthopaedic devices associated with adverse incidents

122

684

1.96

9.42

2.0

3.0

66.32

66.45

g/l

0.06

627

Medial epicondylitis

156

924

1.76

9.41

2.9

3.0

67.21

66.93

g/l

0.19

143

862

Fasciculation

293

2.46

9.40

2.0

2.8

69.40

67.34

g/l

1.64

280

Asthma mixed form (mode), excluding more controls

175

1065

1.69

9.36

1.9

2.1

67.00

67.43

g/l

0.36

160

946

Acute lymphadenitis

222

1436

1.60

9.33

2.5

2.8

65.76

67.04

g/l

1.42

213

1341

Postmenopausal bleeding

1229

5322

1.23

9.32

2.7

66.20

66.19

g/l

0.02

1101

4826

Other strabismus

835

6664

1.27

9.31

2.4

2.6

66.62

66.67

g/l

0.06

780

6169

Other eating disorders

128

713

1.84

9.29

1.3

2.4

65.59

67.85

g/l

2.83

117

680

Congenital malformations of the respiratory system

440

2.15

9.25

2.9

3.2

66.20

66.61

g/l

0.20

413

Convalescence

225

1468

1.59

9.18

2.9

2.5

66.31

67.25

g/l

1.16

199

1343

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

356

2.30

9.16

3.3

2.9

64.79

66.33

g/l

0.89

332

Central retinal artery occlusion

137

798

1.85

9.15

3.8

3.0

66.92

65.96

g/l

0.78

124

727

Mental disorders, not otherwise specified

283

1932

1.50

9.15

2.6

66.13

67.27

g/l

1.93

269

1820

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1570

11581

1.19

9.14

2.4

2.6

66.53

66.93

g/l

1.30

1474

10684

Congenital malformations of the respiratory system, including avohilmo

483

2.08

9.13

2.8

3.1

66.39

66.69

g/l

0.15

454

Other retinal artery occlusion

139

813

1.84

9.12

3.0

3.1

65.73

65.97

g/l

0.14

125

749

Recurrent dislocation and subluxation of joint

214

1377

1.59

9.09

2.1

2.9

67.03

66.87

g/l

0.12

194

1298

Pustulosis palmaris et plantaris

199

1270

1.64

9.08

2.4

3.1

67.30

66.99

g/l

0.24

186

1178

Complications of genitourinary prosthetic devices, implants and grafts

130

744

1.85

9.04

2.2

2.7

65.14

66.80

g/l

1.53

120

687

Amputation of thigh

179

1120

1.70

9.03

2.1

2.6

62.88

65.92

g/l

4.61

162

1009

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

328

2.29

9.01

1.7

2.6

68.17

67.15

g/l

0.60

313

Corneal ulcer

775

6188

1.28

9.01

2.3

2.6

66.66

66.53

g/l

0.20

718

5714

Nonalcoholic steatohepatitis

243

2.60

9.00

2.0

2.9

67.29

67.86

g/l

0.20

233

Hepatocellular carcinoma

123

695

1.89

8.99

2.1

1.6

65.61

66.38

g/l

0.43

110

623

Other secondary gout

3.97

8.99

4.5

2.6

64.62

66.74

g/l

0.79

Use of donepezil

869

10166

0.80

8.98

1.9

2.5

65.74

65.50

g/l

0.40

725

9028

Carcinoma in situ of other and unspecified digestive organs

243

1632

1.57

8.97

2.2

2.9

66.05

66.31

g/l

0.22

230

1512

Other and unspecified trigeminal disorders

398

2.19

8.95

3.8

2.5

67.33

67.32

g/l

0.01

375

Other specified/unspecified disorders of bone/cartilage

125

708

1.86

8.95

2.8

2.7

66.63

66.82

g/l

0.10

114

672

Erythema intertrigo

135

785

1.83

8.95

2.6

3.2

66.30

66.46

g/l

0.09

122

722

Septal defects

236

1531

1.56

8.91

2.2

3.0

65.30

66.63

g/l

1.67

222

1436

Secondary malignant neoplasm of other and unspecified sites

103

554

2.01

8.90

2.3

1.6

65.05

66.95

g/l

1.67

505

Bursitis of shoulder

117

651

1.90

8.88

3.3

66.22

67.03

g/l

0.55

110

604

Other bacterial agents as the cause of diseases classified to other chapters

296

2.43

8.86

3.6

3.1

64.45

66.60

g/l

1.23

277

Retinal detachment with retinal break

645

5064

1.31

8.85

3.0

2.7

65.70

66.16

g/l

0.77

587

4637

Melanoma in situ

252

1713

1.55

8.79

3.2

2.9

66.19

66.36

g/l

0.12

224

1570

Other specified/unspecified hearing loss

458

3438

1.37

8.78

2.7

2.6

65.98

66.12

g/l

0.16

435

3137

Bicipital tendinitis

218

1430

1.59

8.77

2.8

3.1

66.72

66.67

g/l

0.04

207

1330

Impetigo

169

1041

1.68

8.74

3.5

2.8

66.82

67.12

g/l

0.18

160

979

Malignant neoplasm of head and neck

372

2701

1.42

8.73

2.2

1.6

65.19

66.52

g/l

2.56

346

2428

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

303

2.37

8.71

2.1

2.9

64.54

67.46

g/l

2.28

287

Type 1 diabetes, strict definition

187

1173

1.62

8.69

2.0

2.4

64.83

67.93

g/l

8.55

177

1128

Dentofacial anomalies [including malocclusion]

2873

20004

1.13

8.68

2.7

2.6

67.12

66.65

g/l

3.17

2658

18575

Other papulosquamous disorders

311

2.36

8.66

2.9

2.7

66.02

67.10

g/l

0.62

289

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

212

1352

1.58

8.65

3.5

2.5

66.91

67.19

g/l

0.25

201

1273

Other and specified injuries of hip and thigh

124

711

1.86

8.64

2.1

2.9

65.84

66.43

g/l

0.31

115

655

Ectropion of eyelid

242

1637

1.55

8.62

1.8

2.6

65.86

65.73

g/l

0.10

215

1471

Other congenital malformations of the digestive system, including avohilmo

204

1311

1.60

8.61

2.5

3.1

65.82

66.38

g/l

0.49

188

1218

Malignant neoplasm of stomach, including Hilmo

279

1933

1.49

8.57

2.4

1.6

62.83

66.36

g/l

9.90

258

1722

Hyperkinetic disorders

308

2100

1.45

8.56

1.4

2.1

67.41

67.64

g/l

0.25

287

2009

Prepatellar bursitis

201

1302

1.61

8.55

2.5

3.0

66.64

66.59

g/l

0.03

183

1203

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

174

1086

1.66

8.55

2.0

3.0

66.03

66.97

g/l

1.01

162

1010

Carcinoma in situ of skin of lower limb, including hip

141

848

1.80

8.52

2.7

3.0

64.00

66.05

g/l

2.90

132

768

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

112

629

1.93

8.51

2.1

3.0

66.80

66.22

g/l

0.32

574

Disorders of speech understanding and production

159

953

1.69

8.48

2.4

2.9

65.87

65.92

g/l

0.03

146

874

Kela-code for severe mental illness

1440

12278

1.19

8.45

2.0

2.6

66.07

66.70

g/l

2.39

1304

11344

Follow-up examination after treatment for malignant neoplasms

467

3530

1.36

8.43

3.0

2.5

65.83

65.71

g/l

0.12

429

3214

Renal agenesis and other reduction defects of kidney

110

3.45

8.41

2.5

4.3

64.80

66.32

g/l

0.63

105

Alzheimer’s disease (Early onset)

1715

0.53

8.37

1.8

2.5

65.46

65.69

g/l

0.11

1531

Acquired absence of limb

297

2.38

8.36

4.2

2.6

64.48

66.30

g/l

0.98

275

Ulcerative colitis (strict definition, all Crohn cases excluded)

542

4180

1.32

8.35

2.7

2.6

67.69

66.83

g/l

1.97

515

3894

Universal erythroderma, KELA reimbursement

376

2.19

8.33

1.8

3.1

66.67

66.62

g/l

0.02

349

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

425

3184

1.38

8.28

2.8

66.91

66.35

g/l

0.83

381

2927

Dislocation, sprain and strain of joint and ligaments of hip

196

1278

1.61

8.25

2.4

2.8

64.90

66.38

g/l

1.74

179

1183

Hyperprolactinaemia

120

685

1.82

8.25

2.8

66.62

67.49

g/l

0.69

112

650

Lesion of radial nerve

170

1070

1.66

8.24

2.6

2.7

65.46

66.72

g/l

1.25

150

998

Use of disulfiram, acamprosate or naltrexone

343

2480

1.42

8.23

1.8

2.8

66.38

67.04

g/l

0.87

317

2338

Anogenital herpesviral [herpes simplex] infection

195

1259

1.59

8.22

2.7

2.4

66.18

67.62

g/l

2.01

181

1182

Assault by bodily force

249

1694

1.50

8.21

1.9

2.7

66.20

67.52

g/l

1.71

225

1611

Other specified/unspecified dorsopathies

150

916

1.71

8.17

2.8

66.48

66.62

g/l

0.09

134

851

Other drug-induced secondary parkinsonism

294

2.38

8.16

2.1

2.9

66.00

67.05

g/l

0.54

275

Other abnormal findings in urine

506

2.01

8.16

3.2

2.7

66.96

65.97

g/l

0.61

463

Congenital malformations of trachea and bronchus

261

2.46

8.15

2.8

3.4

66.14

66.45

g/l

0.11

239

Additional codes for the location of defect, injury or illness

263

1822

1.50

8.14

2.3

2.9

66.66

66.59

g/l

0.05

254

1689

Rheumatoid lung disease

154

3.12

8.14

1.8

2.4

64.98

65.35

g/l

0.10

139

Other disorders of conjunctiva

707

5679

1.28

8.04

2.5

2.6

66.07

66.10

g/l

0.03

664

5168

Nephropathy induced by other drugs, medicaments and biological substances

5.66

8.01

1.8

66.54

66.97

g/l

0.10

Type1 diabetes, definitions combined, early onset

154

940

1.67

8.00

2.2

2.4

64.40

67.76

g/l

8.12

148

904

Delayed milestone in childhood

185

2.54

8.00

3.1

4.4

63.69

63.22

g/l

0.13

178

Benign neoplasm of meninges

502

3873

1.33

7.98

2.3

2.7

65.15

66.29

g/l

3.00

450

3529

Other ill-defined and unspecified causes of mortality

495

3818

1.34

7.95

2.6

65.94

65.83

g/l

0.11

450

3448

Thyrotoxicosis with toxic multinodular goitre

303

2169

1.45

7.94

2.3

2.8

64.51

66.25

g/l

3.90

275

1968

Hyphaema and other vascular disorders of iris and ciliary body

112

642

1.86

7.87

2.1

3.2

66.22

66.51

g/l

0.15

105

590

Urethral stricture

302

2164

1.45

7.87

2.5

2.8

66.90

66.22

g/l

0.83

272

1979

Spinal instabilities

120

698

1.80

7.86

2.0

2.9

66.83

66.80

g/l

0.02

106

660

Malignant neoplasm of colon

723

5831

1.27

7.85

3.0

1.6

65.19

66.34

g/l

3.33

656

5187

Carcinoma in situ of skin of ear and external auricular canal

108

619

1.91

7.83

2.3

2.7

64.69

65.78

g/l

0.51

555

Localized scleroderma [morphea]

392

2.12

7.81

2.5

3.0

67.04

67.65

g/l

0.27

363

Use of antiglaucoma preparations and miotics

424

3210

1.37

7.79

2.5

2.6

66.37

65.78

g/l

0.79

372

2858

Sleep disorders, other/unspecified

130

773

1.74

7.75

2.1

2.7

66.53

67.38

g/l

0.59

118

728

Other bursitis of hip

108

615

1.86

7.73

3.4

3.3

65.68

66.63

g/l

0.69

562

Brain meningioma, including Hilmo

225

1529

1.53

7.71

2.4

1.5

65.20

66.96

g/l

3.13

207

1372

Other congenital malformations of the digestive system

170

1078

1.62

7.67

2.9

3.1

65.19

66.47

g/l

1.36

158

1002

Complications peculiar to reattachment and amputation

180

2.74

7.67

4.6

2.9

65.06

66.21

g/l

0.48

166

Other mycoses, not elsewhere classified/unspecified, including avohilmo

493

1.97

7.65

3.3

2.6

65.53

67.30

g/l

1.30

457

Trigeminal neuralgia

259

1810

1.48

7.65

2.8

2.6

66.87

66.47

g/l

0.40

244

1671

Abdominal aortic aneurysm (AAA)

531

4114

1.31

7.64

2.0

2.6

65.49

65.79

g/l

0.38

480

3685

Degeneration of the brain due to alcohol

124

740

1.79

7.64

1.6

3.0

65.92

66.30

g/l

0.18

113

690

Dislocation, sprain and strain of joints and ligaments of thorax

156

980

1.66

7.64

2.6

2.8

65.69

66.72

g/l

1.03

147

912

Respiratory tuberculosis, confirmed, including avohilmo

102

574

1.90

7.63

1.9

2.8

66.40

66.10

g/l

0.14

525

Adenomyosis (Endometriosis of uterus)

553

4326

1.30

7.63

2.6

66.26

g/l

0.01

505

3940

Oesophageal obstruction

185

1214

1.60

7.62

2.8

2.9

63.29

66.29

g/l

4.76

165

1114

Degeneration of nervous system due to alcohol

124

741

1.79

7.60

1.6

2.9

65.92

66.38

g/l

0.23

113

690

Malignant neoplasm of oesophagus

135

822

1.73

7.60

2.0

1.6

60.18

66.77

g/l

10.75

129

756

Bulimia nervosa (incl. atypical)

468

1.93

7.53

1.5

2.1

65.70

68.10

g/l

2.51

443

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

206

2.58

7.52

2.1

2.7

64.50

66.69

g/l

1.00

191

Congenital malformations of the musculoskeletal system, not elsewhere classified

280

2.27

7.51

1.8

2.8

68.13

67.22

g/l

0.45

268

Blindness, monocular

284

2.33

7.50

3.1

2.8

65.20

66.43

g/l

0.61

261

Heterophoria

296

2121

1.43

7.49

2.5

2.8

66.37

66.60

g/l

0.22

278

1975

Acne, including avohilmo

538

3380

1.30

7.49

1.9

2.2

67.12

67.47

g/l

0.52

506

3183

Residual foreign body in soft tissue

197

1307

1.55

7.49

2.7

3.0

66.41

66.90

g/l

0.43

185

1216

Other dermatomyositis

118

3.19

7.48

1.3

3.4

63.92

66.33

g/l

0.91

110

Benign neoplasm: Kidney

182

1196

1.60

7.47

2.8

3.1

66.29

66.42

g/l

0.09

168

1105

Acute nasopharyngitis (common cold)

420

3152

1.35

7.46

2.6

66.83

67.26

g/l

0.59

390

2964

Other/unspecified disorders of vestibular function

213

1447

1.54

7.45

2.1

3.0

65.89

66.48

g/l

0.67

184

1333

Mouth breathing

1748

15266

1.16

7.43

2.6

2.8

66.58

66.55

g/l

0.05

1625

14200

Malignant neoplasm of thyroid gland, including Hilmo

284

2026

1.44

7.43

3.1

1.5

66.59

67.07

g/l

0.49

266

1834

Other noninflammatory disorders of vagina

311

2253

1.42

7.41

2.3

2.6

66.06

66.36

g/l

0.27

277

2057

Excessive vomiting in pregnancy

246

1708

1.47

7.36

2.7

2.6

66.31

67.62

g/l

2.31

232

1597

Malignant neoplasm of oral cavity, including Hilmo

195

1300

1.56

7.36

2.5

1.6

65.10

66.82

g/l

2.42

187

1183

Alcoholic gastritis

394

2.07

7.35

1.5

3.4

66.52

66.70

g/l

0.06

364

Respiratory tuberculosis, confirmed

560

1.88

7.30

1.8

2.6

66.37

66.09

g/l

0.12

512

Type 1 diabetes, strict definition, subgroup 1

169

1082

1.59

7.28

1.9

2.4

64.76

67.88

g/l

7.94

159

1039

Idiopathic hypercalciuria

143

2.92

7.26

1.7

3.7

68.31

66.88

g/l

0.81

134

Other otitis externa (chronic)

293

2115

1.43

7.24

2.5

2.9

66.25

66.55

g/l

0.25

245

1962

Carcinoma in situ of colon

160

1033

1.64

7.21

2.4

3.0

65.82

66.42

g/l

0.50

152

954

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

168

2.76

7.19

2.2

2.3

64.42

66.55

g/l

0.85

157

Colorectal cancer

1123

9138

1.20

7.19

2.8

1.7

65.11

66.53

g/l

7.03

1020

8190

Other noninflammatory disorders of vulva and perineum

361

2694

1.37

7.10

2.1

2.5

66.44

66.56

g/l

0.11

325

2473

Other and unspecified abdominal hernia

203

1379

1.54

7.10

2.4

2.7

65.91

66.57

g/l

0.55

189

1274

Unspecified event, undetermined intent

106

614

1.81

7.09

2.5

2.9

66.65

67.26

g/l

0.39

574

Other predominantly sexually transmitted diseases, not elsewhere classified

500

3897

1.30

7.08

2.4

2.5

66.80

67.29

g/l

0.76

460

3648

Benign neoplasm: Pancreas

156

1007

1.65

7.06

3.1

3.2

65.66

66.35

g/l

0.51

149

927

Conduct disorder

299

2.15

7.04

1.7

2.7

65.61

67.78

g/l

1.32

284

Sleep disorders

4196

26508

1.10

7.00

2.1

2.7

66.80

66.45

g/l

2.41

3838

24442

Other diseases of gallbladder

217

1497

1.51

6.99

2.5

2.8

66.19

66.29

g/l

0.08

202

1351

Optic atrophy

466

1.94

6.93

2.9

2.7

66.54

66.90

g/l

0.18

437

Urethritis and urethral syndrome

552

1.85

6.92

3.1

2.9

66.33

67.28

g/l

0.70

510

Renal cell carcinoma of kidney

154

991

1.63

6.91

2.9

1.6

65.90

66.54

g/l

0.46

144

891

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

576

4580

1.27

6.91

2.3

2.4

66.86

67.36

g/l

0.85

531

4305

Other orthopaedic follow-up care

241

1695

1.47

6.91

2.1

2.4

66.37

67.09

g/l

0.76

219

1544

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

324

2.12

6.90

5.4

2.8

63.60

66.92

g/l

1.78

303

Other salmonella infections

162

1054

1.60

6.89

3.3

2.7

67.22

67.03

g/l

0.12

148

973

Nasal polyp

875

7300

1.22

6.86

2.7

66.44

66.35

g/l

0.14

811

6735

Malignant neoplasm of thyroid gland

256

1821

1.45

6.85

2.9

1.5

66.48

67.03

g/l

0.56

242

1649

Sequelae of injuries of upper limb

393

2991

1.34

6.85

3.1

2.9

66.61

66.71

g/l

0.09

359

2782

Benign neoplasm of bone and articular cartilage

326

2416

1.38

6.80

2.9

2.7

67.14

66.76

g/l

0.44

298

2245

Other and unspecified localized connective tissue disorders

3.65

6.80

4.3

2.9

69.59

66.87

g/l

0.62

Diseases of middle ear and mastoid

2295

16726

1.13

6.79

3.0

2.5

66.57

66.56

g/l

0.03

2140

15427

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

135

843

1.66

6.77

2.4

3.0

66.97

67.06

g/l

0.05

130

792

Behavioural disorders

284

2.15

6.75

1.8

2.6

66.04

67.51

g/l

0.75

271

Other and unspecified epidermal thickening

123

754

1.71

6.75

2.6

3.0

64.88

67.04

g/l

2.79

115

702

Ulcerative ileocolitis

152

978

1.61

6.72

2.4

2.8

67.70

67.27

g/l

0.28

145

919

Other disorders of penis

431

3329

1.32

6.72

2.2

2.7

66.56

66.40

g/l

0.18

401

3092

Presence of other devices

1251

10602

1.18

6.71

2.7

2.6

65.85

66.01

g/l

0.34

1131

9559

Campylobacter enteritis

122

747

1.71

6.71

2.7

3.0

65.53

67.02

g/l

1.32

110

693

Meralgia paraesthetica

154

998

1.61

6.69

1.8

2.8

66.96

66.67

g/l

0.20

143

933

Malignant neoplasm of stomach

236

1665

1.46

6.68

2.1

1.6

62.41

66.40

g/l

9.84

217

1492

Brain meningioma

214

1484

1.49

6.68

2.3

1.5

65.23

66.96

g/l

2.97

197

1331

Other endocrine disorders

173

1095

1.56

6.67

2.8

3.1

65.67

66.39

g/l

0.57

161

1022

Alzheimer’s disease (Late onset), excluding more controls

798

4278

1.23

6.67

2.3

3.1

65.57

65.78

g/l

0.30

691

3903

Intermittent heterotropia

189

1271

1.52

6.67

2.2

2.8

66.54

66.77

g/l

0.16

176

1192

Diseases of appendix

3291

26803

1.10

6.65

2.8

2.6

66.60

66.52

g/l

0.25

3034

24808

Respiratory tuberculosis, bacteriologically and histologically confirmed

100

584

1.82

6.64

1.8

2.7

66.44

66.01

g/l

0.21

533

Other bursitis of knee

351

2.06

6.63

2.6

3.2

66.37

67.22

g/l

0.41

328

Injury of other and unspecified intrathoracic organs

293

2150

1.41

6.62

2.4

2.6

64.86

66.48

g/l

3.22

269

1991

Malignant neoplasm of breast, ER-negative, including Hilmo

852

6644

1.22

6.62

2.5

1.5

65.50

66.63

g/l

3.84

771

5910

Hypertrophic disorders of skin

202

1383

1.50

6.62

2.9

2.8

67.51

67.20

g/l

0.28

186

1294

Other and unspecified mononeuropathies of upper limb

127

788

1.68

6.60

3.5

2.8

67.49

66.90

g/l

0.43

120

741

Anogenital herpesviral [herpes simplex] infection, including avohilmo

318

2353

1.37

6.56

2.6

2.4

66.40

67.51

g/l

1.81

296

2212

207

1420

1.48

6.56

1.5

2.0

67.58

68.02

g/l

0.39

199

1338

Endometriosis of pelvic peritoneum

533

3845

1.28

6.52

2.3

2.5

67.08

66.81

g/l

0.41

489

3573

Benign neoplasm: Parathyroid gland

357

2.09

6.51

2.0

3.0

67.61

66.60

g/l

0.50

336

Corneal scars and opacities

134

848

1.66

6.51

2.5

3.0

65.97

66.80

g/l

0.57

122

788

Other infective otitis externa

260

1876

1.43

6.49

2.7

2.8

66.68

66.55

g/l

0.10

234

1747

Other and unspecified disorders of orbit

140

2.84

6.48

2.8

3.2

68.03

67.35

g/l

0.23

129

Burns and corrosions

524

4166

1.28

6.47

2.4

2.6

66.15

66.71

g/l

0.94

486

3887

Examination and encounter for administrative purposes

359

2723

1.35

6.46

3.5

2.6

66.55

66.06

g/l

0.62

335

2508

Hypogonadotropic hypogonadism

115

699

1.71

6.44

3.0

68.09

67.38

g/l

0.52

108

670

Diffuse brain injury

133

837

1.64

6.44

2.7

66.66

66.54

g/l

0.07

124

786

Noninflammatory disorders of female genital tract

1456

6327

1.16

6.41

2.7

2.5

66.87

66.45

g/l

1.26

1332

5778

Parapsoriasis

523

1.84

6.37

2.3

3.3

67.01

66.83

g/l

0.08

489

Optic atrophy, wide definition

487

1.87

6.34

2.9

2.8

66.57

67.01

g/l

0.23

456

Endocrine disorders, other/unspecified

509

1.85

6.34

1.9

3.1

67.54

67.27

g/l

0.14

477

Other and unspecified nail disorders

111

675

1.73

6.33

2.8

2.9

65.23

67.15

g/l

1.85

106

628

Tuberculosis, IBD comorbidity

344

2607

1.36

6.33

2.3

2.5

66.03

65.91

g/l

0.09

303

2359

Cytomegaloviral pneumonitis

4.45

6.29

3.1

2.7

63.62

66.73

g/l

0.57

Other disorders of the genitourinary system

600

4876

1.26

6.27

2.7

66.14

66.17

g/l

0.04

549

4424

Caries of enamel

4411

26657

1.09

6.25

2.8

2.7

67.14

66.44

g/l

8.71

4067

24687

Early lumbar disc prolapse, operated

242

1726

1.42

6.24

2.0

2.5

66.88

67.45

g/l

0.62

237

1653

Polyp of the female genital tract

1197

5811

1.18

6.23

2.7

2.6

66.37

66.33

g/l

0.05

1085

5292

Appendicitis, broad definition

3247

26615

1.10

6.21

2.8

2.6

66.61

66.52

g/l

0.28

2995

24642

Ill-defined and unknown causes of mortality

521

4177

1.28

6.21

2.6

65.98

65.82

g/l

0.17

473

3767

Cauda equina syndrome

361

2.02

6.20

1.9

3.4

65.88

67.20

g/l

0.84

337

Alcohol withdrawal state with delirium

306

2288

1.38

6.18

1.7

2.8

65.69

66.57

g/l

1.12

274

2134

Open wound of hip and thigh

132

840

1.63

6.17

2.1

2.7

65.14

66.99

g/l

1.99

115

788

Alzheimer’s disease, strict definition

1185

11044

0.85

6.16

2.1

2.5

65.43

65.59

g/l

0.28

1017

9847

conjunctival haemorrhage

377

2908

1.34

6.15

2.2

2.7

65.35

66.24

g/l

1.66

355

2670

Otitis media, unspecified

335

2322

1.35

6.14

3.5

2.4

66.90

66.92

g/l

0.02

322

2170

Benign neoplasm: Skin of other and unspecified parts of face

494

3938

1.28

6.13

2.9

2.6

65.98

66.28

g/l

0.41

437

3592

Lagophthalmos

422

1.95

6.13

3.1

2.9

65.85

66.57

g/l

0.33

390

Lichen ruber planus, wide definition including periferal and oral lichen planus

1029

8800

1.19

6.12

2.5

2.7

67.22

66.36

g/l

3.47

941

8072

Benign neoplasm: Pituitary gland, craniopharyngeal duct

217

1535

1.46

6.11

2.7

2.9

66.29

66.75

g/l

0.41

208

1428

Oligomenorrhoea

116

715

1.67

6.11

2.4

2.5

66.52

66.91

g/l

0.24

104

657

UC patients in KELA-register (code 208), prior to 1994

193

1339

1.50

6.11

2.8

3.0

66.42

66.77

g/l

0.26

180

1248

Vertigo of central origin

525

1.83

6.10

2.0

3.3

66.00

66.58

g/l

0.31

477

Dislocation, sprain and strain of joints and ligaments of head

146

952

1.58

6.09

3.0

2.7

66.83

67.21

g/l

0.29

131

897

Lichen planus

602

4910

1.25

6.07

2.5

2.7

67.14

66.21

g/l

2.34

551

4486

Burn and corrosion of ankle and foot

356

2.00

6.06

2.2

2.8

65.17

67.08

g/l

1.08

334

Spinal osteochondrosis

232

2.25

6.04

1.5

2.8

66.86

66.89

g/l

0.01

220

Occupational exposure to risk-factors

160

1074

1.56

6.02

2.9

3.0

67.41

66.56

g/l

0.79

145

1001

Ménière disease

436

3434

1.30

6.02

2.8

65.92

66.30

g/l

0.51

403

3149

Uterine polyps

1136

5688

1.18

6.02

2.5

2.6

66.59

66.31

g/l

0.57

1015

5185

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

125

768

1.62

6.01

3.0

2.6

66.20

67.37

g/l

0.82

119

740

Use of other anti-dementia drugs

1326

12199

0.86

6.00

2.3

2.6

65.49

65.61

g/l

0.21

1095

10893

Use of memantine

1326

12199

0.86

6.00

2.3

2.6

65.49

65.61

g/l

0.21

1095

10893

Recurrent dislocation of patella

125

786

1.62

5.99

3.4

2.7

66.86

67.22

g/l

0.24

119

748

Atrophic disorders of skin

653

5371

1.24

5.97

2.5

2.6

66.39

66.53

g/l

0.18

607

4899

Burns and corrosions of external body surface, specified by site

412

3216

1.31

5.97

2.3

2.7

66.20

66.74

g/l

0.76

376

3012

Car occupant injured in other and unspecified transport accidents

684

5645

1.23

5.97

2.4

2.6

66.93

66.76

g/l

0.24

643

5230

Carcinoma in situ of skin, other sites/unspecified

600

1.78

5.96

3.0

2.9

64.82

66.00

g/l

0.80

545

Schizophrenia or delusion

1187

10270

1.17

5.94

2.3

2.5

65.85

66.72

g/l

3.34

1075

9515

Other superficial mycoses

540

1.78

5.93

3.3

2.9

67.06

67.52

g/l

0.28

512

Ethmoidectomy

513

4117

1.27

5.93

2.6

2.7

66.36

66.74

g/l

0.52

474

3826

Injuries involving multiple body regions

152

1009

1.56

5.91

3.1

2.7

65.74

66.91

g/l

1.10

132

938

Benign neoplasm: Cerebral meninges

445

3523

1.30

5.91

2.4

2.7

65.05

66.29

g/l

3.31

403

3227

Tinnitus

1067

9176

1.18

5.91

2.8

2.7

66.38

66.43

g/l

0.10

985

8464

Other disorders of binocular movement

488

1.82

5.90

2.8

2.6

66.63

67.14

g/l

0.29

459

Haemorrhagic disorder due to circulating anticoagulants

502

1.85

5.90

1.7

3.0

64.26

66.14

g/l

1.24

457

Injuries to the wrist and hand

4813

29652

1.08

5.88

2.5

2.7

66.36

66.46

g/l

0.40

4447

27304

Malignant neoplasm of eye and adnexa, including Hilmo

440

1.88

5.88

5.5

1.5

64.63

66.98

g/l

1.74

398

Sequelae of injuries of head

212

1504

1.45

5.86

2.4

2.9

66.31

66.89

g/l

0.60

195

1410

Melanocytic naevi, other sites/unspecified

330

2510

1.35

5.85

3.4

2.7

65.94

66.78

g/l

1.23

314

2339

Contusion of other and unspecified parts of foot

177

1211

1.50

5.85

1.9

2.7

66.48

67.10

g/l

0.55

165

1139

Subacute thyroiditis

148

981

1.56

5.82

2.5

2.8

67.18

67.13

g/l

0.03

136

911

Single ventricle heart

7.71

5.80

2.2

1.8

69.29

61.18

g/l

1.52

Hereditary sideroblastic anaemia

3.28

5.80

2.9

2.5

66.57

65.49

g/l

0.30

Melanocytic naevi of lower limb, including hip

183

1268

1.49

5.78

3.2

2.9

66.05

66.85

g/l

0.82

175

1183

Myopia

414

3242

1.30

5.78

2.4

2.6

67.32

67.04

g/l

0.32

390

3034

Alzheimer’s disease (undefined)

296

0.23

5.78

1.1

2.1

63.14

64.94

g/l

—

261

Dementia in Alzheimer disease

792

7848

0.83

5.76

2.1

2.5

65.24

65.55

g/l

0.48

643

7016

Tracheo-bronchomalasia

3.65

5.75

1.5

3.8

68.99

68.80

g/l

0.04

Spasmodic torticollis

136

890

1.59

5.72

2.0

2.9

67.67

67.13

g/l

0.39

123

826

Alzheimer disease, including avohilmo

1847

14286

0.88

5.69

2.2

2.6

65.48

65.69

g/l

0.54

1571

12836

Acute appendicitis

3005

25505

1.10

5.69

2.8

2.6

66.61

66.56

g/l

0.15

2772

23645

Intercostal neuropathy

213

2.31

5.69

2.7

2.9

66.61

66.95

g/l

0.12

196

Other superficial mycoses, including avohilmo

367

2840

1.31

5.66

2.2

2.7

67.31

67.03

g/l

0.34

337

2647

Dermatitis herpetiformis

498

1.81

5.64

4.3

2.9

67.64

66.61

g/l

0.65

465

Erectile dysfunction

413

3268

1.30

5.63

2.3

2.7

65.06

65.75

g/l

0.99

382

2984

Crushed, pushed or stepped on by crowd or human stampede

235

1704

1.41

5.62

2.4

2.6

66.79

67.10

g/l

0.26

216

1603

Lichen planus, including avohilmo

870

7397

1.20

5.62

2.4

2.7

67.11

66.35

g/l

2.40

794

6773

Autoimmune thyroiditis

422

1.86

5.62

2.6

3.0

68.15

67.69

g/l

0.25

396

Lactose intolerance

118

749

1.63

5.61

2.2

2.4

66.16

66.89

g/l

0.50

109

689

Pleural plaque without asbestos

212

1529

1.45

5.60

2.0

2.8

66.82

65.93

g/l

1.04

191

1390

Alzheimer disease

1606

12916

0.88

5.59

2.2

2.6

65.31

65.67

g/l

1.08

1367

11559

Severe visual impairment, monocular

311

2.05

5.58

2.5

2.9

66.58

66.43

g/l

0.05

286

Ulcer of vagina/vulva

114

720

1.65

5.57

2.3

2.8

67.49

66.89

g/l

0.43

106

668

Other salmonella infections, including avohilmo

175

1211

1.49

5.57

3.1

2.8

67.27

66.98

g/l

0.20

159

1120

Asthma mixed form (mode)

175

1207

1.48

5.56

1.9

2.1

67.00

67.01

g/l

0.01

160

1079

Schizophrenia, schizotypal and delusional disorders

1189

10348

1.16

5.52

2.3

2.5

65.80

66.72

g/l

3.65

1077

9592

Non-small cell lung cancer, squamous

216

1556

1.43

5.51

1.8

1.6

65.48

66.18

g/l

0.60

201

1374

Acute appendicitis, no complications

2225

19983

1.11

5.50

2.8

2.6

66.74

66.66

g/l

0.20

2063

18596

Benign neoplasm: Spinal meninges

335

2.01

5.49

1.9

2.8

66.40

66.56

g/l

0.06

306

Granuloma annulare

398

1.89

5.47

1.9

3.1

68.08

67.59

g/l

0.27

368

Tuberculosis, wide, including avohilmo

357

2780

1.32

5.45

2.3

2.6

66.01

65.87

g/l

0.12

315

2519

Use of levodopa decarboxylase inhibitor

745

6282

1.21

5.44

2.0

2.6

66.00

65.84

g/l

0.22

654

5669

Contact with heat and hot substances

202

1441

1.44

5.42

2.0

2.8

65.41

66.91

g/l

1.96

182

1343

Pyoderma

519

1.76

5.39

2.8

3.1

66.77

66.97

g/l

0.09

479

Hordeolum and other deep inflammation of eyelid

237

1739

1.40

5.39

2.7

2.8

67.62

66.65

g/l

1.04

216

1618

Pilonidal cyst

259

1921

1.37

5.39

2.4

66.50

67.38

g/l

1.33

244

1823

Infectious mononucleosis, including avohilmo

201

1430

1.43

5.34

2.8

2.3

67.97

67.98

g/l

0.00

196

1360

Infectious mononucleosis

201

1430

1.43

5.34

2.8

2.3

67.97

67.98

g/l

0.00

196

1360

Alzheimer’s disease (undefined), excluding more controls

273

0.24

5.33

1.1

1.9

63.14

64.56

g/l

—

240

Secondary parkinsonism+Parkinsonism in other disease

140

940

1.56

5.33

2.3

3.0

64.74

66.36

g/l

1.63

117

869

Benign neoplasm: Bladder

288

2.07

5.33

2.1

3.1

65.27

66.12

g/l

0.34

263

Memory loss

465

3753

1.27

5.33

2.2

2.6

65.50

66.06

g/l

0.87

410

3420

Maternal care for other conditions predominantly related to pregnancy

523

4138

1.24

5.31

2.4

2.3

67.68

67.57

g/l

0.13

496

3893

Other lesions of median nerve

132

876

1.58

5.30

2.1

2.7

65.56

66.36

g/l

0.63

116

803

Benign neoplasm: Other and unspecified parts of small intestine

525

1.77

5.29

2.7

3.0

64.88

66.66

g/l

1.63

484

Malignant neoplasm of breast, HER-negative

783

6362

1.20

5.29

2.6

1.5

65.38

66.62

g/l

4.06

707

5644

Injury of muscle and tendon at lower leg level

642

5346

1.22

5.26

2.6

2.8

66.22

66.67

g/l

0.74

599

4981

Other disorders starting during childhood or adolescence

108

671

1.62

5.24

3.1

2.7

65.88

66.73

g/l

0.46

103

640

Hypertrophic scar

179

1257

1.46

5.23

2.9

2.7

67.26

67.20

g/l

0.04

166

1174

Tuberculosis, wide

351

2743

1.31

5.23

2.3

2.6

65.98

65.86

g/l

0.10

309

2485

Disorders of breast

1945

15395

1.12

5.22

2.3

2.6

66.76

66.48

g/l

0.94

1768

14032

Other acquired deformities of musculoskeletal system and connective tissue

188

1337

1.45

5.22

2.7

2.8

65.22

66.87

g/l

2.23

174

1243

Triptan medication for migraine, min. 3 purchases

1907

12782

1.12

5.21

2.5

67.24

66.96

g/l

1.02

1782

11927

Dissection of aorta

158

1092

1.51

5.20

2.5

3.0

65.27

66.35

g/l

1.06

138

1005

Left ventricular outflow tract obstruction, narrow definition

188

1336

1.45

5.20

2.5

2.9

64.46

66.55

g/l

3.02

183

1251

Vulvovaginal ulceration/inflammation in other diseases

210

1516

1.41

5.20

2.2

2.6

66.39

67.14

g/l

0.86

194

1421

Hypertrophy of tongue papillae

383

1.89

5.20

2.1

3.2

66.86

67.11

g/l

0.10

363

Other deformities of toe(s)

149

1016

1.52

5.18

2.6

3.0

65.52

65.97

g/l

0.32

131

923

Injury of intra-abdominal organs

616

1.67

5.17

3.0

63.98

67.21

g/l

3.06

574

Other and unspecified injuries of ankle and foot

148

1005

1.51

5.16

2.1

2.9

67.44

67.23

g/l

0.12

142

938

Follow-up care involving plastic surgery

152

1041

1.51

5.15

3.2

2.6

66.97

67.40

g/l

0.28

129

958

Malignant neoplasm of renal pelvis, including Hilmo

320

1.97

5.10

3.1

1.6

66.63

66.50

g/l

0.04

284

Medicines for HER+ breast cancer

1596

13262

1.13

5.10

2.8

2.7

66.46

66.33

g/l

0.29

1438

12021

Malignant neoplasm of tongue, including Hilmo

113

730

1.62

5.10

2.6

1.5

65.03

66.92

g/l

1.61

107

664

Meningitis

196

1410

1.43

5.08

2.8

66.16

66.84

g/l

0.60

181

1318

Disorder of external ear, unspecified

150

1031

1.51

5.05

2.6

3.0

65.92

66.72

g/l

0.59

133

959

FESS (DNB20)

486

3954

1.25

5.03

2.5

2.7

66.48

66.77

g/l

0.34

448

3677

Malignant neoplasm of oral cavity

148

1016

1.51

5.00

2.0

1.6

64.87

66.90

g/l

2.30

140

924

Papillary adenocarcinoma of thyroid gland

189

1354

1.43

5.00

2.8

1.6

66.79

67.26

g/l

0.38

179

1233

Hypergammalglobulinemia, unspecified

7.18

4.99

4.8

1.7

72.99

66.70

g/l

1.04

Amblyopia ex anopsia

147

1006

1.50

4.97

2.1

3.1

66.73

66.43

g/l

0.18

133

937

Insomnia

4019

25997

1.08

4.96

2.1

2.7

66.82

66.45

g/l

2.46

3677

23967

Personal history of risk-factors, not elsewhere classified

264

2.02

4.96

2.0

2.9

63.92

67.23

g/l

1.59

247

Senility

271

2.01

4.94

2.7

2.2

65.80

65.83

g/l

0.01

242

Prolonged pregnancy

210

2444

0.73

4.92

2.5

2.2

66.89

67.85

g/l

1.18

196

2305

Bruxism

395

1.82

4.91

1.4

2.6

67.42

67.64

g/l

0.10

370

Ovarian dysfunction

179

1268

1.43

4.91

2.3

2.2

67.15

67.74

g/l

0.47

171

1199

Congenital malformations of the nervous system

394

1.81

4.91

2.2

3.3

66.70

67.02

g/l

0.17

373

Focal brain injury

251

1887

1.36

4.88

2.4

2.8

65.81

65.99

g/l

0.14

227

1740

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1085

9471

1.16

4.88

2.1

2.6

66.66

66.80

g/l

0.25

996

8820

Calcific tendinitis of shoulder

213

1563

1.40

4.87

2.8

3.0

66.25

66.83

g/l

0.56

196

1446

Parkinson's disease, including avohilmo

828

7112

1.19

4.87

2.0

2.6

65.82

65.84

g/l

0.02

728

6427

Idiopathic progressive neuropathy

4.05

4.87

1.3

3.0

68.72

67.63

g/l

0.26

Injury of nerves and spinal cord at neck level

101

645

1.64

4.84

2.5

3.3

65.08

66.75

g/l

1.07

599

Secondary parkinsonism

136

928

1.53

4.83

2.2

3.0

64.60

66.45

g/l

1.97

113

856

Inflammatory disorders of male genital organs, not elsewhere classified

377

1.85

4.83

1.3

3.3

65.60

66.74

g/l

0.45

353

Gestational [pregnancy-induced] hypertension

718

6062

1.19

4.81

2.6

2.4

66.75

67.20

g/l

0.90

684

5619

Use of rivastigmine

661

7783

0.83

4.81

2.2

2.5

65.64

65.49

g/l

0.22

559

6897

Separation of retinal layers (serosa)

176

1257

1.45

4.81

2.9

66.65

66.96

g/l

0.22

162

1175

Other neurotic disorders

198

1443

1.41

4.79

1.9

3.0

66.51

66.71

g/l

0.14

173

1328

Exposure to other and unspecified animate mechanical forces

105

676

1.60

4.73

2.4

2.8

65.61

67.36

g/l

1.42

643

Other facial nerve disorders

120

799

1.56

4.73

2.7

2.6

67.03

67.05

g/l

0.01

106

742

Ulcerative rectosigmoiditis

298

2309

1.32

4.69

2.5

2.7

67.84

66.89

g/l

1.36

280

2163

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

393

1.80

4.69

2.5

3.1

65.38

66.91

g/l

0.84

371

Other congenital malformations of skin

145

1003

1.49

4.68

2.1

3.1

67.13

66.71

g/l

0.28

136

934

Nonspecific lymphadenitis

207

1522

1.39

4.68

2.8

2.7

65.86

67.13

g/l

1.49

195

1431

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

587

1.66

4.68

2.3

1.5

65.52

67.03

g/l

0.96

535

Endometriosis ASRM stages 1,2

547

4534

1.22

4.67

2.3

2.5

67.02

67.01

g/l

0.01

501

4207

Cysts of oral region, not elsewhere classified

240

1810

1.36

4.66

3.8

2.8

65.98

66.63

g/l

0.65

220

1689

Muscle strain

118

783

1.55

4.66

2.3

3.0

67.42

67.09

g/l

0.19

113

725

Allergic contact dermatitis due to drugs in contact with skin

636

1.63

4.64

2.9

3.0

66.45

67.06

g/l

0.31

593

Ventricular septal defect, a heart condition

408

1.77

4.62

2.5

3.1

65.55

66.14

g/l

0.19

384

Myocardial infarction, with ST-elevation

878

7603

1.17

4.62

2.2

2.6

65.03

65.90

g/l

2.69

802

6860

Moyamoya

8.96

4.59

1.1

1.4

65.37

67.01

g/l

—

Other degenerative diseases of the basal ganglia

107

707

1.61

4.57

2.3

3.3

65.43

65.87

g/l

0.28

650

Other and unspecified iridocyclitis

191

1395

1.41

4.57

2.8

2.9

67.87

66.81

g/l

1.27

180

1292

Congenital malformations of aortic and mitral valves

159

1126

1.45

4.56

2.5

3.0

64.08

66.73

g/l

3.76

154

1056

Crystalline deposits in vitreous body

306

1.95

4.52

3.2

64.80

66.37

g/l

0.65

284

Anisometropia and aniseikonia

132

906

1.51

4.50

2.4

3.1

65.73

66.65

g/l

0.81

119

840

Chronic Coagulation defects

560

1.65

4.49

3.0

66.53

67.34

g/l

0.58

524

Exposure to sunlight

3.35

4.46

3.3

65.45

67.57

g/l

0.38

Vestibular neuronitis

386

3115

1.27

4.44

2.5

2.9

67.06

66.39

g/l

1.14

350

2879

Explicit viral Sepsis, including avohilmo

9.16

4.44

1.1

1.4

69.14

66.71

g/l

—

Benign neoplasm: Long bones of lower limb

118

793

1.54

4.43

2.7

2.9

67.05

67.28

g/l

0.15

108

744

Benign neoplasm of eye and adnexa

476

3929

1.24

4.41

2.9

2.7

65.92

66.25

g/l

0.49

430

3616

Atrial septal defect, secundum type

639

1.60

4.41

1.7

3.1

65.73

66.54

g/l

0.42

603

Certain zoonotic bacterial diseases, including avohilmo

129

886

1.51

4.41

2.4

3.1

65.82

66.96

g/l

0.99

121

823

Benign neoplasm: Other and unspecified parts of mouth

151

1070

1.47

4.41

3.3

3.1

67.15

66.81

g/l

0.21

135

994

Leiomyoma of uterus

2557

13157

1.10

4.40

2.7

2.6

66.26

66.53

g/l

1.02

2296

11978

Contusion of ankle

140

973

1.48

4.40

1.9

3.0

65.91

66.91

g/l

1.07

133

919

Neuroendocrine tumor and carcinoma of small intestine

381

1.80

4.39

2.7

1.6

65.59

67.75

g/l

1.35

350

Other puerperal infections

177

1279

1.40

4.38

2.5

2.2

67.34

67.83

g/l

0.44

164

1210

Operations for atrial fibrillation

491

1.72

4.37

1.7

3.3

65.95

66.40

g/l

0.20

455

Other contact dermatitis

291

2270

1.31

4.37

2.3

2.8

67.07

66.53

g/l

0.55

260

2092

Open bite

139

964

1.47

4.36

1.6

2.7

66.91

67.40

g/l

0.31

132

915

Single delivery by forceps and vacuum extractor

219

1742

0.74

4.34

1.9

2.0

68.03

67.63

g/l

0.35

208

1636

Other acute skin changes due to ultraviolet radiation

149

1056

1.46

4.32

2.1

2.9

66.43

66.77

g/l

0.18

135

970

Anomalies of dental arch relationship, including avohilmo

624

4763

1.20

4.31

2.9

2.7

67.06

67.00

g/l

0.08

577

4455

Benign neoplasm of major salivary glands

433

3551

1.24

4.30

2.3

2.8

66.12

66.27

g/l

0.15

401

3256

Other and unspecified injuries of shoulder and upper arm

130

899

1.49

4.27

2.4

2.8

66.73

66.97

g/l

0.13

113

836

Melanoma in situ of other and unspecified parts of face

489

1.72

4.25

2.8

3.1

65.08

65.79

g/l

0.32

444

Inguinal or femoral hernia, bilateral

521

4359

1.22

4.23

2.6

2.7

65.85

66.17

g/l

0.41

468

4018

Disorders of synovium and tendon in diseases classified elsewhere

562

1.63

4.22

2.9

2.8

65.71

66.96

g/l

0.82

519

Other, unspecified and serous retinal detachments

146

1037

1.46

4.22

2.7

3.0

67.11

66.53

g/l

0.40

136

965

Nontoxic single thyroid nodule

292

2295

1.30

4.21

2.3

2.7

66.74

66.52

g/l

0.21

264

2110

Perforation of tympanic membrane

404

3294

1.25

4.21

3.3

2.7

65.79

66.43

g/l

0.95

364

3035

Inguinal hernia, bilateral

512

4280

1.22

4.20

2.6

2.7

65.88

66.18

g/l

0.37

461

3946

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

192

1419

1.37

4.18

2.2

2.3

65.72

67.84

g/l

3.58

181

1344

Atopic conjunctivitis

153

1092

1.43

4.18

2.2

2.6

66.35

66.99

g/l

0.53

141

1031

Alzheimer’s disease (Late onset)

1127

10445

0.88

4.18

2.2

2.5

65.38

65.51

g/l

0.23

964

9293

Haemangioma, any site

339

2715

1.27

4.17

2.8

67.16

66.52

g/l

0.88

308

2510

Unspecified chronic bronchitis

158

1138

1.43

4.17

2.1

3.0

65.83

66.32

g/l

0.32

146

1040

Other and unspecified mononeuropathies of lower limb

121

832

1.51

4.15

1.7

2.6

66.09

67.00

g/l

0.82

107

772

Other congenital malformations of nervous system

156

2.22

4.13

2.8

65.22

67.23

g/l

1.20

145

Injury of eye and orbit

516

4312

1.21

4.12

3.0

2.6

65.67

66.80

g/l

2.85

476

4037

Benign neoplasm: Skin of eyelid, including canthus

710

6110

1.18

4.11

3.1

2.6

66.57

66.13

g/l

0.85

627

5578

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

261

2027

1.31

4.11

3.8

1.6

65.12

66.71

g/l

2.39

234

1827

L02BA Anti-estrogens

659

5632

1.19

4.10

2.8

2.6

66.21

66.52

g/l

0.51

598

5134

Explicit viral Sepsis

9.72

4.10

1.1

1.4

69.79

67.57

g/l

—

Flatulence and related conditions

270

1.92

4.08

1.9

2.9

66.08

67.53

g/l

0.72

252

Melanoma in situ of trunk

548

1.65

4.06

3.6

3.2

65.70

66.32

g/l

0.28

508

Malignant neoplasm of other and unspecified parts of tongue

382

1.76

4.06

1.6

1.5

65.86

67.27

g/l

0.61

355

Acute epiglottitis

366

1.77

4.06

5.1

3.3

66.37

67.29

g/l

0.42

345

Perioral dermatitis

527

1.63

4.05

2.2

2.7

66.86

67.23

g/l

0.14

492

Exposure to other and unspecified man-made environmental factors

435

1.70

4.03

3.4

2.9

66.82

67.63

g/l

0.48

411

Personal history of malignant neoplasm

325

2601

1.27

4.02

3.0

2.5

65.81

66.82

g/l

1.77

303

2389

Lactose intolerance, other/unspecified

100

664

1.55

4.02

1.7

2.5

66.29

66.90

g/l

0.34

610

Other vitreous opacities

185

1379

1.38

3.99

3.0

66.55

66.38

g/l

0.13

167

1271

Benign neoplasm: salivary glands, exclude unknown (D119)

385

3147

1.25

3.99

2.4

2.8

66.36

66.32

g/l

0.03

355

2893

Alopecia areata

650

1.56

3.96

3.4

2.6

66.41

66.86

g/l

0.21

606

Single spontaneous delivery

1375

8095

0.89

3.96

2.7

2.4

66.47

66.22

g/l

0.57

1254

7292

Varicose veins of other sites

254

1978

1.31

3.96

2.8

66.30

66.76

g/l

0.48

228

1839

Epiphora

106

719

1.54

3.95

2.9

3.1

66.27

66.99

g/l

0.46

656

Hypermetropia

261

2036

1.31

3.95

3.0

2.9

66.18

66.36

g/l

0.15

239

1884

Patent foramen ovale

524

1.62

3.94

1.9

3.0

65.45

66.55

g/l

0.74

497

Haemangioma and lymphangioma, any site

358

2905

1.26

3.93

3.0

2.8

67.17

66.51

g/l

0.96

326

2690

Aphakia

423

1.70

3.93

4.0

2.6

66.70

66.09

g/l

0.31

399

Other and unspecified injuries of wrist and hand

136

964

1.45

3.90

2.1

2.7

66.66

67.09

g/l

0.32

128

902

Malignant neoplasm of oropharynx, including Hilmo

551

1.61

3.88

4.2

1.6

65.31

66.97

g/l

1.02

502

Injury of muscle and tendon at shoulder and upper arm level

1698

15463

1.11

3.87

2.6

2.8

66.39

66.40

g/l

0.01

1583

14323

Alport

5.21

3.87

1.7

6.9

63.35

66.59

g/l

0.99

Other peripheral vertigo

415

3432

1.23

3.85

1.9

2.8

66.19

66.30

g/l

0.10

374

3155

Congenital deformities of feet, including avohilmo

122

851

1.47

3.81

2.0

3.0

67.65

67.06

g/l

0.34

110

801

Tuberculosis of other organs

100

677

1.54

3.79

2.1

3.0

66.29

66.05

g/l

0.10

616

Benign neoplasm: Liver/bile ducts

104

707

1.52

3.78

2.6

2.9

67.27

67.40

g/l

0.07

659

Parkinson's disease

781

6820

1.16

3.78

2.0

2.6

65.87

65.83

g/l

0.04

689

6170

Dronedarone medication

132

943

1.45

3.76

2.0

2.9

65.27

66.83

g/l

1.55

115

852

Medical abortion

2487

12424

1.09

3.75

2.2

2.6

66.37

66.47

g/l

0.25

2243

11333

Unspecified jaundice

218

1679

1.33

3.75

1.9

2.6

63.65

66.32

g/l

4.39

201

1534

Dependent personality disorder

516

1.61

3.74

2.7

3.0

64.80

67.38

g/l

2.06

484

Felty syndrome

159

2.20

3.70

1.9

3.1

63.64

66.53

g/l

1.14

145

Parkinson's disease, strict definition

731

6365

1.17

3.70

2.0

2.6

65.97

65.84

g/l

0.17

643

5761

Anorexia (incl.atypical)

159

1166

1.38

3.68

2.3

2.5

66.49

67.52

g/l

1.17

147

1089

Maltreatment syndromes

137

981

1.42

3.68

2.1

2.5

67.63

67.75

g/l

0.07

124

935

Dislocation of lens

505

1.62

3.64

2.7

65.83

65.79

g/l

0.02

474

Benign neoplasm: Connective and other soft tissue, unspecified

326

1.78

3.64

2.4

2.8

65.95

67.00

g/l

0.41

310

Disorders of globe

118

831

1.47

3.64

2.9

66.10

66.46

g/l

0.20

107

758

Transient acantholytic dermatosis [Grover]

3.04

3.63

1.3

2.0

66.56

65.17

g/l

0.43

Other benign neoplasms of connective and other soft tissue

388

3205

1.23

3.62

2.8

2.7

66.61

66.52

g/l

0.09

359

2955

Malignant neoplasm of vulva, including Hilmo

404

1.70

3.61

2.8

1.5

64.54

67.15

g/l

1.71

365

Drug-induced acute pancreatitis

4.34

3.61

3.5

3.8

64.19

66.67

g/l

0.46

Malignant neoplasm of tongue

545

1.59

3.61

2.1

1.5

64.94

67.22

g/l

1.53

506

Benign neoplasm: Other parts of oropharynx

260

1.89

3.61

5.1

2.6

66.82

66.77

g/l

0.02

243

Primary open-angle glaucoma, strict

1388

12550

1.12

3.56

2.6

66.44

65.74

g/l

2.68

1255

11240

Benign neoplasm of middle ear and respiratory system

336

2744

1.25

3.55

2.4

2.8

65.87

66.47

g/l

0.82

310

2531

Other effects of reduced temperature

3.09

3.55

1.7

2.3

67.38

66.59

g/l

0.21

Delivery

1390

8106

0.90

3.54

2.8

2.4

66.45

66.23

g/l

0.52

1270

7303

Other appendicitis

314

2544

1.26

3.53

3.1

2.8

66.41

66.78

g/l

0.43

287

2378

Complications of labour and delivery

1931

11688

0.91

3.52

2.8

2.6

66.96

66.66

g/l

0.98

1792

10742

Superficial injuries involving multiple body regions

678

1.51

3.49

3.9

2.9

66.02

67.06

g/l

0.73

630

Other and unspecified acute skin changes due to ultraviolet radiation

113

797

1.47

3.48

2.2

3.0

65.85

66.77

g/l

0.52

102

728

Endovascular or surgical operations to intracerebral aneurysms

253

2008

1.29

3.47

2.0

3.0

65.69

66.59

g/l

1.15

231

1847

Tuberculosis of other organs, strict

111

781

1.48

3.47

2.2

2.9

66.27

66.02

g/l

0.12

709

Juvenile Open Angle Glaucoma

115

2.33

3.44

3.1

2.9

68.11

68.03

g/l

0.01

108

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

2.79

3.41

1.3

2.3

64.76

66.83

g/l

0.40

Use of galantamine

293

3599

0.80

3.41

1.9

2.5

66.62

65.49

g/l

1.86

244

3190

Other congenital malformations of skin, including avohilmo

274

2195

1.27

3.41

2.0

2.8

66.59

66.72

g/l

0.10

251

2036

Effects of foreign body entering through natural orifice

949

8437

1.14

3.41

2.6

2.7

66.72

66.57

g/l

0.24

876

7853

Alzheimer’s disease (Atypical or mixed), excluding more controls

461

2901

1.21

3.40

2.3

2.8

64.93

65.56

g/l

0.89

387

2625

Fistulae involving female genital tract

481

1.61

3.40

2.7

67.41

66.92

g/l

0.19

440

Other and unspecified corneal deformities and disorders

129

934

1.42

3.38

2.6

3.1

67.40

67.12

g/l

0.17

121

866

584

1.53

3.38

2.4

2.9

66.58

67.97

g/l

1.00

550

Burns and corrosions of multiple and unspecified body regions

536

1.56

3.38

2.4

3.2

66.51

66.83

g/l

0.13

502

Tuberculosis of other organs, strict, including avohilmo

112

794

1.46

3.37

2.2

2.9

66.13

66.04

g/l

0.04

722

Contracture of muscle

2.45

3.36

1.2

3.7

62.73

66.83

g/l

1.63

Foreign body in ear

473

1.60

3.36

2.1

3.5

67.34

66.83

g/l

0.26

442

Foreign body in alimentary tract

217

1698

1.31

3.34

1.8

2.8

66.16

66.34

g/l

0.13

196

1568

Spontaneous abortion

1312

9709

0.90

3.34

2.6

66.83

66.71

g/l

0.25

1210

8967

Schizoaffective disorder

243

1925

1.28

3.33

1.9

2.8

65.26

67.06

g/l

3.05

225

1809

Lichen sclerosus et atrophicus

464

3931

1.20

3.32

2.5

2.6

66.72

66.56

g/l

0.18

429

3565

237

1868

1.29

3.32

2.8

2.4

65.71

65.76

g/l

0.03

223

1641

Certain zoonotic bacterial diseases

524

1.57

3.32

2.6

2.8

65.73

67.18

g/l

0.97

484

Other disorders of optic disc

358

1.69

3.30

1.8

2.8

65.55

67.31

g/l

0.96

336

Rheumatic valve diseases

101

705

1.49

3.29

3.3

2.5

65.40

66.04

g/l

0.35

636

Glaucoma suspect

1806

16625

1.10

3.28

2.5

2.7

66.34

66.05

g/l

0.82

1652

15086

Primary open-angle glaucoma

1695

14978

1.10

3.28

2.6

66.33

65.80

g/l

1.99

1521

13442

Other specified disorders of external ear

173

1321

1.35

3.28

3.1

2.9

65.63

66.42

g/l

0.70

155

1239

Benign neoplasm: Parotid gland

342

2826

1.23

3.27

2.4

2.8

66.31

66.38

g/l

0.05

315

2605

Right hemicolectomy

273

2206

1.27

3.27

3.1

2.8

64.68

66.20

g/l

2.29

257

2019

Dementia, including avohilmo

2680

17064

1.08

3.26

2.2

2.8

65.71

65.91

g/l

0.66

2314

15487

Subarachnoid haemorrhage

456

3867

1.20

3.26

2.3

2.7

65.72

66.13

g/l

0.54

403

3508

Triptan medication for migraine, single purchase ok

2916

18462

1.07

3.25

2.5

2.7

67.04

66.71

g/l

1.72

2718

17146

Migraine, single triptan purchase ok & required. ICD-code if available is included

2916

18462

1.07

3.25

2.5

2.7

67.04

66.71

g/l

1.72

2718

17146

Endometriosis of ovary

585

4753

1.17

3.24

2.3

2.6

66.79

66.51

g/l

0.39

537

4375

Injury of muscle and tendon at hip and thigh level

390

3260

1.21

3.24

2.2

2.8

66.13

66.81

g/l

1.11

368

3045

Colon adenocarcinoma

538

4624

1.18

3.24

2.9

1.6

65.28

66.35

g/l

2.32

487

4108

Coalworker pneumoconiosis

6.37

3.24

1.9

2.5

62.14

65.68

g/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

169

1289

1.35

3.21

2.7

2.9

64.88

66.55

g/l

2.40

156

1196

Bitten or struck by other mammals

380

3172

1.21

3.18

2.8

2.7

66.88

66.93

g/l

0.04

358

2952

Stenosis and insufficiency of lacrimal passages

397

3337

1.21

3.15

2.5

2.6

66.82

66.22

g/l

0.94

364

3034

L02BG Aromatase inhibitors

1315

11813

1.11

3.15

2.7

2.8

66.42

66.25

g/l

0.38

1185

10694

Benign neoplasm: Skin of trunk

169

1292

1.34

3.14

3.9

3.0

66.79

66.60

g/l

0.13

155

1200

Arthropod-borne viral fevers and viral haemorrhagic fevers

377

3156

1.21

3.13

3.1

2.8

65.34

66.57

g/l

2.37

361

2925

Scar conditions and fibrosis of skin

142

1057

1.37

3.13

2.5

2.8

65.45

67.22

g/l

1.59

133

981

Other disorders of Eustachian tube

121

880

1.42

3.12

2.1

2.8

65.63

66.72

g/l

0.63

115

820

Benign neoplasm: Choroid

296

2426

1.25

3.11

3.1

2.9

66.04

66.32

g/l

0.29

264

2229

Foreign body entering into or through eye or natural orifice

290

2366

1.25

3.11

2.6

2.8

66.23

66.68

g/l

0.42

263

2218

Other and unspecified injuries of abdomen, lower back and pelvis

379

1.64

3.11

2.3

2.9

66.65

66.87

g/l

0.08

350

Injury of blood vessels at shoulder and upper arm level

3.12

3.11

4.1

1.9

64.76

66.80

g/l

0.55

Other melanin hyperpigmentation

104

740

1.46

3.10

3.6

3.1

65.84

66.87

g/l

0.79

674

Chromophobe cell carcinoma of kidney

135

2.16

3.08

2.6

1.3

67.00

67.25

g/l

0.06

123

Small cell lung cancer, including Hilmo

105

747

1.45

3.08

2.0

1.6

65.25

66.35

g/l

0.86

664

Small cell lung cancer

105

747

1.45

3.08

2.0

1.6

65.25

66.35

g/l

0.86

664

Benign neoplasm: Liver

599

1.50

3.04

2.5

3.0

66.98

67.49

g/l

0.29

559

Benign neoplasm: Thymus

2.74

3.03

2.1

3.1

64.81

67.21

g/l

0.77

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

200

1.92

3.03

2.2

1.7

65.97

66.34

g/l

0.11

179

Left hemicolectomy

108

779

1.44

3.01

2.4

3.0

65.15

66.34

g/l

0.77

101

724

Procedures for purposes other than remedying health state

617

1.49

3.00

1.9

2.5

66.30

67.66

g/l

1.22

574

Malignant neoplasm of vulva

300

1.73

2.96

2.7

1.5

63.74

67.33

g/l

1.99

269

Conductive hearing loss, unspecified

320

2653

1.23

2.96

3.5

2.7

66.71

66.50

g/l

0.20

300

2450

Alzheimer’s disease (Early onset), excluding more controls

1255

0.70

2.92

1.8

2.7

65.46

65.55

g/l

0.04

1130

Other intracranial haemorrhages

157

1205

1.34

2.92

3.3

2.8

65.12

66.01

g/l

0.68

143

1101

Peritonsillar abscess

688

6059

1.14

2.91

2.8

2.6

67.13

66.80

g/l

0.58

652

5651

Mental and behavioural disorders due to cocaine

4.37

2.90

1.3

4.4

66.78

67.51

g/l

—

Open wound of wrist and hand

1838

16437

1.09

2.90

2.7

2.6

66.41

66.64

g/l

0.71

1725

15298

Chalazion

429

3658

1.19

2.88

3.2

2.7

66.83

66.54

g/l

0.39

398

3386

Inflammation of lacrimal passages (acute and unspecified)

525

1.52

2.88

4.2

2.7

66.33

67.22

g/l

0.52

483

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

179

1395

1.31

2.87

2.5

2.8

66.36

67.36

g/l

1.00

167

1312

Superficial injury of neck

402

1.58

2.86

1.5

3.4

66.97

67.26

g/l

0.14

376

Burns classified according to extent of body surface involved

233

1.80

2.86

2.8

2.9

65.93

67.26

g/l

0.44

221

Acute and transient psychotic disorders

387

3273

1.20

2.85

2.1

2.7

65.95

66.92

g/l

1.68

351

3064

Disorders of eyelid in diseases classified elsewhere

126

938

1.38

2.84

1.7

3.1

65.94

66.89

g/l

0.80

116

863

Iliotibial band syndrome

248

1.76

2.84

3.3

3.4

66.60

67.00

g/l

0.12

233

Acute otitis externa, noninfective

470

1.55

2.82

2.7

3.3

66.11

67.16

g/l

0.50

440

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

4.00

2.82

8.3

1.5

66.38

67.43

g/l

—

Ankle and foot

227

1.81

2.82

4.9

2.7

67.24

67.21

g/l

0.00

212

Other and unspecified intracranial injuries

120

889

1.39

2.80

2.0

2.9

67.32

66.30

g/l

0.72

108

819

Viral haemorrhagic fevers, not elsewhere classified/unspecified

302

2507

1.23

2.79

3.2

2.8

65.12

66.61

g/l

2.63

290

2341

Vertical strabismus

131

984

1.37

2.79

2.4

3.0

66.73

66.78

g/l

0.02

122

919

Rheumatic fever incl heart disease

131

985

1.37

2.79

4.0

2.8

65.29

66.20

g/l

0.65

123

895

Eustachian salpingitis and obstruction

219

1754

1.26

2.77

2.7

2.5

66.53

67.46

g/l

0.99

207

1657

Unspecified maternal hypertension

182

1.87

2.77

1.6

2.2

65.98

68.20

g/l

1.18

171

Nontraumatic intracranial haemmorrhage

962

8681

1.12

2.77

2.3

2.6

65.35

65.93

g/l

1.51

857

7807

Sequelae of infectious and parasitic diseases

278

2290

1.23

2.77

3.0

2.6

65.98

66.60

g/l

0.65

256

2113

Unspecific neurodegenerative disorder

2178

15950

0.93

2.75

2.3

2.7

65.54

65.79

g/l

0.79

1837

14417

Sequelae of other and unspecified infectious and parasitic diseases

176

1378

1.30

2.74

2.5

2.8

66.25

67.40

g/l

1.23

164

1297

Other disorders of cornea

402

3429

1.19

2.74

2.6

2.7

66.29

66.38

g/l

0.09

365

3167

Haemoglobinuria due to haemolysis from other external causes

9.29

2.73

1.6

1.7

61.62

69.67

g/l

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

250

2045

1.25

2.73

2.2

3.0

67.11

66.43

g/l

0.89

235

1871

Vasomotor rhinitis (mode)

281

2323

1.23

2.72

2.3

2.9

66.36

66.44

g/l

0.06

251

2149

Thyroiditis, unspecified

369

1.60

2.71

2.0

2.5

65.45

67.65

g/l

1.20

344

Perforation of oesophagus

165

1.97

2.68

1.8

3.5

62.37

66.34

g/l

1.55

152

Tuberculosis

279

2312

1.23

2.67

2.5

2.6

65.64

65.87

g/l

0.18

250

2090

Hereditary angioödema type 2

7.05

2.66

3.2

1.3

68.00

67.07

g/l

—

Retinoblastoma

8.36

2.66

30.4

1.0

62.16

62.97

g/l

—

Pneumoconiosis due to asbestos and other mineral fibres

107

790

1.40

2.63

1.7

2.5

67.47

65.82

g/l

1.58

715

Other and unspecified degenerative diseases of nervous system

138

1059

1.35

2.62

1.9

2.9

65.90

65.77

g/l

0.07

123

975

Benign neoplasm: Skin of ear and external auricular canal

172

1356

1.30

2.62

1.9

2.8

65.95

66.49

g/l

0.40

149

1245

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

289

2404

1.22

2.61

2.0

2.7

65.95

66.94

g/l

1.44

272

2224

Other disorders of male genital organs

138

1055

1.33

2.60

2.8

2.9

65.83

66.80

g/l

0.85

121

989

All dysplastic lesions of the cervix uteri, vagina or vulva

809

7067

1.12

2.60

2.3

66.79

67.10

g/l

0.57

737

6576

Contact with sharp object, undetermined intent

569

1.46

2.58

3.0

2.9

66.34

67.03

g/l

0.38

534

Pneumonia due to Haemophilus influenzae

2.29

2.57

5.6

1.7

67.01

66.99

g/l

0.00

Disturbances of smell and taste

164

1287

1.30

2.57

2.6

3.2

66.80

66.72

g/l

0.05

152

1195

Contact with other hot fluids

100

730

1.40

2.56

1.5

3.0

65.10

67.03

g/l

1.65

687

Sequelae of infectious and parasitic diseases, including avohilmo

284

2366

1.22

2.55

3.0

2.6

65.96

66.56

g/l

0.64

262

2179

Family history of malignant neoplasm

353

2998

1.19

2.51

3.3

2.5

66.51

67.22

g/l

1.14

331

2774

Endometriosis of rectovaginal septum and vagina

273

2270

1.22

2.50

2.2

2.6

67.15

66.14

g/l

1.72

247

2065

hereditary angioödema type 3

4.84

2.50

2.4

1.6

71.79

68.31

g/l

—

All dysplastic lesions of the vulva

151

1177

1.31

2.49

2.4

2.7

65.49

67.13

g/l

1.33

130

1092

Oral lichen planus, including avohilmo , including avohilmo

281

2347

1.22

2.49

2.8

2.9

68.21

66.53

g/l

4.32

260

2157

Contusion of toe(s) with damage to nail

258

1.69

2.49

2.8

2.7

65.20

67.19

g/l

0.64

240

Other and unspecified injuries of forearm

160

1.89

2.49

1.8

3.3

66.19

66.50

g/l

0.08

154

Female genital prolapse

1120

5670

1.11

2.49

2.4

2.6

66.67

66.27

g/l

1.00

1012

5153

Proteinuria and renal glomerular damage; focal glomerulonephritis

3.52

2.48

1.5

4.1

64.65

64.99

g/l

—

Haemorrhage in early pregnancy

822

7180

1.12

2.48

2.7

2.5

66.43

67.01

g/l

1.50

762

6662

Severe visual impairment, binocular

147

1.96

2.47

3.1

2.8

64.11

65.68

g/l

0.37

133

Retinoblastoma, including Hilmo

7.18

2.46

30.4

1.0

62.16

63.50

g/l

—

Desensitization to allergens

124

939

1.34

2.46

2.4

68.76

67.82

g/l

0.87

118

894

Mixed conductive and sensorineural hearing loss

558

4923

1.15

2.45

2.8

2.7

65.68

66.02

g/l

0.49

503

4488

Personal history of allergy to drugs, medicaments and biological substances

275

1.66

2.45

1.9

2.3

67.15

67.73

g/l

0.19

263

Other sexually transmitted chlamydial diseases

121

913

1.34

2.44

1.7

1.9

68.04

68.27

g/l

0.14

115

871

Juvenile osteochondrosis

625

1.42

2.44

2.7

2.5

65.98

67.52

g/l

0.99

592

Other fall from one level to another

859

7756

1.12

2.44

2.7

2.6

66.26

66.50

g/l

0.45

797

7185

Blood alcohol or alcohol intoxication level

509

1.47

2.43

2.0

2.6

64.95

67.25

g/l

2.13

482

Vascular syndromes of brain in cerebrovascular disorders

213

1740

1.25

2.43

2.8

66.35

66.09

g/l

0.20

200

1603

Marfan's syndrome

105

2.12

2.41

1.5

3.1

65.70

67.12

g/l

0.34

Other injuries of spine and trunk, level unspecified

238

1.72

2.41

3.5

2.7

66.22

67.12

g/l

0.31

224

Contraceptive management

1112

8501

0.91

2.41

2.7

2.6

67.44

67.15

g/l

0.69

1042

8015

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

219

1786

1.24

2.41

2.2

2.7

66.94

67.15

g/l

0.18

203

1666

Graves disease, strict definition

333

2828

1.19

2.41

2.4

2.7

65.93

67.02

g/l

1.89

306

2619

Burn and corrosion of wrist and hand

118

893

1.35

2.40

2.1

2.9

66.61

67.15

g/l

0.37

108

837

Crossbite

182

1337

1.27

2.40

2.9

66.51

66.97

g/l

0.38

167

1268

Ulcerative proctitis

203

1646

1.25

2.39

2.2

2.7

67.35

66.87

g/l

0.38

190

1532

Abrasion of teeth

1483

13748

1.09

2.38

3.0

2.7

66.94

66.57

g/l

1.21

1370

12700

Seminoma of testis, including Hilmo

155

1.87

2.37

1.8

64.48

67.84

g/l

1.55

140

Benign neoplasm of ovary

670

5991

1.13

2.35

2.7

65.93

66.40

g/l

0.86

618

5419

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

459

1.50

2.34

2.5

3.4

64.88

66.36

g/l

0.73

420

Graves ophthalmopathy, strict

616

1.42

2.34

1.6

2.9

66.11

67.46

g/l

0.92

578

Malignant neoplasm of other and unspecified male genital organs, including Hilmo

3.00

2.34

1.5

1.4

58.70

66.00

g/l

1.34

Disorders of lacrimal system and orbit in diseases classified elsewhere

684

1.40

2.34

1.6

2.9

66.38

67.33

g/l

0.61

636

Striae atrophicae

240

1.68

2.31

1.9

2.8

67.28

67.72

g/l

0.14

227

Embolic stroke with flimmer

116

884

1.35

2.31

2.1

2.3

65.77

66.05

g/l

0.13

104

793

Poor fetal growth

248

2055

1.22

2.31

1.6

2.2

67.68

67.77

g/l

0.07

231

1939

Oral lichen planus

116

886

1.35

2.30

3.4

3.0

67.85

66.96

g/l

0.76

107

826

Hypersensitivity pneumonitis due to organic dust

477

1.48

2.28

2.8

3.4

66.86

66.62

g/l

0.07

445

Increased muscle tone

173

1.82

2.28

3.6

3.7

64.74

66.19

g/l

0.47

162

Female infertility, tubal origin

129

996

1.31

2.27

2.3

2.5

67.70

67.55

g/l

0.08

119

942

Other injuries of upper limb, level unspecified

321

1.58

2.27

3.7

3.0

63.09

67.18

g/l

3.30

304

Kaposi sarcoma, including Hilmo

3.67

2.27

1.6

1.8

60.26

65.74

g/l

—

Hypertrophy of breast in women and men

661

5914

1.13

2.27

2.2

2.6

66.49

66.77

g/l

0.46

616

5498

Foreign body in respiratory tract

180

1454

1.26

2.24

2.4

2.9

66.36

66.49

g/l

0.08

165

1350

Female infertility, associated with anovulation

147

1155

1.28

2.23

1.8

2.0

67.46

67.93

g/l

0.34

139

1092

Wilms' tumor, including Hilmo

145

1.90

2.22

4.7

1.8

64.73

66.26

g/l

0.39

128

Struck by thrown, projected or falling objec

178

1437

1.26

2.22

2.4

2.8

66.26

66.83

g/l

0.51

167

1346

Other diseases of peritoneum

173

1395

1.27

2.22

1.9

2.9

66.29

66.49

g/l

0.14

154

1283

Other osteochondropathies

228

1891

1.22

2.19

3.1

2.8

66.33

66.91

g/l

0.55

213

1772

Fourth [trochlear] nerve palsy

711

1.38

2.19

1.8

3.3

67.45

66.62

g/l

0.55

665

Other disorders of choroid

448

1.48

2.18

1.9

3.2

66.81

66.40

g/l

0.17

413

Colorectal adenocarcinoma

882

7931

1.11

2.18

2.7

1.7

65.13

66.49

g/l

5.26

796

7105

Convergent concomitant strabismus

159

1269

1.27

2.17

2.5

2.9

67.33

67.05

g/l

0.16

151

1195

Delivery, wide proxy

1179

6792

0.91

2.17

2.7

2.4

66.58

66.15

g/l

1.11

1073

6079

Moderate mental retardation

117

1.96

2.14

2.9

4.2

68.41

66.02

g/l

0.72

111

All dysplastic lesions of the vagina

686

1.37

2.13

2.2

2.8

67.09

67.42

g/l

0.15

646

Non-allergic asthma

321

2750

1.18

2.13

2.5

2.9

66.85

66.29

g/l

0.64

302

2539

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1091

6963

0.91

2.13

2.6

2.4

67.67

67.21

g/l

1.39

1032

6488

Other and/or unspecified nontoxic goitre

323

2774

1.18

2.12

2.3

2.7

66.09

66.32

g/l

0.24

298

2520

Anxious personality disorder

325

1.54

2.11

2.0

3.0

67.59

68.34

g/l

0.39

306

Dislocation, sprain and strain of joints and ligaments of knee

2361

20165

1.06

2.10

2.2

2.7

66.55

66.84

g/l

1.17

2183

18780

Acute appendicitis, with complications

780

7078

1.11

2.10

2.7

2.6

66.25

66.49

g/l

0.40

709

6548

Seminoma of testis

132

1.88

2.10

2.0

1.8

64.73

68.03

g/l

1.37

120

Use of rasagiline

118

919

1.33

2.09

1.6

3.2

65.51

66.49

g/l

0.84

102

846

Other diseases of appendix

345

1.54

2.09

1.8

2.5

65.96

67.43

g/l

0.53

324

Wide developmental disorders

438

1.45

2.08

1.4

2.6

67.33

66.83

g/l

0.19

419

Burn and corrosion of trunk

106

811

1.34

2.07

1.7

3.0

65.98

66.88

g/l

0.56

757

Laparoscopic right hemicolectomy

271

2306

1.20

2.06

3.0

2.8

66.13

66.26

g/l

0.10

242

2109

Pedestrian injured in transport accident

256

2162

1.20

2.05

1.9

2.7

66.46

66.52

g/l

0.04

229

2001

Dislocations, sprains and strains involving multiple body regions

3.07

2.04

1.7

1.4

69.59

65.77

g/l

—

HSIL lesion of the cervix uteri, vagina or vulva

520

4617

1.13

2.04

2.2

2.4

66.89

67.15

g/l

0.36

473

4296

Injury of blood vessels at lower leg level

120

1.95

2.04

2.1

2.9

65.98

67.08

g/l

0.32

114

Beta thalassaemia

5.27

2.03

12.6

1.3

67.08

69.42

g/l

—

Malignant neoplasm of rectum, including Hilmo

487

4317

1.14

2.03

2.6

1.6

65.16

66.53

g/l

3.25

445

3859

Gonococcal infection

108

831

1.33

2.03

2.5

2.6

66.48

67.48

g/l

0.58

100

776

Pathological resorption of teeth

137

1088

1.28

2.02

2.0

3.0

65.90

66.85

g/l

0.78

124

1016

Endometriosis ASRM stages 3,4

777

7064

1.11

2.02

2.3

2.5

66.78

66.57

g/l

0.34

712

6439

Graves ophthalmopathy

694

1.36

2.01

1.6

2.8

66.32

67.36

g/l

0.70

645

Secondary malignant neoplasm of respiratory and digestive organs

532

1.42

2.01

1.9

1.5

63.88

66.68

g/l

1.63

481

196

1.71

2.00

2.8

2.4

66.40

68.08

g/l

0.62

184

Abnormal spermatozoa

597

5371

1.13

1.99

2.7

2.8

66.25

65.95

g/l

0.45

545

4944

Helminthiases, including avohilmo

124

973

1.29

1.99

3.1

2.8

66.88

66.96

g/l

0.05

119

915

Hypothermia

567

1.40

1.99

1.7

3.0

63.75

66.37

g/l

1.68

527

Other and unspecified myoneural disorders

107

2.01

1.98

1.6

2.8

64.57

67.65

g/l

1.04

102

Respiratory tuberculosis, confirmed and not-confirmed

232

1953

1.21

1.98

2.5

2.7

66.20

65.90

g/l

0.23

208

1773

Eosinophilic cellulitis [Wells]

3.81

1.97

2.4

2.2

68.96

66.60

g/l

—

Respiratory tuberculosis

232

1954

1.21

1.97

2.5

2.7

66.20

65.89

g/l

0.23

208

1774

Ankylosing hyperostosis [Forestier]

391

1.48

1.96

3.6

3.0

66.87

66.66

g/l

0.07

366

Erythema ab igne [dermatitis ab igne]

4.22

1.96

1.0

1.2

68.77

67.05

g/l

—

Gonococcal infection, including avohilmo

112

871

1.31

1.95

2.4

2.6

66.38

67.43

g/l

0.63

104

814

Simple and mucopurulent chronic bronchitis

168

1373

1.25

1.94

1.9

2.8

66.11

66.08

g/l

0.01

150

1248

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

2.32

1.93

1.9

3.1

65.14

66.89

g/l

0.38

Loose body in joint

603

1.37

1.93

2.8

3.1

66.78

66.41

g/l

0.15

556

Dissection of cerebral arteries, nonruptured

175

1.73

1.91

2.5

64.27

67.99

g/l

2.41

165

Normotensive glaucoma

419

3704

1.15

1.91

2.2

2.6

66.42

65.90

g/l

0.77

384

3340

Primary angle-closure glaucoma

194

1615

1.23

1.90

2.2

2.8

66.16

66.03

g/l

0.09

173

1463

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

312

2702

1.17

1.88

2.3

2.8

66.40

66.49

g/l

0.07

286

2492

Adenocarcinoma of pancreas

933

0.72

1.87

1.6

64.19

66.53

g/l

1.44

833

Certain conditions originating in the perinatal period

160

1153

1.24

1.86

3.0

2.5

65.23

67.21

g/l

2.08

152

1094

Complications predominantly related to the puerperium

732

6663

1.10

1.86

2.6

2.5

67.21

67.06

g/l

0.22

682

6205

Malignant neoplasm of palate

2.20

1.86

1.9

65.99

66.62

g/l

0.12

2.30

1.85

3.8

3.9

64.95

68.78

g/l

0.66

LSIL lesion of the vagina

371

1.47

1.83

1.7

2.6

66.20

67.61

g/l

0.63

347

Discharge of firework

3.75

1.82

1.7

3.1

62.48

69.19

g/l

—

Infections of genitourinary tract in pregnancy

274

2352

1.18

1.82

2.7

2.6

66.37

67.10

g/l

0.95

255

2163

Vascular dementia (undefined)

203

1688

1.21

1.80

2.1

2.3

64.68

65.18

g/l

0.37

163

1490

Malignant neoplasm of penis

2.00

1.80

2.6

1.9

66.67

66.82

g/l

0.02

Perineal laceration during delivery

273

2566

0.85

1.79

2.0

2.1

67.53

67.77

g/l

0.22

257

2412

Carcinoma in situ of other and unspecified sites

195

1637

1.22

1.79

2.6

2.8

65.68

66.12

g/l

0.36

177

1509

Unspecified lump in breast

580

5238

1.12

1.78

2.2

2.7

66.38

66.48

g/l

0.13

531

4771

Peripheral retinal degeneration

117

931

1.28

1.75

3.0

66.18

66.84

g/l

0.57

112

862

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

219

1853

1.19

1.74

2.2

2.7

66.94

67.39

g/l

0.44

203

1728

Respiratory tuberculosis, clinically confirmed

368

1.46

1.73

2.3

3.1

66.94

66.02

g/l

0.43

336

Injury of urinary and pelvic organs

546

1.37

1.73

3.0

2.9

63.98

66.54

g/l

2.02

510

Congenital mitral valve regurgitation

2.80

1.72

1.9

2.5

68.44

64.67

g/l

—

Postmenopausal atrophic vaginitis

1048

5287

1.09

1.72

2.4

2.7

67.06

66.23

g/l

3.13

957

4819

Thromboangiitis obliterans

1.96

1.71

1.6

3.0

64.48

66.87

g/l

0.63

Macular cyst

143

1171

1.25

1.70

3.1

3.0

64.85

66.26

g/l

1.23

130

1087

HSIL lesion of the vulva

514

1.38

1.70

2.9

2.8

65.82

67.45

g/l

0.76

479

Undefined dementia

473

4860

0.89

1.69

2.0

2.4

64.70

65.52

g/l

1.37

396

4242

Benign neoplasm: Lip

654

1.33

1.68

3.7

3.0

66.50

66.74

g/l

0.10

599

Purulent endophthalmitis

223

1.61

1.68

3.5

3.1

66.33

66.32

g/l

0.00

202

Male infertility

109

862

1.28

1.68

1.7

2.8

67.29

67.42

g/l

0.06

101

832

Serous carcinoma of ovary

207

1.63

1.67

2.6

1.6

63.04

67.01

g/l

1.63

186

Subclinical iodine-deficiency hypothyroidism

2.55

1.66

2.8

3.4

69.84

67.48

g/l

—

Inflammatory disorders of breast

177

1477

1.21

1.66

2.8

2.6

66.47

67.25

g/l

0.79

165

1368

Macular hole

265

2297

1.17

1.66

2.4

2.8

66.10

66.15

g/l

0.03

244

2104

Benign neoplasm: Tongue

111

886

1.28

1.65

4.0

3.1

66.18

66.84

g/l

0.47

105

821

Tooth eruption problems

306

2575

1.15

1.65

3.0

2.3

66.37

67.45

g/l

1.85

295

2429

Abscess of Bartholin gland

567

1.35

1.64

2.9

2.7

67.51

67.52

g/l

0.00

536

All dysplastic lesions of the cervix uteri

650

5830

1.10

1.64

2.4

66.90

67.19

g/l

0.46

599

5446

Outcome of delivery

261

1859

0.86

1.63

2.0

2.3

68.10

67.71

g/l

0.40

247

1746

Malignant neoplasm of nasal cavity and sinuses

160

1.69

1.63

4.4

1.8

66.12

66.93

g/l

0.26

147

Femoral hernia

182

1531

1.21

1.63

2.6

2.7

66.15

66.41

g/l

0.18

164

1414

Obstructed labour due to malposition and malpresentation of fetus

423

4388

0.89

1.62

2.0

2.4

67.40

67.39

g/l

0.00

399

4136

Maternal care for known or suspected abnormality of pelvic organs

501

3759

0.90

1.62

2.6

2.4

66.93

67.48

g/l

0.97

466

3509

Other corneal oedema

274

1.53

1.62

5.3

3.0

66.19

66.69

g/l

0.14

255

Spinal enthesopathy

104

823

1.28

1.60

2.9

2.3

66.89

65.31

g/l

1.32

723

conjunctival degenerations and deposits

669

1.32

1.59

3.3

2.7

67.72

66.81

g/l

0.61

618

Dementia

2459

16052

1.05

1.58

2.3

2.8

65.66

65.87

g/l

0.64

2108

14558

Carcinoma in situ, bladder

177

1493

1.21

1.58

2.8

65.66

66.11

g/l

0.35

159

1377

Hydrocephalus

327

2885

1.15

1.58

2.6

2.7

66.88

66.11

g/l

1.13

290

2614

Chondromalacia

757

1.29

1.58

2.8

2.9

66.96

67.05

g/l

0.05

715

Vascular dementia

490

4268

1.12

1.56

2.4

64.73

65.51

g/l

1.32

414

3790

Contact with lifting and transmission devices, not elsewhere classified

478

1.37

1.56

2.7

3.3

68.07

66.93

g/l

0.65

447

Congenital dislocation of hip, unilateral

108

1.82

1.55

2.2

2.6

66.75

65.62

g/l

0.23

102

Benign neoplasm of other and unspecified sites

124

1011

1.25

1.54

2.5

3.0

65.28

66.79

g/l

1.50

114

934

Ankylosis of joint

124

1.77

1.54

1.2

3.1

69.07

66.19

g/l

1.21

113

Benign neoplasm: Prostate

245

1.55

1.54

4.5

3.3

65.39

66.11

g/l

0.23

222

Central nervous system disorder causing precocious puberty

2.97

1.53

4.2

5.1

68.48

59.71

g/l

—

Drug-induced autoimmune haemolytic anaemia

2.47

1.52

6.3

1.4

66.43

66.48

g/l

—

Malignant neoplasm of palate, including Hilmo

148

1.69

1.51

3.5

1.8

65.80

67.75

g/l

0.72

137

Any dementia, excluding more controls

1986

12969

1.06

1.51

2.3

2.8

65.41

65.90

g/l

2.03

1717

11759

Retinal breaks without detachment

670

6156

1.10

1.51

2.6

2.7

66.43

66.40

g/l

0.04

605

5665

Sequelae of tuberculosis

604

1.32

1.50

3.4

2.5

65.71

65.44

g/l

0.10

537

Preterm labour and delivery

763

7040

1.09

1.50

3.0

2.6

66.56

66.91

g/l

0.68

710

6548

Multiple delivery

183

2153

0.84

1.49

3.5

2.3

67.56

66.83

g/l

0.74

177

1990

Maternal care for known or suspected malpresentation of fetus

300

2436

0.87

1.49

2.4

2.1

67.28

67.89

g/l

0.84

289

2296

Malignant neoplasm of eye, brain and central nervous system

142

1177

1.22

1.49

4.0

1.5

65.02

67.07

g/l

1.99

126

1075

Benign neoplasm of brain and other parts of central nervous system

240

2082

1.17

1.49

3.0

2.9

65.62

66.56

g/l

1.16

210

1929

LSIL lesion of the cervix uteri, vagina or vulva

370

3297

1.13

1.48

2.5

66.32

67.24

g/l

1.40

338

3064

Foreign body or object entering through skin

199

1701

1.18

1.47

2.4

2.9

66.60

66.94

g/l

0.31

184

1590

Supervision of high-risk pregnancy

462

2495

1.12

1.47

2.0

2.3

67.65

67.54

g/l

0.13

436

2351

Benign neoplasm: Skin, unspecified

149

1244

1.22

1.47

2.1

2.9

65.58

66.65

g/l

0.88

136

1143

Habit and impulse disorders

286

1.46

1.47

1.9

2.9

65.55

67.77

g/l

0.89

272

Other perinatal haematological disorders

3.31

1.47

1.2

3.3

64.84

59.65

g/l

—

Dyshidrosis [pompholyx]

346

1.42

1.45

2.6

3.1

67.80

67.30

g/l

0.15

327

Disorders of pituitary gland, other and/or unspecified

158

1.66

1.45

2.0

2.2

63.52

67.39

g/l

1.14

147

Degenerative diseases of the nervous system

1884

14226

0.95

1.45

2.2

2.6

65.35

65.76

g/l

1.42

1620

12784

Congenital obstruction of the pelviureteric junction

198

1.57

1.44

3.1

2.9

65.47

67.03

g/l

0.58

184

Congenital malformations of genital organs

226

1941

1.17

1.43

2.2

2.5

66.92

67.18

g/l

0.24

212

1819

Toxic effects of substances chiefly nonmedicinal as to source

377

3375

1.13

1.42

2.0

2.7

66.45

66.75

g/l

0.31

354

3145

Paranoid personality disorder

416

1.37

1.42

2.4

3.1

67.67

67.42

g/l

0.09

389

Malignant neoplasm of floor of mouth, including Hilmo

215

1.54

1.42

1.5

1.6

63.16

67.04

g/l

2.28

192

Use of biperiden

180

1534

1.19

1.41

2.1

2.8

65.11

66.65

g/l

1.62

157

1430

Benign lipomatous neoplasm of other sites/unspecified

356

3184

1.13

1.41

2.9

2.7

65.57

66.27

g/l

0.98

328

2913

Vascular dementia (other)

258

1.50

1.41

1.8

2.7

64.67

65.22

g/l

0.15

233

Malignant neoplasm of larynx, including Hilmo

557

1.32

1.40

2.2

1.6

66.26

66.50

g/l

0.10

500

Burn and corrosion of hip and lower limb, except ankle and foot

583

1.31

1.40

1.4

3.1

66.38

67.10

g/l

0.36

540

Glaucoma-related operations

258

2265

1.16

1.40

2.4

2.8

66.05

66.07

g/l

0.01

232

2047

Nontoxic diffuse goitre

118

969

1.24

1.40

2.6

2.8

66.82

66.80

g/l

0.01

107

881

Symptoms and signs involving appearance and behaviour

183

1.58

1.40

1.2

2.9

64.83

67.19

g/l

0.94

170

Dementia in other diseases classified elsewhere

213

1845

1.17

1.39

1.8

2.7

66.01

66.02

g/l

0.01

178

1690

Sickle-cell disorders

2.17

1.39

2.5

2.7

64.05

65.73

g/l

0.18

Divergent concomitant strabismus

235

2046

1.16

1.39

2.2

2.8

66.55

66.72

g/l

0.12

221

1900

Other sexually transmitted chlamydial diseases, including avohilmo

174

1476

1.18

1.39

1.6

1.9

68.15

68.07

g/l

0.05

167

1410

Early lumbar disc prolapse operation

249

2174

1.15

1.38

2.0

2.4

66.96

67.88

g/l

1.28

244

2078

Melanoma in situ of lower limb, including hip

234

1.52

1.38

1.9

2.9

65.07

66.78

g/l

0.71

219

Toxic effect of ethanol

110

896

1.24

1.38

1.9

2.6

65.16

67.03

g/l

2.17

103

838

Other disorders of amino-acid metabolism

121

1.74

1.37

4.8

2.5

66.02

66.80

g/l

0.16

112

Carcinoma in situ of uteri, other/unspecified

146

0.46

1.37

3.9

2.1

65.91

67.58

g/l

—

138

Presbyopia

263

2310

1.15

1.37

2.3

2.9

66.85

66.90

g/l

0.03

244

2167

Pedal cyclist injured in noncollision transport accidents

386

3469

1.12

1.37

1.8

2.7

66.48

66.83

g/l

0.46

356

3231

Noonan syndrome

2.73

1.35

1.3

3.4

55.33

62.88

g/l

—

Other degenerative disorders of eyelid and periocular area

1.91

1.35

2.0

2.6

66.48

67.01

g/l

0.18

Benign neoplasm: other/unspecified salivary gland

109

893

1.25

1.35

1.9

3.0

65.84

66.54

g/l

0.46

103

823

Polypectomy (DHB20)

252

2213

1.15

1.35

2.6

2.8

66.24

66.57

g/l

0.30

237

2059

Unspecified dementia

469

4621

0.90

1.34

2.0

2.5

64.74

65.58

g/l

1.45

394

4095

HSIL lesion of the cervix uteri

432

3909

1.11

1.33

2.2

2.4

67.05

67.31

g/l

0.32

399

3654

Benign neoplasm of breast

431

3907

1.11

1.33

2.5

2.6

66.40

66.47

g/l

0.08

390

3545

Endometriosis diagnosis and infertility diagnosis occurring together

260

2286

1.15

1.32

2.3

2.6

67.76

67.45

g/l

0.34

242

2136

LSIL lesion of the vulva

722

1.27

1.32

2.3

2.7

65.08

67.66

g/l

1.79

676

Other disturbances of cerebral status of newborn

3.00

1.32

3.2

5.0

65.40

62.62

g/l

—

Pregnancy with abortive outcome

2515

12558

1.05

1.32

2.4

2.6

66.57

66.47

g/l

0.26

2261

11435

Benign neoplasm: Extrahepatic bile ducts

100

1.82

1.32

3.4

3.0

68.56

67.44

g/l

0.30

Family history of certain disabilities and chronic diseases leading to disablement

120

991

1.22

1.32

1.5

2.7

65.75

67.53

g/l

1.72

109

924

Other disorders of breast

457

4156

1.11

1.31

2.3

2.6

67.00

66.68

g/l

0.46

402

3814

Congenital ichthyosis

1.97

1.30

4.7

2.4

63.94

67.38

g/l

0.72

Benign neoplasm of male genital organs

681

1.28

1.30

3.4

3.0

66.11

66.14

g/l

0.01

634

Sequelae of tuberculosis, including avohilmo

627

1.29

1.30

3.3

2.6

65.68

65.52

g/l

0.06

555

Benign lipomatous neoplasm

1236

11682

1.06

1.29

2.9

2.7

66.12

66.35

g/l

0.50

1135

10714

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

1.92

1.28

3.4

3.1

69.19

66.46

g/l

0.70

Calculus of lower urinary tract

231

2027

1.16

1.28

2.5

2.8

66.35

66.12

g/l

0.15

211

1858

Benign neoplasm: Skin of scalp and neck

772

1.25

1.27

2.4

3.1

66.20

66.76

g/l

0.32

716

Other specified/unspecified deforming dorsopathies

408

1.35

1.26

2.5

3.1

66.59

67.30

g/l

0.26

387

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

113

936

1.23

1.25

1.8

2.9

68.14

66.67

g/l

1.59

104

873

Disorders of muscle tone of newborn

2.77

1.24

1.4

1.9

59.70

60.12

g/l

—

Lesion of sciatic nerve

183

1584

1.17

1.24

1.7

2.5

66.81

65.81

g/l

0.96

167

1433

Bacterial meningitis

118

983

1.22

1.24

3.2

2.9

65.59

66.95

g/l

0.98

106

915

Pneumoconiosis due to other inorganic dusts

1.80

1.24

1.3

2.3

67.46

66.22

g/l

0.30

Embedded teeth, including avohilmo

201

1746

1.16

1.23

3.2

2.3

66.62

67.58

g/l

1.37

194

1644

Distal bite

606

1.27

1.23

3.2

2.7

66.05

67.15

g/l

0.58

578

Postpartum haemorrhage

507

4564

0.91

1.23

2.2

2.4

67.50

67.29

g/l

0.27

476

4288

Other retinal disorders in diseases classified elsewhere

2.14

1.22

1.1

3.5

65.97

66.22

g/l

—

Vascular dementia (subcortical)

170

1469

1.18

1.20

2.8

2.6

65.67

65.49

g/l

0.11

150

1317

Problems related to social environment

786

1.24

1.19

2.8

2.9

65.52

66.45

g/l

0.62

721

Calcific tendinitis

233

1.46

1.18

2.5

4.2

67.09

67.22

g/l

0.03

217

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

661

1.26

1.17

2.3

2.6

67.10

67.13

g/l

0.01

615

Schizotypal disorder

474

1.31

1.17

1.6

2.7

67.42

67.93

g/l

0.18

451

Fall on and from ladder

305

2741

1.12

1.16

3.1

2.9

65.89

66.36

g/l

0.58

283

2536

Inflammatory disease of cervix uteri

221

1948

1.15

1.16

2.3

2.7

66.48

g/l

0.00

198

1779

Other spirochaetal diseases, including avohilmo

1420

13523

1.05

1.15

2.6

2.7

66.87

66.43

g/l

1.67

1278

12481

Spirochaetal infections, other/unspecified, including avohilmo

1402

13350

1.05

1.15

2.6

2.7

66.87

66.43

g/l

1.60

1262

12314

Other spirochaetal diseases

1403

13361

1.05

1.14

2.6

2.7

66.87

66.43

g/l

1.64

1263

12326

Deep endometriosis

306

2751

1.12

1.14

2.1

2.5

67.10

66.57

g/l

0.73

279

2508

Chronic drug-induced interstitial lung disorders

2.11

1.14

7.9

4.6

63.92

66.54

g/l

—

Benign mammary dysplasia

538

4971

1.09

1.14

2.5

2.6

66.74

66.28

g/l

0.73

486

4491

HSIL lesion of the vagina

346

1.36

1.14

2.8

2.9

68.11

67.78

g/l

0.10

325

Cicatricial alopecia [scarring hair loss]

227

1.45

1.13

1.7

2.5

67.20

67.42

g/l

0.07

212

Pedal cyclist injured in transport accident

802

7518

1.07

1.13

2.3

2.6

66.64

66.57

g/l

0.09

735

6971

Complications following abortion and ectopic and molar pregnancy

123

1041

1.20

1.12

2.3

3.0

66.53

66.71

g/l

0.11

104

959

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

140

1194

1.18

1.12

2.4

2.3

67.31

67.57

g/l

0.19

132

1123

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

2.53

1.12

2.2

1.2

67.60

65.97

g/l

—

Acute thyroiditis

1.72

1.11

2.6

67.21

68.04

g/l

0.30

Adenocarcinoma and ductal carcinoma of pancreas

1155

0.82

1.11

1.7

1.6

63.45

66.50

g/l

2.83

1043

Malignant neoplasm of accessory sinuses, including Hilmo

105

1.68

1.11

3.4

2.0

66.46

67.65

g/l

0.32

Disorders of brain, other and unspecified

262

1.41

1.11

1.4

2.4

64.08

66.95

g/l

1.03

239

Alzheimer’s disease (Atypical or mixed)

496

5298

0.92

1.10

2.2

2.4

64.77

65.45

g/l

1.12

415

4667

Deep bite

313

2476

1.12

1.10

3.7

2.8

66.58

66.82

g/l

0.23

289

2324

Unspecified renal colic

162

1.54

1.09

1.6

2.7

64.67

66.81

g/l

0.72

154

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

706

1.24

1.09

3.1

66.27

67.01

g/l

0.42

657

Female infertility

826

4642

1.07

2.5

67.17

66.88

g/l

0.55

761

4318

Osteitis due to dental implant

265

1.41

1.06

5.8

3.0

67.63

66.60

g/l

0.34

244

Malignant neoplasm of other and unspecified major salivary glands

1.77

1.06

1.9

1.4

66.29

66.76

g/l

0.09

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

115

1355

0.84

1.05

2.6

2.8

67.45

66.85

g/l

0.39

108

1249

Valgus deformity, not elsewhere classified

163

1.51

1.05

1.2

3.7

66.93

67.08

g/l

0.04

151

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

214

1.44

1.04

3.2

3.8

64.55

66.60

g/l

0.92

201

Major anomalies of jaw size

609

1.25

1.04

2.0

3.0

67.12

67.40

g/l

0.13

576

Lyme disease

1388

13256

1.05

1.03

2.7

66.89

66.43

g/l

1.73

1249

12236

Lyme disease, including avohilmo

1388

13256

1.05

1.03

2.7

66.89

66.43

g/l

1.73

1249

12236

Embolic stroke

203

1797

1.14

1.02

1.8

2.7

65.39

65.75

g/l

0.27

186

1640

Kela-code for behavioural disturbances in mental retardation

224

0.61

1.02

1.5

2.5

63.04

66.47

g/l

0.71

210

Embolism and thrombosis of abdominal aorta

1.97

1.02

1.4

2.5

67.31

67.10

g/l

—

Long labour

501

4586

0.92

1.01

2.3

2.4

67.37

67.20

g/l

0.20

473

4294

Melanocytic naevi of scalp and neck

603

1.25

1.01

3.0

66.41

66.98

g/l

0.27

564

Pedestrian injured in collision with car, pick-up truck or van

685

1.23

1.00

1.8

2.9

67.53

67.03

g/l

0.27

636

Other and unspecified hydrocephalus

560

1.26

0.99

3.4

3.1

66.29

66.37

g/l

0.03

515

Dementia due to Parkinsons disease, excluding more controls

797

1.21

0.99

1.5

3.1

65.68

65.67

g/l

0.00

734

Changes in corneal membranes

109

1.63

0.98

1.5

3.3

69.11

67.24

g/l

0.81

104

Other and unspecified injuries of thorax

470

1.28

0.98

2.5

2.9

65.69

67.15

g/l

1.05

434

Labour and delivery complicated by fetal stress [distress]

400

2834

0.91

0.97

1.9

2.1

67.11

67.73

g/l

0.96

378

2672

Dysplasia of cervi uteri

686

4520

1.07

0.96

2.5

2.4

67.01

66.77

g/l

0.36

625

4176

Pedal cyclist injured in other and unspecified transport accidents

381

3500

1.10

0.96

2.7

66.77

66.60

g/l

0.17

350

3248

Underdevelopment of the second kidney

2.30

0.95

2.2

4.5

63.23

65.57

g/l

—

Benign neoplasm: Skin of lip

402

1.30

0.95

3.4

2.6

68.07

66.95

g/l

0.45

368

Chronic mastoiditis

838

1.20

0.95

2.0

2.9

66.14

66.33

g/l

0.08

770

Diseases of thymus

1.84

0.94

2.0

2.5

65.11

66.60

g/l

0.21

Hand

143

1.52

0.94

2.8

2.2

68.04

67.29

g/l

0.21

137

Diabetes mellitus in pregnancy

688

4097

1.07

0.94

1.8

2.2

66.97

67.64

g/l

1.77

646

3863

L02BX Other hormone antagonists and related agents

275

2500

1.11

0.93

3.7

2.8

64.80

65.76

g/l

1.36

243

2291

Benign lipomatous neoplasm of of intra-abdominal organs

1.66

0.92

3.9

2.7

64.95

67.02

g/l

0.65

Carcinoma in situ of larynx

2.00

0.92

2.1

4.9

67.95

66.48

g/l

—

Assault by drugs, medicaments and biological substances

2.19

0.92

1.3

66.42

67.65

g/l

—

Corneal degeneration

557

1.25

0.92

1.7

3.1

64.72

66.91

g/l

1.23

516

Congenital hypothyroidism without goiter

119

1.57

0.92

1.2

2.6

67.26

66.31

g/l

0.27

110

Injury of nerves at wrist and hand level

115

987

1.18

0.92

3.9

3.1

66.82

66.96

g/l

0.07

102

922

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

119

1.56

0.92

2.2

3.3

67.38

66.84

g/l

0.13

114

Beningn neoplasm: Meninges, unspecified

495

1.26

0.90

2.4

3.0

65.17

66.75

g/l

0.78

455

Carcinoma in situ of vagina

136

1.52

0.90

4.2

2.4

65.95

67.59

g/l

0.22

128

Other and unspecified disease of Bartholin gland

833

1.19

0.90

2.7

2.9

66.21

66.62

g/l

0.19

767

Other maternal disorders predominantly related to pregnancy

1680

10923

0.96

0.89

2.5

2.6

66.79

66.91

g/l

0.29

1563

10125

Personality and behavioural disorders due to brain disease, damage and dysfunction

406

1.28

0.88

3.1

66.28

66.36

g/l

0.03

379

Benign neoplasm: Brain, supratentorial

398

1.28

0.87

2.0

3.0

67.54

66.92

g/l

0.25

368

Cardiovascular disorders originating in the perinatal period

1.82

0.86

1.4

4.5

65.89

62.96

g/l

—

Premature rupture of membranes

411

3158

0.92

0.85

2.2

2.3

67.71

67.68

g/l

0.03

383

2968

Polycystic ovarian syndrome, broad definition

201

1800

1.12

0.85

1.8

2.0

67.81

67.93

g/l

0.08

189

1694

Spermatocele

310

2846

1.10

0.84

2.3

2.7

65.60

66.28

g/l

0.88

297

2613

Other benign neoplasms of uterus

215

1941

1.12

0.84

3.1

2.5

66.25

66.10

g/l

0.10

178

1724

Benign neoplasm: Rectum/anal canal icd-9

303

1.32

0.84

2.1

2.9

66.42

65.93

g/l

0.16

270

Single delivery by caesarean section

369

2283

0.92

0.83

2.1

2.0

66.94

67.36

g/l

0.51

353

2149

Other benign neoplasm of uterus: Other parts/unspecified

172

1536

1.14

0.83

3.1

2.5

66.20

65.81

g/l

0.26

143

1356

Use of ropinirole

143

1262

1.15

0.83

2.0

3.1

65.97

66.42

g/l

0.28

119

1171

Persons encountering health services in circumstances related to reproduction

1867

12953

0.96

0.83

2.7

67.06

66.93

g/l

0.34

1743

12143

Transient global amnesia

343

3711

0.92

0.83

2.4

2.7

66.13

66.25

g/l

0.10

304

3404

Congenital malformation of optic disc

1.93

0.82

1.0

4.4

66.73

65.28

g/l

—

Benign neoplasm: Conjunctiva

115

1001

1.16

0.80

2.3

3.1

65.09

66.87

g/l

2.29

107

933

Squamous cell neoplasms and carcinoma of cervix

148

1.45

0.80

4.0

1.6

66.54

67.51

g/l

0.40

140

Contact with nonpowered hand tool

136

1198

1.15

0.80

2.3

2.8

68.06

66.77

g/l

1.45

126

1126

Intentional self-harm by sharp object

420

1.25

0.79

1.9

2.6

64.54

67.73

g/l

1.71

400

Urticaria due to cold and heat

174

1.41

0.79

1.7

2.3

69.59

67.61

g/l

0.68

163

Fetal death of unspecified cause

2.28

0.78

3.8

3.2

71.30

68.22

g/l

—

Other benign neoplasm of uterus: Corpus uteri

236

1.35

0.78

4.1

2.5

65.66

67.25

g/l

0.47

220

Acute alcohol intoxication ICD-9

119

1042

1.16

0.77

1.5

3.1

66.07

66.30

g/l

0.13

107

966

Malignant neoplasm of peripheral nerves and autonomic nervous system

2.21

0.77

1.6

1.3

55.98

68.23

g/l

—

Disorders of multiple cranial nerves

2.17

0.76

1.4

1.5

69.66

66.06

g/l

—

Premenstrual syndrome

227

1.34

0.76

1.2

2.7

67.83

68.39

g/l

0.16

213

Pregnancy, childbirth and the puerperium

1082

5899

0.95

0.75

2.4

66.49

66.12

g/l

0.86

964

5248

Benign neoplasm: Skin of upper limb, including shoulder

571

1.21

0.75

3.9

3.3

64.82

66.98

g/l

1.49

532

317

3423

0.92

0.74

1.6

2.7

64.81

66.08

g/l

1.59

281

3141

Tonsillectomy and adenotomy

1560

11243

0.96

0.74

2.4

67.01

66.99

g/l

0.04

1467

10564

Pedestrian injured in collision with two- or three-wheeled motor vehicle

1.63

0.74

1.2

2.8

66.65

66.82

g/l

0.04

Contact with sharp glass

848

1.17

0.74

2.7

2.8

67.62

67.35

g/l

0.14

802

Other protozoal intestinal diseases, including avohilmo

498

1.22

0.74

2.2

3.1

66.27

67.29

g/l

0.67

467

Labour and delivery complicated by umbilical cord complications

119

1045

1.15

0.73

2.8

2.6

67.72

67.61

g/l

0.06

113

978

Dengue, including avohilmo

1.74

0.72

3.6

2.5

65.75

66.52

g/l

—

Hypertrophy of breast

520

4898

1.07

0.72

2.0

2.6

66.58

66.91

g/l

0.48

480

4547

Intrahepatic Cholestasis of Pregnancy (ICP)

140

1244

1.13

0.72

2.4

2.3

67.31

67.83

g/l

0.44

132

1177

Crowding of teeth, including avohilmo

168

1248

1.12

0.71

2.9

2.5

65.89

67.62

g/l

2.12

157

1191

Abnormal findings on antenatal screening of mother

102

1169

0.87

0.71

2.2

1.9

66.88

68.15

g/l

1.02

1100

Childhood allergy (age < 16)

201

1501

1.11

0.71

1.5

2.0

66.93

67.53

g/l

0.54

188

1437

Colour vision deficiencies

1.60

0.70

2.2

2.9

68.28

66.52

g/l

0.43

Benign neoplasm: Larynx

114

1005

1.15

0.70

2.4

3.0

66.28

66.35

g/l

0.04

103

926

Impacted teeth

396

3177

1.07

0.68

2.3

2.2

66.80

67.55

g/l

1.25

383

3006

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

241

1.30

0.67

1.5

3.3

67.72

66.19

g/l

0.49

231

Congenital ovarian cysts

828

1.16

0.67

1.9

2.4

67.57

67.80

g/l

0.13

780

Burns and corrosions confined to eye and internal organs

624

1.18

0.67

2.9

2.8

66.09

67.24

g/l

0.68

586

Malignant neoplasm of pancreas

224

2439

0.91

0.66

1.7

1.6

63.97

66.43

g/l

4.19

200

2179

Other disorders of prostate

137

1227

1.13

0.66

3.3

2.8

66.23

66.10

g/l

0.07

128

1126

L02BB Anti-androgens

441

4155

1.07

0.66

3.1

2.6

65.39

65.69

g/l

0.36

400

3745

Female infertility, cervical, vaginal, other or unspecified origin

745

4539

1.05

0.66

2.5

67.03

66.91

g/l

0.17

686

4223

Qualitative platelet defects

1.54

0.66

1.7

2.8

65.35

66.26

g/l

0.14

Supervision of normal pregnancy

415

2526

0.93

0.66

2.4

2.3

68.13

67.60

g/l

0.96

393

2380

Malignant neoplasm of rectum

375

3512

1.07

0.66

2.7

1.6

65.16

66.53

g/l

2.61

343

3153

Toxic effect of other noxious substances eaten as food

1.54

0.66

2.2

2.9

67.75

66.77

g/l

0.13

Non-small cell lung cancer, squamous, helper endpoint

216

1982

1.10

0.65

1.8

2.7

65.48

65.73

g/l

0.17

201

1795

Chronic diseases of tonsils and adenoids

2959

19093

0.98

0.65

2.5

2.7

66.85

66.56

g/l

1.36

2756

17714

Defect, injury or illness of neck

138

1.41

0.65

1.4

2.4

68.17

66.97

g/l

0.42

130

Rubella [German measles]

100

879

1.15

0.65

2.7

2.6

67.81

67.20

g/l

0.37

848

Small plaque parapsoriasis

1.55

0.64

4.2

2.7

69.81

66.31

g/l

0.87

Hereditary corneal dystrophies

135

1212

1.13

0.64

2.1

3.1

66.89

66.54

g/l

0.22

122

1112

LSIL lesion of the cervix uteri

263

2433

1.09

0.63

2.7

2.5

66.45

67.44

g/l

1.24

240

2280

Glanders and melioidosis, including avohilmo

0.00

0.63

0.0

1.6

—

65.91

—

Glanders and melioidosis

0.00

0.63

0.0

1.6

—

65.91

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

490

1.20

0.63

2.5

3.2

66.07

67.08

g/l

0.50

447

Huntington disease

1.75

0.63

3.2

1.5

67.26

66.52

g/l

—

Burn and corrosion confined to eye and adnexa

526

1.19

0.63

2.5

2.8

66.31

67.31

g/l

0.50

497

Rubella [German measles], including avohilmo

100

881

1.15

0.63

2.7

2.6

67.81

67.21

g/l

0.37

850

Caught, crushed, jammed or pinched in or between objects

153

1382

1.11

0.63

1.5

2.8

66.61

66.76

g/l

0.09

141

1301

Psoriatic arthropathies, strict definition

0.00

0.62

0.0

7.7

—

66.32

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

187

0.69

0.62

1.7

2.7

67.49

66.90

g/l

0.10

176

Malignant neoplasm of brain

854

1.15

0.61

2.6

1.6

65.50

67.11

g/l

1.01

791

Cyst of Bartholin Gland

101

892

1.14

0.61

2.3

2.7

65.52

67.28

g/l

1.24

837

Gender identity disorders

139

1.38

0.61

1.2

2.4

69.23

67.10

g/l

0.51

133

Vascular dementia (mixed)

792

1.15

0.60

2.3

2.6

63.68

65.46

g/l

1.35

724

Vascular dementia (sudden onset)

111

0.62

0.60

1.6

2.7

63.94

65.22

g/l

—

Pituitary-dependent Cushing's disease

1.54

0.60

1.6

3.2

62.05

66.57

g/l

1.11

Prolapse and hernia of ovary and fallopian tube

152

1366

1.11

0.59

2.1

2.3

65.17

65.24

g/l

0.04

132

1170

Malignant neoplasm of brain, including Hilmo

145

1313

1.11

0.58

3.3

1.6

65.32

67.02

g/l

1.64

130

1196

Antepartum haemorrhage, not elsewhere classified

168

1532

1.10

0.58

2.1

2.2

67.38

67.86

g/l

0.38

159

1448

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

1028

0.88

0.57

3.3

2.8

65.24

66.13

g/l

0.46

932

Rheumatic fever with heart involvement

133

1.39

0.57

9.7

3.2

65.23

66.80

g/l

0.33

124

Benign neoplasm: Skin of lower limb, including hip

842

1.14

0.57

3.7

2.9

66.71

67.11

g/l

0.23

785

Congenital musculoskeletal deformities of head, face, spine and chest

212

1.29

0.57

1.6

2.9

68.79

65.79

g/l

1.43

204

Obstructed labour due to maternal pelvic abnormality

419

4427

0.94

0.56

3.0

2.6

66.65

66.89

g/l

0.28

385

4104

Intracerebral haemorrhage

569

5430

1.05

0.55

2.2

2.6

65.06

65.88

g/l

1.63

511

4859

Congenital malformations of eye, ear, face and neck

163

1489

1.10

0.55

3.0

2.8

67.77

66.95

g/l

0.64

149

1396

Postpartum haemorrhage due to anatomy

173

1584

1.10

0.55

1.9

2.1

67.97

67.57

g/l

0.30

161

1497

Injury of muscle and tendon at ankle and foot level

637

1.16

0.55

2.4

3.1

67.99

67.28

g/l

0.35

597

Colon adenocarcinoma, helper endpoint

538

5633

0.95

0.53

2.9

2.6

65.28

65.83

g/l

0.84

487

5084

Lesion of plantar nerve

215

1997

1.08

0.52

2.3

2.7

66.65

66.34

g/l

0.25

190

1829

Congenital malformations of ovaries, fallopian tubes and broad ligaments

126

1141

1.11

0.52

2.0

2.4

67.83

67.49

g/l

0.24

119

1071

Dental pulpitis, including avohilmo

3723

23418

1.02

0.50

2.5

2.7

67.04

66.63

g/l

2.97

3471

21800

Malignant neoplasm of oropharyng

1.55

0.49

5.6

2.3

64.10

67.09

g/l

—

Inhalation and ingestion of food causing obstruction of respiratory tract

263

1.24

0.49

3.0

2.7

69.29

66.21

g/l

1.40

245

Small cell lung cancer, helper endpoint

105

948

1.12

0.49

2.0

2.8

65.25

65.75

g/l

0.31

858

Calcaneal spur

327

1.21

0.49

3.4

3.5

66.99

67.48

g/l

0.18

304

Carcinoma in situ of vulva

236

1.25

0.48

1.6

3.6

64.70

67.60

g/l

0.86

220

Impacted maxillary canine

137

1.33

0.48

1.9

3.1

64.36

64.87

g/l

0.09

132

Melanocytic naevi of other and unspecified parts of face

183

1697

1.08

0.47

3.3

2.8

67.00

66.70

g/l

0.23

174

1570

Adenocarcinoma and papillary adenocarcinoma of stomach

835

1.12

0.47

1.5

1.6

62.12

66.53

g/l

5.21

753

Malignant neoplasm of larynx

421

1.18

0.47

2.0

1.6

65.84

66.78

g/l

0.41

380

Chronic suppurative otitis media, including avohilmo

256

2404

1.07

0.47

2.0

2.8

66.84

66.53

g/l

0.26

238

2217

Inguinal hernia, unilateral

894

1.12

0.46

2.4

2.7

66.09

66.56

g/l

0.30

828

Inguinal of femoral hernia, unilateral

894

1.12

0.46

2.4

2.7

66.09

66.56

g/l

0.30

828

Femoral hernia, unilateral

894

1.12

0.46

2.4

2.7

66.09

66.56

g/l

0.30

828

Glaucoma, exfoliation

502

4808

1.05

0.46

2.6

2.5

66.09

65.56

g/l

0.75

438

4263

Pterygium

117

1068

1.11

0.45

3.0

2.9

66.72

66.37

g/l

0.22

108

988

Congenital glaucoma

1.63

0.44

1.4

1.6

69.86

63.71

g/l

—

Postpolio syndrome

1.45

0.44

10.8

3.7

63.57

65.10

g/l

—

Postpartum hemorraghe, parous women as controls

507

4423

0.96

0.43

2.2

2.4

67.50

67.32

g/l

0.22

476

4160

Hyperfunction of pituitary gland, other and/or unspecified

1.41

0.43

11.1

2.8

67.28

67.32

g/l

—

Niacin deficiency [pellagra]

0.00

0.43

0.0

2.3

—

66.76

—

Operations 1 for CAVS

1.44

0.42

1.7

3.2

63.12

66.25

g/l

0.74

Exposure to vibration

0.00

0.42

0.0

5.7

—

68.75

—

Other specified air transport accidents

0.00

0.42

0.0

1.3

—

67.25

—

Malignant neoplasm of nasal cavity and middle ear

114

1.34

0.42

4.6

1.9

64.91

66.62

g/l

0.43

104

Pedestrian injured in collision with pedal cycle

881

1.11

0.42

2.3

2.9

66.29

66.79

g/l

0.31

816

Other cestode infections

101

0.68

0.41

6.6

3.5

63.51

66.29

g/l

—

Benign neoplasm of thyroid gland

113

1036

1.10

0.41

2.7

2.9

68.19

66.86

g/l

1.17

104

953

Other respiratory conditions originating in the perinatal period

0.00

0.41

0.0

7.3

—

58.58

—

Other congenital malformations of eye

1.48

0.40

1.4

2.0

69.86

63.43

g/l

—

Benign leiomyoma with endometriosis

576

5553

1.04

0.40

2.8

2.6

66.01

66.32

g/l

0.43

521

5031

Other specified and unspecified disorders of lens

326

1.19

0.40

2.5

2.7

65.49

65.66

g/l

0.06

298

Benign neoplasm: Respiratory system, unspecified

1.41

0.40

1.3

1.8

70.61

67.39

g/l

—

Failed induction of labour

892

1.10

0.40

1.7

1.9

66.74

68.02

g/l

1.17

836

False labour

601

3868

0.96

0.39

2.2

2.3

67.83

67.60

g/l

0.38

569

3643

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

112

0.70

0.39

2.4

3.0

63.90

66.07

g/l

—

102

Malignant neoplasm of gallbladder, including Hilmo

179

1.25

0.38

2.1

1.4

65.65

66.76

g/l

0.22

158

Toxic effect of contact with venomous animals

129

1194

1.09

0.38

2.4

3.0

67.86

66.68

g/l

0.99

121

1115

Other specified/unspecified disorders of middle ear and mastoid

1.43

0.38

2.0

2.2

70.00

66.38

g/l

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

327

1.17

0.38

3.2

3.1

66.58

67.35

g/l

0.25

310

Deep bite that required surgery

246

0.81

0.38

1.5

2.3

70.20

68.33

g/l

0.97

235

Malignant neoplasm of pyriform sinus, including Hilmo

1.52

0.38

1.2

2.8

63.35

66.46

g/l

—

Carcinoma in situ of other and unspecified genital organs

583

1.13

0.37

2.7

2.8

63.99

67.43

g/l

1.80

539

Bradycardia, unspecified, drug-induced

1.38

0.36

1.5

2.9

64.17

66.07

g/l

0.41

Puerperal sepsis

392

3763

1.04

0.36

2.8

2.7

67.00

66.96

g/l

0.03

362

3495

Communicating hydrocephalus

681

1.11

0.35

2.2

3.3

67.39

66.42

g/l

0.52

631

Other congenital malformations of face and neck

633

1.11

0.35

2.2

2.9

66.78

67.25

g/l

0.20

596

Other menopausal disorders

913

5225

0.97

0.35

2.5

2.7

66.67

66.38

g/l

0.62

839

4812

Dementia due to Parkinson's disease

1030

0.91

0.34

1.5

2.8

65.68

65.83

g/l

0.07

933

Postprocedural disorders of ear and mastoid process, not elsewhere classified

263

0.82

0.34

1.5

2.6

61.67

66.34

g/l

1.65

241

Other inflammation of vagina/vulva

769

1.10

0.33

1.3

2.6

67.39

67.40

g/l

0.00

725

Other noninflammatory disorders of cervix uteri

169

1592

1.07

0.33

2.9

2.6

65.65

66.20

g/l

0.41

148

1437

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

486

4696

1.04

0.33

3.2

2.7

66.08

66.52

g/l

0.62

439

4345

Other disorders affecting eyelid function

284

0.83

0.33

2.7

2.9

65.67

66.78

g/l

0.44

262

Carcinoma in situ of breast, other/unspecified

446

1.13

0.33

2.3

2.8

68.13

67.08

g/l

0.45

407

Ankyloglossia

191

1.21

0.33

5.7

3.1

66.32

65.04

g/l

0.38

182

Carcinoma in situ of cervix uteri

218

2070

1.06

0.32

2.2

2.3

67.22

67.32

g/l

0.08

200

1928

Oral leukoplakia, including avohilmo

878

1.09

0.32

3.2

3.0

66.90

66.91

g/l

0.01

819

Postpartum hemorraghe, all women as controls

507

5110

0.97

0.32

2.2

2.3

67.50

67.38

g/l

0.14

476

4800

Premature separation of placenta [abruptio placentae]

411

0.87

0.31

1.5

2.6

70.01

67.94

g/l

1.36

390

Cleft lip

1.34

0.31

3.3

64.40

67.41

g/l

—

Toxic effect of other gases, fumes and vapours

138

1.25

0.31

1.6

3.4

64.75

67.44

g/l

0.58

131

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2223

16995

1.02

0.31

2.5

2.6

66.64

66.52

g/l

0.32

2052

15675

Other complications of labour and delivery, not elsewhere classified

173

1622

0.94

0.30

2.0

1.9

67.51

68.13

g/l

0.63

159

1524

Gestational diabetes (for exclusion)

754

5322

0.97

0.30

2.2

2.3

67.21

67.46

g/l

0.45

704

5017

Erosion and ectropion of cervix uteri

872

1.09

0.29

2.8

2.6

65.57

66.13

g/l

0.28

796

Frontotemporal dementia

186

1.20

0.29

2.4

2.8

65.53

66.53

g/l

0.24

170

Injury of muscle and tendon at wrist and hand level

465

4508

1.03

0.28

3.1

2.7

66.87

66.68

g/l

0.23

440

4190

Mucinous and mucinous cystic tumor, including Hilmo

168

1.21

0.28

5.3

1.5

65.51

67.86

g/l

1.37

157

Oesophagitis, drug-induced

1.34

0.27

1.2

1.6

66.48

67.09

g/l

—

Motorcycle rider injured in other and unspecified transport accidents

133

1253

1.06

0.27

1.9

2.6

65.83

67.28

g/l

1.69

126

1191

Dislocation, sprain and strain of joints and ligaments of elbow

171

1624

1.06

0.27

2.6

2.8

65.89

67.03

g/l

1.32

159

1526

Open wound of neck

178

1.19

0.27

2.0

2.9

67.28

67.34

g/l

0.01

171

Use of levodopa decarbox-comt-inhibitor

116

1232

0.94

0.26

1.3

3.0

64.96

66.27

g/l

1.05

101

1137

Mucinous and mucinous cystic tumor of rectum

127

0.77

0.26

1.4

1.9

66.60

67.01

g/l

—

114

Pregnancy examination and test

290

1727

1.04

0.26

1.8

2.1

67.73

67.86

g/l

0.13

281

1622

Familial erythrocytosis

114

1.25

0.26

2.3

2.9

68.44

67.56

g/l

0.20

105

Generalized epilepsy, strict definition

444

1.11

0.26

3.0

2.7

67.52

67.32

g/l

0.06

417

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

214

2234

0.95

0.26

2.7

2.8

66.36

66.52

g/l

0.12

200

2070

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

1.28

0.25

4.1

2.1

68.16

66.47

g/l

0.34

Other specified/unspecified diseases of inner ear

142

1.22

0.25

2.5

2.0

66.39

65.99

g/l

0.11

127

Use of amantadine

484

1.10

0.25

1.8

2.9

66.94

66.98

g/l

0.02

448

Laparoscopic left hemicolectomy

600

1.09

0.25

2.4

2.7

65.92

66.86

g/l

0.42

554

Injury of blood vessels at hip and thigh level

106

1.25

0.24

2.2

2.7

63.17

66.94

g/l

0.89

100

Complications following myocardial infarction

266

1.14

0.23

1.5

2.5

65.41

65.58

g/l

0.03

235

Acquired stenosis of external ear canal

316

0.88

0.23

2.0

2.7

66.21

66.45

g/l

0.07

297

Benign neoplasm: Short bones of lower limb

247

1.14

0.23

5.7

3.0

64.49

67.40

g/l

0.84

229

Smallpox, including avohilmo

0.00

0.23

0.0

1.1

—

67.38

—

Smallpox

0.00

0.23

0.0

1.1

—

67.38

—

Systemic sclerosis induced by drugs and chemicals

0.00

0.23

0.0

1.6

—

67.01

—

Handgun discharge, undetermined intent

0.00

0.22

0.0

6.8

—

63.61

—

Vascular dementia (multiple infarctions)

450

0.90

0.22

2.4

64.33

65.44

g/l

0.42

408

Obstetric and gynaecological devices associated with adverse incidents

0.00

0.22

0.0

1.1

—

68.43

—

Frontotemporal dementia, wide, incl. Pick's disease

212

1.15

0.20

2.3

2.9

65.79

66.38

g/l

0.15

194

Maternal care for cervical incompetence

1025

0.94

0.20

4.2

2.9

66.07

66.99

g/l

0.72

943

Twin gestation

175

1681

1.04

0.20

2.5

2.3

66.73

67.70

g/l

1.12

169

1590

Normal-pressure hydrocephalus

207

1998

1.04

0.20

2.6

67.00

66.01

g/l

1.25

185

1815

Malignant neoplasm of floor of mouth

137

1.18

0.19

1.6

1.8

62.83

66.84

g/l

1.14

124

Contact with machinery

376

3857

0.97

0.19

3.1

2.7

66.26

66.40

g/l

0.14

348

3582

Open bite that required surgery (Lefort1 or BSSO)

156

1.16

0.19

1.1

2.0

68.93

68.02

g/l

0.37

148

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1494

11126

0.99

0.19

2.4

2.5

66.79

66.83

g/l

0.06

1379

10266

Maternal care for other known or suspected fetal problems

430

2762

0.98

0.18

1.7

2.1

67.59

67.81

g/l

0.26

409

2604

Adenocarcinoma and papilloma adenocarcinoma of rectum

356

3471

1.03

0.18

2.7

1.6

64.99

66.50

g/l

2.90

320

3118

Embedded and impacted teeth

575

4574

1.02

0.18

2.6

2.3

66.72

67.42

g/l

1.60

555

4315

Exposure to excessive natural heat

1.14

0.18

2.4

2.7

62.33

66.36

g/l

—

Malignant neoplasm of pancreas, including Hilmo

314

3061

1.03

0.17

2.0

1.6

64.34

66.36

g/l

4.34

286

2727

Noise effects on inner ear

125

1302

0.96

0.16

2.1

2.9

66.40

66.27

g/l

0.07

114

1219

Disorders of acoustic nerve

867

1.05

0.16

3.2

2.9

65.35

66.87

g/l

1.04

805

Other obstructed labour

187

1811

1.03

0.16

2.5

2.7

67.30

67.21

g/l

0.06

174

1693

Malignant neoplasm of other and ill-defined sites

1.15

0.15

1.7

1.4

64.99

67.06

g/l

—

Antenatal screening

460

2626

0.98

0.15

2.2

2.3

68.15

67.56

g/l

1.09

439

2476

Explosion of other materials

0.81

0.15

3.9

2.9

65.53

65.68

g/l

—

Glaucoma secondary to eye trauma

198

1.12

0.15

3.0

66.27

66.45

g/l

0.06

179

Postpartum haemorrhage due to retained placenta

220

2262

0.97

0.15

2.1

2.2

67.87

67.53

g/l

0.27

202

2128

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

179

0.88

0.14

2.5

3.8

61.52

63.09

g/l

0.29

171

Prophylactic surgery

139

0.86

0.14

4.8

2.3

65.52

69.06

g/l

0.56

132

Deaf mutism, not elsewhere classified

128

0.85

0.14

2.2

2.5

68.83

67.29

g/l

0.41

122

Mandibular prognathia

315

0.92

0.13

2.0

3.0

65.52

67.10

g/l

0.52

300

Other cestode infections, including avohilmo

109

0.81

0.13

7.1

3.3

64.40

66.33

g/l

—

100

Chronic suppurative otitis media

206

2007

1.03

0.13

1.9

2.6

66.68

66.47

g/l

0.14

191

1847

Postpartum care and examination

232

1491

0.98

0.12

2.2

2.1

67.03

68.13

g/l

1.68

223

1400

Other abnormal products of conception

709

4711

0.99

0.12

2.1

2.4

67.65

67.42

g/l

0.40

669

4441

Congenital malformations of breast

272

0.92

0.12

1.8

2.0

67.28

67.52

g/l

0.05

257

Cleft lip and cleft lip and palate

133

1.13

0.12

2.5

2.7

65.04

67.20

g/l

0.70

128

Carcinoma in situ of breast, intraductal

287

2927

0.98

0.12

2.6

66.41

66.60

g/l

0.16

254

2679

Mandibular retrognathia

137

1325

1.03

0.12

3.8

2.7

66.72

67.27

g/l

0.39

130

1257

Malignant neoplasm of gallbladder

143

1.13

0.12

2.2

1.3

64.81

66.57

g/l

0.28

128

Cervical polyps

307

3012

1.02

0.12

2.7

2.6

66.71

66.45

g/l

0.28

291

2768

Respiratory tuberculosis, not confirmed, including avohilmo

148

1440

1.03

0.11

2.9

2.8

66.12

65.98

g/l

0.07

135

1307

Benign neoplasm: Vulva

618

0.95

0.11

3.0

2.9

65.28

67.05

g/l

0.78

570

Inflammation of lacrimal passages (chronic)

514

1.06

0.11

2.1

2.8

66.50

66.74

g/l

0.09

464

Left side

144

1.13

0.11

1.8

2.9

66.63

66.18

g/l

0.07

138

Ectopic pregnancy

464

4705

0.99

0.10

2.3

2.7

67.10

66.90

g/l

0.28

422

4409

Multiple gestation

178

1738

1.03

0.10

2.5

2.3

66.72

67.67

g/l

1.11

172

1645

Foreign body on external eye

472

4656

1.01

0.10

3.1

2.7

67.05

66.78

g/l

0.35

441

4379

Obstructive hydrocephalus

437

1.06

0.10

1.4

3.2

69.41

66.69

g/l

1.68

401

Carcinoma in situ of middle ear and respiratory system

135

1.12

0.10

1.7

3.0

67.13

66.31

g/l

0.16

126

Other disorders of breast and lactation associated with childbirth

248

0.93

0.09

2.4

2.1

68.06

67.92

g/l

0.04

235

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

134

1374

0.97

0.09

2.9

3.0

67.40

66.77

g/l

0.47

129

1275

Maxillary retrognathism

299

0.93

0.09

2.3

3.1

67.42

67.28

g/l

0.04

287

Gastric ulcer - Acute with haemorrhage, drug-induced

1.15

0.09

2.3

2.0

65.93

67.23

g/l

—

Carcinoma in situ of oesophagus

1.06

0.09

1.3

2.8

67.43

66.19

g/l

—

Abnormalities of forces of labour

219

2150

1.02

0.09

2.1

2.4

68.63

67.64

g/l

1.35

201

2037

Acquired atrophy of ovary and fallopian tube

1.04

0.08

1.3

3.9

65.40

68.32

g/l

—

Congenital retinoschisis

1.12

0.08

7.6

2.1

75.71

65.94

g/l

—

Down's syndrome

0.83

0.08

6.2

3.5

65.94

66.51

g/l

—

Other disorders of amniotic fluid and membranes

259

2461

1.02

0.08

2.3

2.1

67.25

67.71

g/l

0.66

243

2319

Eccrine sweat disorders

1.05

0.08

1.6

3.3

69.20

67.78

g/l

—

Schizoid personality disorder

411

1.05

0.08

2.0

2.8

65.21

67.67

g/l

1.52

389

Maternal care for known or suspected fetal abnormality and damage

288

2474

0.99

0.08

1.7

2.2

67.28

67.78

g/l

0.66

277

2333

Traumatic amputation of wrist and hand

134

1369

0.98

0.07

1.9

2.8

66.58

66.46

g/l

0.07

126

1284

Habitual aborter

264

1.06

0.07

3.6

2.3

65.38

68.42

g/l

1.23

248

Pedal cyclist injured in collision with motor vehicle

793

0.97

0.07

2.0

2.8

67.23

67.08

g/l

0.05

740

Benign neoplasm: Retina

147

1.10

0.07

2.4

2.7

65.65

66.73

g/l

0.32

136

Malignant neoplasm of rectosigmoid junction

481

1.04

0.07

3.4

1.5

63.17

66.75

g/l

1.76

433

Otosclerosis

261

2574

1.02

0.07

2.2

3.0

66.12

66.44

g/l

0.31

237

2374

Other and unspecified water transport accidents

1.08

0.07

3.1

2.8

64.29

66.55

g/l

—

Foreign object accidentally left in body during surgical and medical care

1.05

0.07

4.7

3.5

65.19

66.63

g/l

—

Accessory breast

122

0.90

0.07

2.5

2.2

68.66

68.08

g/l

0.12

114

Any dementia

2164

14898

1.00

0.06

2.3

2.7

65.27

65.81

g/l

2.56

1867

13426

Unspecified abortion

121

1186

1.02

0.06

1.7

2.9

67.44

67.35

g/l

0.05

113

1116

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

119

1.10

0.06

2.8

2.3

67.63

66.11

g/l

0.43

109

Benign neoplasm: Cranial nerves

920

1.02

0.06

3.6

3.0

64.95

66.84

g/l

1.45

847

Corneal pigmentations and deposits

100

1.11

0.05

1.1

2.8

68.60

66.08

g/l

0.67

Congenital malformations of breast, including avohilmo

292

0.96

0.04

1.8

2.2

67.89

67.47

g/l

0.09

276

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

366

3633

1.01

0.04

2.7

1.6

65.04

66.50

g/l

2.81

330

3266

Malignant neoplasm of rectosigmoid junction, including Hilmo

875

1.02

0.04

3.2

1.6

62.45

66.63

g/l

3.95

796

Other congenital malformations of female genitalia

121

1.08

0.04

2.2

2.9

67.61

67.30

g/l

0.06

114

Myocardial infarction, unclassifiable

1040

9317

1.00

0.03

2.3

2.5

64.88

65.72

g/l

2.84

950

8294

Use of selegiline

170

1684

1.01

0.03

2.0

2.8

65.65

66.34

g/l

0.59

140

1551

Contact with other sharp object(s)

167

1654

1.01

0.03

2.8

2.7

66.61

67.21

g/l

0.51

157

1558

Cleft lip and palate

108

0.92

0.03

1.7

2.4

66.31

67.98

g/l

—

103

Moderate visual impairment, monocular

128

0.93

0.02

1.8

3.1

69.31

67.40

g/l

0.45

119

Brain glioblastoma and astrocytoma

440

0.98

0.02

1.7

1.5

65.24

67.59

g/l

1.11

407

Malignant neoplasm of lip, including Hilmo

301

1.03

0.02

2.5

1.6

64.74

66.57

g/l

0.68

266

Respiratory tuberculosis, not confirmed

144

1427

1.01

0.02

2.9

2.8

65.90

65.98

g/l

0.04

131

1296

Medical treatment for female infertility

398

3925

1.00

0.02

2.0

2.2

67.36

67.51

g/l

0.17

378

3697

Schizophrenia

472

4735

1.00

0.02

2.2

2.7

65.06

66.89

g/l

5.59

425

4429

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

137

0.95

0.01

1.4

3.2

68.89

66.27

g/l

0.58

132

Chloasma

126

0.95

0.00

1.0

3.0

68.60

67.24

g/l

0.37

117

Cholesteatoma of middle ear

180

1793

1.00

0.00

2.2

2.6

66.30

66.31

g/l

0.00

168

1649

Thyrotoxicosis with toxic single thyroid nodule

226

0.97

0.00

2.8

2.4

67.23

67.33

g/l

0.02

209

Circumscribed brain atrophy

774

1.01

0.00

2.0

3.1

66.43

66.11

g/l

0.15

714

Other congenital malformations of tongue, mouth and pharynx

194

1.03

0.00

6.5

3.0

65.36

65.70

g/l

0.07

183

Retained placenta and membranes, without haemorrhage

322

3223

1.00

0.00

2.8

2.6

66.98

67.00

g/l

0.02

298

2989

Mucinous and mucinous cystic tumor

117

1.03

0.00

7.8

1.4

65.85

67.48

g/l

0.60

108

Persistent delusional disorders

247

2470

1.00

0.00

2.8

2.7

65.02

66.35

g/l

1.94

223

2274

Carcinoma in situ of breast, lobular

213

0.98

0.00

5.4

2.5

65.34

67.32

g/l

0.58

200

Benign neoplasm of other and unspecified female genital organs

133

1325

1.00

0.00

2.8

66.31

66.76

g/l

0.26

119

1207

Occupant of special vehicle mainly used on industrial premises injured in transport accident

125

1.04

0.00

2.6

3.3

69.42

67.57

g/l

0.17

116

Recurrent cholesteatoma of postmastoidectomy cavity

1.05

0.00

1.1

1.6

60.43

66.96

g/l

—

Pinta [carate]

0.00

0.0

1.0

—

65.05

—

Otorhinolaryngological devices associated with adverse incidents

0.00

0.0

3.3

—

68.82

—

Acute necrotizing ulcerative gingivitis

0.00

0.0

1.0

—

67.08

—

Relapsing panniculitis [Weber-Christian]

0.00

0.0

1.8

—

65.88

—

Monkeypox

0.00

-0.00

0.0

1.4

—

62.30

—

Hereditary factor IX deficiency

0.00

-0.00

0.0

1.1

—

67.17

—

Keratoderma in diseases classified elsewhere

0.00

-0.00

0.0

1.8

—

65.50

—

Hereditary factor XI deficiency

0.00

-0.00

0.0

1.2

—

68.13

—

Anthrax

0.00

-0.00

0.0

2.5

—

67.13

—

Benign neoplasm: Connective and other soft tissue of abdomen

0.97

-0.00

2.7

1.9

62.84

67.36

g/l

—

Accident to nonpowered aircraft causing injury to occupant

0.00

-0.00

0.0

1.1

—

69.31

—

Peutz-Jeghers syndrome

0.00

-0.00

0.0

1.0

—

70.09

—

Exposure to unspecified type of radiation

0.00

-0.00

0.0

1.0

—

67.94

—

Other sex chromosome abnormalities, female phenotype, not elsewhere classified

0.00

-0.00

0.0

1.4

—

70.35

—

Androgen resistance syndrome

0.00

-0.00

0.0

15.0

—

64.07

—

Granuloma inguinale

0.00

-0.00

0.0

10.8

—

65.57

—

Enophthalmos

0.00

-0.00

0.0

8.9

—

67.97

—

Other obstetric trauma

910

1.00

-0.00

1.8

2.3

67.09

67.95

g/l

0.41

862

Anthrax, including avohilmo

0.00

-0.00

0.0

2.3

—

68.54

—

Pedal cyclist injured in collision with train or tram

0.00

-0.00

0.0

1.0

—

65.06

—

Monkeypox, including avohilmo

0.00

-0.00

0.0

1.4

—

63.68

—

Granuloma inguinale, including avohilmo

0.00

-0.00

0.0

9.4

—

67.20

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Protein [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS